
<html lang="en"     class="pb-page"  data-request-id="dbf482b5-7fa1-4d9d-b4d1-c1ba94022a28"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;wgroup:string:ACHS website Group;issue:issue:10.1021/jmcmar.2021.64.issue-6;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text;article:article:10.1021/acs.jmedchem.0c02008"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="citation_journal_title" content="Journal of Medicinal Chemistry" /></meta><meta name="dc.Title" content="Discovery of GLPG1972/S201086, a Potent, Selective, and Orally Bioavailable ADAMTS-5 Inhibitor for the Treatment of Osteoarthritis" /></meta><meta name="dc.Creator" content="Franck  Brebion" /></meta><meta name="dc.Creator" content="Romain  Gosmini" /></meta><meta name="dc.Creator" content="Pierre  Deprez" /></meta><meta name="dc.Creator" content="Marie  Varin" /></meta><meta name="dc.Creator" content="Christophe  Peixoto" /></meta><meta name="dc.Creator" content="Luke  Alvey" /></meta><meta name="dc.Creator" content="Hélène  Jary" /></meta><meta name="dc.Creator" content="Natacha  Bienvenu" /></meta><meta name="dc.Creator" content="Nicolas  Triballeau" /></meta><meta name="dc.Creator" content="Roland  Blanque" /></meta><meta name="dc.Creator" content="Céline  Cottereaux" /></meta><meta name="dc.Creator" content="Thierry  Christophe" /></meta><meta name="dc.Creator" content="Nele  Vandervoort" /></meta><meta name="dc.Creator" content="Patrick  Mollat" /></meta><meta name="dc.Creator" content="Robert  Touitou" /></meta><meta name="dc.Creator" content="Philip  Leonard" /></meta><meta name="dc.Creator" content="Frédéric De  Ceuninck" /></meta><meta name="dc.Creator" content="Iuliana  Botez" /></meta><meta name="dc.Creator" content="Alain  Monjardet" /></meta><meta name="dc.Creator" content="Ellen  van der Aar" /></meta><meta name="dc.Creator" content="David  Amantini" /></meta><meta name="dc.Description" content="There are currently no approved disease-modifying osteoarthritis (OA) drugs (DMOADs). The aggrecanase ADAMTS-5 is key in the degradation of human aggrecan (AGC), a component of cartilage. Therefore..." /></meta><meta name="Description" content="There are currently no approved disease-modifying osteoarthritis (OA) drugs (DMOADs). The aggrecanase ADAMTS-5 is key in the degradation of human aggrecan (AGC), a component of cartilage. Therefore..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="March 15, 2021" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.0c02008" /></meta><meta name="dc.Language" content="en" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2021 The Authors. Published by American Chemical Society" /></meta><meta name="citation_fulltext_world_readable" content=""/></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.0c02008" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.0c02008" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.0c02008" /></link>
        
    
    

<title>Discovery of GLPG1972/S201086, a Potent, Selective, and Orally Bioavailable ADAMTS-5 Inhibitor for the Treatment of Osteoarthritis | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.0c02008" /></meta><meta property="og:title" content="Discovery of GLPG1972/S201086, a Potent, Selective, and Orally Bioavailable ADAMTS-5 Inhibitor for the Treatment of Osteoarthritis" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-6/acs.jmedchem.0c02008/20210429/images/large/jm0c02008_0021.jpeg" /></meta><meta property="og:description" content="There are currently no approved disease-modifying osteoarthritis (OA) drugs (DMOADs). The aggrecanase ADAMTS-5 is key in the degradation of human aggrecan (AGC), a component of cartilage. Therefore, ADAMTS-5 is a promising target for the identification of DMOADs. We describe the discovery of GLPG1972/S201086, a potent and selective ADAMTS-5 inhibitor obtained by optimization of a promising hydantoin series following an HTS. Biochemical activity against rat and human ADAMTS-5 was assessed via a fluorescence-based assay. ADAMTS-5 inhibitory activity was confirmed with human aggrecan using an AGC ELISA. The most promising compounds were selected based on reduction of glycosaminoglycan release after interleukin-1 stimulation in mouse cartilage explants and led to the discovery of GLPG1972/S201086. The anticatabolic activity was confirmed in mouse cartilage explants (IC50 &lt; 1.5 μM). The cocrystal structure of GLPG1972/S201086 with human recombinant ADAMTS-5 is discussed. GLPG1972/S201086 has been investigated in a phase 2 clinical study in patients with knee OA (NCT03595618)." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.0c02008"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.0c02008">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-14/achre4.2021.54.issue-14/20210720/achre4.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-29/aamick.2021.13.issue-29/20210728/aamick.2021.13.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-14/acncdm.2021.12.issue-14/20210721/acncdm.2021.12.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-7/amlcef.2021.3.issue-7/20210705/amlcef.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-29/acsodf.2021.6.issue-29/20210727/acsodf.2021.6.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-29/ascecg.2021.9.issue-29/20210726/ascecg.2021.9.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-29/ancham.2021.93.issue-29/20210727/ancham.2021.93.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-29/bichaw.2021.60.issue-29/20210727/bichaw.2021.60.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-27/cgeabj.2021.99.issue-27/20210726-01/cgeabj.2021.99.issue-27.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-7/cgdefu.2021.21.issue-7/20210707/cgdefu.2021.21.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-14/esthag.2021.55.issue-14/20210720/esthag.2021.55.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-29/iecred.2021.60.issue-29/20210728/iecred.2021.60.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-14/inocaj.2021.60.issue-14/20210719/inocaj.2021.60.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-29/jafcau.2021.69.issue-29/20210728/jafcau.2021.69.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-29/jacsat.2021.143.issue-29/20210728/jacsat.2021.143.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-7/jamsef.2021.32.issue-7/20210707/jamsef.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-29/langd5.2021.37.issue-29/20210727/langd5.2021.37.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-7/mpohbp.2021.18.issue-7/20210705/mpohbp.2021.18.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.0c02008&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.0c02008&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.0c02008&amp;href=/doi/10.1021/acs.jmedchem.0c02008" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2021</span><span class="cit-fg-volume">, 64</span><span class="cit-fg-issue">, 6</span><span class="cit-fg-pageRange">, 2937-2952</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/64/6" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.0c02120" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Drug Annotation</span><a href="/doi/10.1021/acs.jmedchem.1c00049" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Discovery of GLPG1972/S201086, a Potent, Selective, and Orally Bioavailable ADAMTS-5 Inhibitor for the Treatment of Osteoarthritis</span></h1><ul class="loa"><li><span><span class="hlFld-ContribAuthor">Franck Brebion</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Franck Brebion</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Galapagos SASU, 102 Avenue Gaston Roussel, 93230 Romainville, France</div></div><span class="conrtib-corresp"><strong>*</strong>E-mail: <a href="/cdn-cgi/l/email-protection#490f3b28272a22670b3b2c2b202627092e25392e672a2624"><span class="__cf_email__" data-cfemail="9adce8fbf4f9f1b4d8e8fff8f3f5f4dafdf6eafdb4f9f5f7">[email protected]</span></a>. Phone: +33 1 49 42 46 70.</span><span class="conrtib-corresp"></span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Franck++Brebion">Franck Brebion</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-5293-0408" title="Orcid link">http://orcid.org/0000-0002-5293-0408</a></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Romain Gosmini</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Romain Gosmini</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Galapagos SASU, 102 Avenue Gaston Roussel, 93230 Romainville, France</div></div><span class="conrtib-corresp"><strong>*</strong>E-mail: <a href="/cdn-cgi/l/email-protection#85d7eae8e4ecebabc2eaf6e8ecebecc5e2e9f5e2abe6eae8"><span class="__cf_email__" data-cfemail="6f3d00020e06014128001c020601062f08031f08410c0002">[email protected]</span></a>. Phone: +33 6 17 16 94 49.</span><span class="conrtib-corresp"></span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Romain++Gosmini">Romain Gosmini</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Pierre Deprez</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Pierre Deprez</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Galapagos SASU, 102 Avenue Gaston Roussel, 93230 Romainville, France</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Pierre++Deprez">Pierre Deprez</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Marie Varin</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Marie Varin</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Galapagos SASU, 102 Avenue Gaston Roussel, 93230 Romainville, France</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Marie++Varin">Marie Varin</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Christophe Peixoto</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Christophe Peixoto</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Galapagos SASU, 102 Avenue Gaston Roussel, 93230 Romainville, France</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Christophe++Peixoto">Christophe Peixoto</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Luke Alvey</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Luke Alvey</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Galapagos SASU, 102 Avenue Gaston Roussel, 93230 Romainville, France</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Luke++Alvey">Luke Alvey</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Hélène Jary</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Hélène Jary</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Galapagos SASU, 102 Avenue Gaston Roussel, 93230 Romainville, France</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=H%C3%A9l%C3%A8ne++Jary">Hélène Jary</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Natacha Bienvenu</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Natacha Bienvenu</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Galapagos SASU, 102 Avenue Gaston Roussel, 93230 Romainville, France</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Natacha++Bienvenu">Natacha Bienvenu</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Nicolas Triballeau</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Nicolas Triballeau</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Galapagos SASU, 102 Avenue Gaston Roussel, 93230 Romainville, France</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Nicolas++Triballeau">Nicolas Triballeau</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Roland Blanque</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Roland Blanque</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Galapagos SASU, 102 Avenue Gaston Roussel, 93230 Romainville, France</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Roland++Blanque">Roland Blanque</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Céline Cottereaux</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Céline Cottereaux</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Galapagos SASU, 102 Avenue Gaston Roussel, 93230 Romainville, France</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=C%C3%A9line++Cottereaux">Céline Cottereaux</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Thierry Christophe</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Thierry Christophe</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Galapagos NV, Generaal De Wittelaan L11 A3, 2800 Mechelen, Belgium</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Thierry++Christophe">Thierry Christophe</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Nele Vandervoort</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Nele Vandervoort</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Galapagos NV, Generaal De Wittelaan L11 A3, 2800 Mechelen, Belgium</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Nele++Vandervoort">Nele Vandervoort</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Patrick Mollat</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Patrick Mollat</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Galapagos SASU, 102 Avenue Gaston Roussel, 93230 Romainville, France</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Patrick++Mollat">Patrick Mollat</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Robert Touitou</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Robert Touitou</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Galapagos SASU, 102 Avenue Gaston Roussel, 93230 Romainville, France</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Robert++Touitou">Robert Touitou</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Philip Leonard</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Philip Leonard</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Structural Biology, Charles River, Chesterford Research Park, CB10 1XL Saffron Walden, United Kingdom</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Philip++Leonard">Philip Leonard</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Frédéric De Ceuninck</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Frédéric De Ceuninck</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Institut de Recherches Servier, Center for Therapeutic Innovation, Immuno-inflammatory Disease, 78290 Croissy sur Seine, France</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Fr%C3%A9d%C3%A9ric+De++Ceuninck">Frédéric De Ceuninck</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Iuliana Botez</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Iuliana Botez</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Institut de Recherches Servier, Chemistry Center of Excellence, 78290 Croissy sur Seine, France</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Iuliana++Botez">Iuliana Botez</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Alain Monjardet</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Alain Monjardet</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Galapagos SASU, 102 Avenue Gaston Roussel, 93230 Romainville, France</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Alain++Monjardet">Alain Monjardet</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Ellen van der Aar</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Ellen van der Aar</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Galapagos NV, Generaal De Wittelaan L11 A3, 2800 Mechelen, Belgium</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Ellen++van+der+Aar">Ellen van der Aar</a></span></div></div></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor">David Amantini</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">David Amantini</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Galapagos SASU, 102 Avenue Gaston Roussel, 93230 Romainville, France</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=David++Amantini">David Amantini</a></span></div></div></span></li><span class="comma-separator"></span></ul><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.0c02008&amp;href=/doi/10.1021%2Facs.jmedchem.0c02008" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2021</span></span><span class="cit-volume">, 64</span><span class="cit-issue">, 6</span><span class="cit-pageRange">, 2937–2952</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">March 15, 2021</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>19 November 2020</li><li><span class="item_label"><b>Published</b> online</span>15 March 2021</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 25 March 2021</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.0c02008" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c02008</a></div><div class="article_header-article-copyright"><strong>Copyright © 2021 The Authors. Published by American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/page/rightslinkno.jsp">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"><a href="https://acsopenscience.org/open-access/licensing-options/"><img src="/pb-assets/images/programsLogos/OA_Icons_Ac-1612971054130.svg" alt="ACS AuthorChoice" /></img><span>ACS AuthorChoice</span></a><span class="article_header-cc-by"><a href="https://creativecommons.org/licenses/by/4.0/"><img src="/pb-assets/images/licensesLogos/OA_Icons_cc-1612971093887.svg" alt="CC: Creative Commons" /></img><span><strong>CC: </strong>Creative Commons</span></a><a href="https://creativecommons.org/licenses/by/4.0/"><img src="/pb-assets/images/licensesLogos/OA_Icons_by-1612971093257.svg" alt="BY: Credit must be given to the creator" /></img><span><strong>BY: </strong>Credit must be given to the creator</span></a></span></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.0c02008"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">3604</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">2</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.0c02008" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Discovery of GLPG1972/S201086, a Potent, Selective, and Orally Bioavailable ADAMTS-5 Inhibitor for the Treatment of Osteoarthritis&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Franck&quot;,&quot;last_name&quot;:&quot;Brebion&quot;},{&quot;first_name&quot;:&quot;Romain&quot;,&quot;last_name&quot;:&quot;Gosmini&quot;},{&quot;first_name&quot;:&quot;Pierre&quot;,&quot;last_name&quot;:&quot;Deprez&quot;},{&quot;first_name&quot;:&quot;Marie&quot;,&quot;last_name&quot;:&quot;Varin&quot;},{&quot;first_name&quot;:&quot;Christophe&quot;,&quot;last_name&quot;:&quot;Peixoto&quot;},{&quot;first_name&quot;:&quot;Luke&quot;,&quot;last_name&quot;:&quot;Alvey&quot;},{&quot;first_name&quot;:&quot;Hélène&quot;,&quot;last_name&quot;:&quot;Jary&quot;},{&quot;first_name&quot;:&quot;Natacha&quot;,&quot;last_name&quot;:&quot;Bienvenu&quot;},{&quot;first_name&quot;:&quot;Nicolas&quot;,&quot;last_name&quot;:&quot;Triballeau&quot;},{&quot;first_name&quot;:&quot;Roland&quot;,&quot;last_name&quot;:&quot;Blanque&quot;},{&quot;first_name&quot;:&quot;Céline&quot;,&quot;last_name&quot;:&quot;Cottereaux&quot;},{&quot;first_name&quot;:&quot;Thierry&quot;,&quot;last_name&quot;:&quot;Christophe&quot;},{&quot;first_name&quot;:&quot;Nele&quot;,&quot;last_name&quot;:&quot;Vandervoort&quot;},{&quot;first_name&quot;:&quot;Patrick&quot;,&quot;last_name&quot;:&quot;Mollat&quot;},{&quot;first_name&quot;:&quot;Robert&quot;,&quot;last_name&quot;:&quot;Touitou&quot;},{&quot;first_name&quot;:&quot;Philip&quot;,&quot;last_name&quot;:&quot;Leonard&quot;},{&quot;first_name&quot;:&quot;Frédéric&quot;,&quot;last_name&quot;:&quot;De Ceuninck&quot;},{&quot;first_name&quot;:&quot;Iuliana&quot;,&quot;last_name&quot;:&quot;Botez&quot;},{&quot;first_name&quot;:&quot;Alain&quot;,&quot;last_name&quot;:&quot;Monjardet&quot;},{&quot;first_name&quot;:&quot;Ellen&quot;,&quot;last_name&quot;:&quot;van der Aar&quot;},{&quot;first_name&quot;:&quot;David&quot;,&quot;last_name&quot;:&quot;Amantini&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2021&quot;,&quot;month&quot;:&quot;03&quot;,&quot;day&quot;:&quot;15&quot;,&quot;issue&quot;:&quot;6&quot;,&quot;volume&quot;:&quot;64&quot;,&quot;pages&quot;:&quot;2937-2952&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.0c02008&quot;},&quot;abstract&quot;:&quot;There are currently no approved disease-modifying osteoarthritis (OA) drugs (DMOADs). The aggrecanase ADAMTS-5 is key in the degradation of human aggrecan (AGC), a component of cartilage. Therefore, ADAMTS-5 is a promising target for the identification of DMOADs. We describe the discovery of GLPG1972/S201086, a potent and selective ADAMTS-5 inhibitor obtained by optimization of a promising hydantoin series following an HTS. Biochemical activity against rat and human ADAMTS-5 was assessed via a fluorescence-based assay. ADAMTS-5 inhibitory activity was confirmed with human aggrecan using an AGC ELISA. The most promising compounds were selected based on reduction of glycosaminoglycan release after interleukin-1 stimulation in mouse cartilage explants and led to the discovery of GLPG1972/S201086. The anticatabolic activity was confirmed in mouse cartilage explants (IC50 &lt; 1.5 μM). The cocrystal structure of GLPG1972/S201086 with human recombinant ADAMTS-5 is discussed. GLPG1972/S201086 has been investigated in a&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.0c02008&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.0c02008" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.0c02008&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.0c02008" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.0c02008&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.0c02008" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.0c02008&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.0c02008&amp;href=/doi/10.1021/acs.jmedchem.0c02008" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.0c02008" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.0c02008" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (5 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c02008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.0c02008%26sid%3Dliteratum%253Aachs%26pmid%3D33719441%26genre%3Darticle%26aulast%3DBrebion%26date%3D2021%26atitle%3DDiscovery%2Bof%2BGLPG1972%252FS201086%252C%2Ba%2BPotent%252C%2BSelective%252C%2Band%2BOrally%2BBioavailable%2BADAMTS-5%2BInhibitor%2Bfor%2Bthe%2BTreatment%2Bof%2BOsteoarthritis%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D64%26issue%3D6%26spage%3D2937%26epage%3D2952%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (2)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=292524" title="Peptides and proteins">Peptides and proteins</a>,</li><li><a href="/action/doSearch?ConceptID=291350" title="Assays">Assays</a>,</li><li><a href="/action/doSearch?ConceptID=292464" title="Rodent models">Rodent models</a>,</li><li><a href="/action/doSearch?ConceptID=291793" title="Inhibition">Inhibition</a>,</li><li><a href="/action/doSearch?ConceptID=291711" title="Selectivity">Selectivity</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/64/6" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-6/jmcmar.2021.64.issue-6/20210325/jmcmar.2021.64.issue-6.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="_i1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-6/acs.jmedchem.0c02008/20210429/images/medium/jm0c02008_0021.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-6/acs.jmedchem.0c02008/20210429/images/large/jm0c02008_0021.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c02008&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">There are currently no approved disease-modifying osteoarthritis (OA) drugs (DMOADs). The aggrecanase ADAMTS-5 is key in the degradation of human aggrecan (AGC), a component of cartilage. Therefore, ADAMTS-5 is a promising target for the identification of DMOADs. We describe the discovery of GLPG1972/S201086, a potent and selective ADAMTS-5 inhibitor obtained by optimization of a promising hydantoin series following an HTS. Biochemical activity against rat and human ADAMTS-5 was assessed via a fluorescence-based assay. ADAMTS-5 inhibitory activity was confirmed with human aggrecan using an AGC ELISA. The most promising compounds were selected based on reduction of glycosaminoglycan release after interleukin-1 stimulation in mouse cartilage explants and led to the discovery of GLPG1972/S201086. The anticatabolic activity was confirmed in mouse cartilage explants (IC<sub>50</sub> < 1.5 μM). The cocrystal structure of GLPG1972/S201086 with human recombinant ADAMTS-5 is discussed. GLPG1972/S201086 has been investigated in a phase 2 clinical study in patients with knee OA (NCT03595618).</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div class="extra-info-sec articleNote"><h4><span></span> Note</h4><p class="last">This paper was initially published March 15, 2021, with an incorrect copyright line. The copyright was corrected and the paper reposted April 29, 2021.</p></div><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i3">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_81322" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_81322" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Human osteoarthritis (OA) is the most common form of arthritis and a major cause of disability worldwide.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> Current clinical management is inadequate and mainly focused on symptom relief using drugs often associated with side effects.<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a></div><div class="NLM_p">OA is a whole-organ disease characterized by the progressive degradation of cartilage and significant alterations in subchondral bone and synovium.<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a></div><div class="NLM_p">Aggrecan (AGC) is the major structural proteoglycan found in articular cartilage. In OA, increased aggrecanase activity is observed.<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a> Inhibition of pathological aggrecanolysis has therefore been proposed as a promising therapeutic approach to delay or even halt OA progression.</div><div class="NLM_p">A disintegrin and metalloproteinase with thrombospondin motifs (ADAMTS) subtype 5 (ADAMTS-5) is a member of a family of zinc-dependent endopeptidases with key functions in organ and tissue homeostasis.<a onclick="showRef(event, 'ref5 ref6'); return false;" href="javascript:void(0);" class="ref ref5 ref6">(5,6)</a> In mice, genetic deletion of ADAMTS-5 resulted in protection from cartilage degeneration, reduction of subchondral bone thickening, and attenuation of OA-induced mechanical allodynia.<a onclick="showRef(event, 'ref7 ref8 ref9 ref10'); return false;" href="javascript:void(0);" class="ref ref7 ref8 ref9 ref10">(7−10)</a> ADAMTS-5 gene polymorphisms have been associated with human OA susceptibility,<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a> while in human OA cartilage explants, silencing of ADAMTS-5 by siRNA led to reduced aggrecan loss.<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> Based on this evidence, ADAMTS-5 is a promising molecular target for the discovery of disease-modifying OA drugs (DMOADs), agents that have so far failed to achieve regulatory approval.</div><div class="NLM_p">To our knowledge, despite several drug development programs, only one ADAMTS-5 small molecule inhibitor has entered clinical development for the treatment of OA, AGG-523, a dual ADAMTS-5/4 inhibitor developed by Wyeth/Pfizer (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>).<a onclick="showRef(event, 'ref13 ref14 ref15 ref16 ref17 ref18 ref19 ref20'); return false;" href="javascript:void(0);" class="ref ref13 ref14 ref15 ref16 ref17 ref18 ref19 ref20">(13−20)</a> Several pharmaceutical companies have opted to develop monoclonal antibodies that neutralize ADAMTS-5,<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> demonstrating the challenge to develop small molecules targeting this enzyme.</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Activity, Selectivity, and Binding Mode of Advanced ADAMTS-5 Inhibitors Developed for Oral Treatment</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-6/acs.jmedchem.0c02008/20210429/images/medium/jm0c02008_0007.gif" alt="" id="gr7" /></img><div></div></div><div class="NLM_p">Nonselective inhibition of matrix metalloproteinases (MMPs) results in musculoskeletal syndrome,<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> indicating that selectivity over other MMPs and A disintegrin and metalloproteinases (ADAMs) is an essential requirement for the development of a well-tolerated ADAMTS-5 inhibitor for OA.<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a> Owing to the nature of classical zinc binding groups (carboxylic acid, hydroxamic acids, and reverse hydroxamate) and the high lipophilicity featured by most of the inhibitors of this target class, identifying candidates with moderate plasma protein binding and good oral PK properties has been challenging.<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a></div><div class="NLM_p last">Here, we report the discovery, SAR, ADME, PK, and selectivity profile data for GLPG1972/S201086, a novel, potent, selective, orally available ADAMTS-5 inhibitor that has been investigated in a phase 2 clinical trial (NCT03595618) in patients with knee OA. GLPG1972/S201086, further referred to as GLPG1972, was codeveloped by Galapagos and Servier.</div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i5">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_37055" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_37055" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i6" class="anchor-spacer"></div><h3 class="article-section__title" id="_i6"> Hit Identification</h3><div class="NLM_p">An HTS campaign was prepared for approximately 50 000 compounds. With the goal to enrich this screening library with metalloproteinase-like inhibitors, a ligand-based virtual screening workflow was implemented. Its core component comprised 2 elements. The first was a structural filter aiming at selecting compounds with zinc binding group (ZBG) moieties (carboxylic acid, hydroxamic acid, hydantoin, trifluoromethyl-ketone, sulfonamide, etc.). The second was a two-class categorization model (Naı̈ve Bayes classifier) built with PipelinePilot (Dassault Systems BIOVIA, version 8.0, San Diego, CA) using extended-connectivity fingerprints (ECFP6),<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> as descriptors for 212 metalloproteinase inhibitors (IC<sub>50</sub> < 1 μM) extracted from PubChem (“active”) and 6891 inactive compounds of similar molecular weights (“inactive”). The area under the receiver operating characteristic (ROC) curve of this model was 0.95, characterizing an excellent discriminatory power (0.5 for random, 1 ideally).<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> For instance, by setting a selecting cutoff at 4.26, a good split between active (194 true positives and 18 false negatives) and inactive (640 false positives and 6251 true negatives) compounds was obtained.</div><div class="NLM_p">The HTS campaign was based on inhibition of ADAMTS-5 protease activity using a fluorescent-based assay and was initially conducted using the matured form of rat recombinant ADAMTS-5 (rn-ADAMTS-5; AA 262–564). Hits were confirmed by dose–response curves using human recombinant ADAMTS-5 (hs-ADAMTS-5; AA 262–567).</div><div class="NLM_p">Following the HTS campaign, a hydantoin series originating from the statistical model was identified, and its activity was confirmed after resynthesis. While NH hydantoins had been reported as ZBGs,<a onclick="showRef(event, 'ref26 ref27'); return false;" href="javascript:void(0);" class="ref ref26 ref27">(26,27)</a> they have been less explored than carboxylic and hydroxamic acids as metalloproteinases inhibitors. Interestingly, during the course of our investigations, Eli Lilly also reported a hydantoin ADAMTS-5 inhibitor.<a onclick="showRef(event, 'ref16 ref20'); return false;" href="javascript:void(0);" class="ref ref16 ref20">(16,20)</a></div><div class="NLM_p">Our series displayed a similar potency against rn- and hs-ADAMTS-5 (<a href="/doi/suppl/10.1021/acs.jmedchem.0c02008/suppl_file/jm0c02008_si_001.pdf" class="ext-link">Figure S1</a>). The properties of compound <b>1</b>, selected as the hit compound from the hydantoin series, are summarized in <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>. Compound <b>1</b> had a very attractive overall profile, displaying promising ADME properties, low PPB, druglike physicochemical properties, and multiple vectors for potency and selectivity optimization. The hit was assessed in a panel of MMPs and did not show counter-selectivity (<a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>).</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. Compound <b>1</b> Overall Profile</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-6/acs.jmedchem.0c02008/20210429/images/medium/jm0c02008_0008.gif" alt="" id="GRAPHIC-d7e536-autogenerated" /></img><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col></colgroup><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">hs-/rn-ADAMTS-5, IC<sub>50</sub>, nM</td><td class="colsep0 rowsep0" align="left">1530/1167</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">hs-ADAMTS-4, IC<sub>50</sub>, nM</td><td class="colsep0 rowsep0" align="left">715</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">ADAMTS-1, IC<sub>50</sub>, nM</td><td class="colsep0 rowsep0" align="left">>20 000</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">MMP-2, IC<sub>50</sub>, nM</td><td class="colsep0 rowsep0" align="left">5037</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">MMP-14, IC<sub>50</sub>, nM</td><td class="colsep0 rowsep0" align="left">>20 000</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">TACE, IC<sub>50</sub>, nM</td><td class="colsep0 rowsep0" align="left">>10 000</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">scaled Cl<sub>int</sub>, mic (L/(h kg)), human/rat</td><td class="colsep0 rowsep0" align="left"><0.88/1.07</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">CYP450 inhibition (CYP1A2, 2C19, 2C9, 2D6, 3A4_BFC, 3A4_DBF) (% inhibition at 10 μM)</td><td class="colsep0 rowsep0" align="left">no inhibition</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">rat PPB, % bound</td><td class="colsep0 rowsep0" align="left">30</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">MDCK-Papp (A2B)/efflux ratio</td><td class="colsep0 rowsep0" align="left">1.85/5.2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">toxicity—PBMC/HEK (LD<sub>50</sub>), μM</td><td class="colsep0 rowsep0" align="left">>18.2/>18.2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">hERG inhibition (% inhibition at 10 μM)</td><td class="colsep0 rowsep0" align="left">no inhibition</td></tr></tbody></table></div></div></div><div id="sec2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i8" class="anchor-spacer"></div><h3 class="article-section__title" id="_i8"> Hypothesized Binding Mode of Compound <b>1</b></h3><div class="NLM_p">Since compound <b>1</b> was evaluated as a racemic mixture, one of the earliest questions to be addressed was whether the stereochemistry of the chiral carbon had an impact on the on-target potency and what would be the absolute configuration of the active stereoisomer. Based on the high-resolution X-ray structures of ADAMTS-5 published earlier by Pfizer<a onclick="showRef(event, 'ref28 ref29'); return false;" href="javascript:void(0);" class="ref ref28 ref29">(28,29)</a> and Wyeth,<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> docking studies could provide a clear answer. Metalloproteinases, including MMPs, ADAMs, and ADAMTSs, exhibit a homologous fold and a characteristic active site with three histidines (numbered 410, 414, and 420 in human ADAMTS-5) coordinating a zinc ion. Assisted by a conserved glutamic acid residue (Glu<sup>411</sup> in this case), this zinc ion polarizes and activates a water molecule enabling its reaction with a peptide bond of the substrate (proteoglycans in this case). The substrate itself is bound in an extended conformation as if it prolonged a beta-sheet of the catalytic domain by one additional beta strand. Specificity is provided by several pockets occupied by the side chains of substrate residues. By convention, protease pockets are numbered S<sub>1</sub>, S<sub>2</sub>, and S<sub>3</sub> from the cleaved bond to the N-terminal residue and S′<sub>1</sub>, S′<sub>2</sub>, and S′<sub>3</sub> from the cleaved bond to the C-terminal. The S′<sub>1</sub> pocket of metalloproteinases in particular is typically well-defined and relatively hydrophobic and varies significantly between members of the superfamily, which explains why it is often targeted to improve both potency and selectivity.<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> In order to dock compound <b>1</b> to an X-ray structure of ADAMTS-5 (PDB ID <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3B8Z">3B8Z</a>), two constraints were used: first, the hydantoin moiety should bind in a similar way to an ADAM17 (aka TACE) inhibitor published earlier (PDB ID <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3L0%2520V">3L0 V</a>),<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> adopting a tautomer form that allows hydrogen bonding with Glu<sup>411</sup> and coordination of the zinc by the N-acyl amide nitrogen. An additional hydrogen bond between the remaining hydantoin NH and Gly<sup>380</sup> locks the hydantoin ring in a well-defined orientation. The second constraint imposed that the carbonyl of the piperazine-amide acts as a hydrogen bond acceptor orienting the phenyl-piperazine group in the S′<sub>1</sub> pocket described above. Upon docking (Dassault Systems BIOVIA, Discovery Studio Modeling Environment, Release 3.1, San Diego: Dassault Systems, 2011), only the <i>R</i> configuration could meet both geometrical requirements as shown in <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>. Indeed, if the first condition is met for the <i>S</i> enantiomer, it is impossible to also meet the second condition since the hydantoin substitution would point 180° away from the direction of the S′<sub>1</sub> pocket.</div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-6/acs.jmedchem.0c02008/20210429/images/medium/jm0c02008_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-6/acs.jmedchem.0c02008/20210429/images/large/jm0c02008_0001.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Docking of compound <b>1</b> in PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3B8Z">3B8Z</a> (ADAMTS-5). The carbon atoms of the binding site and the local backbone structure of ADAMTS-5 are depicted in dark green. Compound <b>1</b> is shown in sticks with light green carbons. The zinc of the catalytic site is magenta. Protein–ligand interactions are presented with dashed lines (hydrogen bond in green, metal interaction in gray, and hydrophobic contacts in pink). The surface is colored by hydrophobicity of the residue (from brown for hydrophobic to blue for hydrophilic).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-6/acs.jmedchem.0c02008/20210429/images/large/jm0c02008_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c02008&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i9" class="anchor-spacer"></div><h3 class="article-section__title" id="_i9"> SAR Optimization</h3><div id="sec2_3_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i10" class="anchor-spacer"></div><h4 class="article-section__title" id="_i10"> Phenyl Substitution</h4><div class="NLM_p">Based on the docking studies, the S′<sub>1</sub> pocket was occupied by the aryl-piperazine moiety. Given that only limited space appeared to be available in the vicinity of the piperazine group, we first explored phenyl substitution and replacement (<a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a></a>). Our SAR optimization indicated that halogen atoms and small groups were preferred in the para position, with CF<sub>3</sub> being tolerated, but not OMe (compounds <b>2</b>–<b>6</b>). A broad range of substituents (halogen atoms, OMe, large Ph groups, etc.) were tolerated in the meta position (compounds <b>7</b>–<b>10</b>), whereas ortho substitution tended to reduce the potency (compounds <b>11</b> and <b>12</b>). Furthermore, phenyl replacement by cycloalkyl or heteroaryl groups was associated with a decrease in potency, except for the 3-pyridine (compounds <b>13</b>–<b>16</b>). Fluoro and chloro substituents in meta and para positions resulted in the best potency, and disubstitution afforded an increased potency of one log unit (compounds <b>17</b> and <b>18</b>).</div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. SAR of the Phenyl Substitution and Replacement</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-6/acs.jmedchem.0c02008/20210429/images/medium/jm0c02008_0009.gif" alt="" id="GRAPHIC-d7e819-autogenerated" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-6/acs.jmedchem.0c02008/20210429/images/medium/jm0c02008_0010.gif" alt="" id="gr8" /></img><div></div></div></div><div id="sec2_3_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i12" class="anchor-spacer"></div><h4 class="article-section__title" id="_i12"> Hydantoin C5-Substitution</h4><div class="NLM_p">Analogues with methyl and phenyl groups resulted in a significant improvement in potency, which prompted further investigations (<a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a></a>). Aryl and alkyl groups were well tolerated in that position, with aryl and heteroaryl groups being among the most potent substituents, as illustrated by compounds <b>23</b> and <b>24</b>. Generally, alkyl substituents decreased potency, with the exception of the c-Pr group (compound <b>21</b>), which was as potent as the aryl groups and provided better ligand efficiency (LE) and ligand-lipophilicity efficiency (LLE). It is worth mentioning that, across the series, a slightly superior oral exposure in rat was observed for c-Pr analogues compared to their phenyl and pyridine counterparts as illustrated with compounds <b>21</b>, <b>23</b>, and <b>24</b> (<a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a></a>).</div><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. Hydantoin C5-Substitution SAR</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-6/acs.jmedchem.0c02008/20210429/images/medium/jm0c02008_0011.gif" alt="" id="GRAPHIC-d7e859-autogenerated" /></img><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center" char="."> </th><th class="colsep0 rowsep0" align="center" char="."> </th><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="2" align="center" char=".">oral rat PK<a class="ref internalNav" href="#t4fn2" aria-label="b">b</a>, 5 mg/kg</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">R (compound)</th><th class="colsep0 rowsep0" align="center" char=".">hs-ADAMTS-5, IC<sub>50</sub>, nM</th><th class="colsep0 rowsep0" align="center" char=".">XlogP3<a class="ref internalNav" href="#t4fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center">LE/LLE</th><th class="colsep0 rowsep0" align="center" char=".">AUC (ng h/mL)</th><th class="colsep0 rowsep0" align="center" char="."><i>C</i><sub>max</sub> (ng/mL)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">H (<b>8</b>)</td><td class="colsep0 rowsep0" align="char" char=".">667</td><td class="colsep0 rowsep0" align="char" char=".">1.00</td><td class="colsep0 rowsep0" align="left">0.36/5.18</td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char="."> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Me (<b>19</b>)</td><td class="colsep0 rowsep0" align="char" char=".">287</td><td class="colsep0 rowsep0" align="char" char=".">1.19</td><td class="colsep0 rowsep0" align="left">0.37/5.35</td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char="."> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">i-Pr (<b>20</b>)</td><td class="colsep0 rowsep0" align="char" char=".">123</td><td class="colsep0 rowsep0" align="char" char=".">2.15</td><td class="colsep0 rowsep0" align="left">0.36/4.76</td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char="."> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">c-Pr (<b>21</b>)</td><td class="colsep0 rowsep0" align="char" char=".">41</td><td class="colsep0 rowsep0" align="char" char=".">1.57</td><td class="colsep0 rowsep0" align="left">0.38/5.82</td><td class="colsep0 rowsep0" align="char" char=".">1944</td><td class="colsep0 rowsep0" align="char" char=".">1555</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">c-butyl (<b>22</b>)</td><td class="colsep0 rowsep0" align="char" char=".">247</td><td class="colsep0 rowsep0" align="char" char=".">2.11</td><td class="colsep0 rowsep0" align="left">0.33/4.50</td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char="."> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Ph (<b>23</b>)</td><td class="colsep0 rowsep0" align="char" char=".">71</td><td class="colsep0 rowsep0" align="char" char=".">2.48</td><td class="colsep0 rowsep0" align="left">0.33/4.65</td><td class="colsep0 rowsep0" align="char" char=".">1384</td><td class="colsep0 rowsep0" align="char" char=".">306</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">3-pyridine (<b>24</b>)</td><td class="colsep0 rowsep0" align="char" char=".">32</td><td class="colsep0 rowsep0" align="char" char=".">1.41</td><td class="colsep0 rowsep0" align="left">0.35/6.08</td><td class="colsep0 rowsep0" align="char" char=".">335</td><td class="colsep0 rowsep0" align="char" char=".">141</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t4fn1"><div class="footnote" id="t4fn1"><sup><sup>a</sup></sup><p class="last">XlogP3<a onclick="showRef(event, 'ref36'); return false;" href="javascript:void(0);" class="ref ref36">(36)</a> Version 3.2.0, State Key lab of Bioorganic Chemistry, Shanghai Institute of Organic Chemistry, China.</p></div><div class="footnote" id="t4fn2"><sup><sup>b</sup></sup><p class="last">For each compound, 3 male Sprague Dawley rats were used to generate the PK data.</p></div></div></div></div><div id="sec2_3_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i14" class="anchor-spacer"></div><h4 class="article-section__title" id="_i14"> Configuration of the C5-Hydantoin Center</h4><div class="NLM_p">Both enantiomers of compound <b>25</b> were obtained via chiral separation, and only one enantiomer (<i>S</i>) displayed activity against ADAMTS-5 (<a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a></a>). This was in accordance with the docking studies, and the absolute configuration of the active enantiomer for the series was established at a later stage by cocrystallization of GLPG1972 in ADAMTS-5 (see <a class="ref internalNav" href="#sec2_10" aria-label="Cocrystallization of ADAMTS-5 with GLPG1972">Cocrystallization of ADAMTS-5 with GLPG1972</a>).</div><div class="NLM_table-wrap" id="tbl5"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 5. Racemic versus Enantiomerically Enriched Compounds</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-6/acs.jmedchem.0c02008/20210429/images/medium/jm0c02008_0012.gif" alt="" id="GRAPHIC-d7e1121-autogenerated" /></img><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compound</th><th class="colsep0 rowsep0" align="center">enantiomeric ratio <i>S</i>/<i>R</i></th><th class="colsep0 rowsep0" align="center" char=".">hs-ADAMTS-5, IC<sub>50</sub>, nM</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>25</b></td><td class="colsep0 rowsep0" align="left">50/50</td><td class="colsep0 rowsep0" align="char" char=".">251</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">(<i>S</i>)-<b>25</b></td><td class="colsep0 rowsep0" align="left">99.3/0.7</td><td class="colsep0 rowsep0" align="char" char=".">84</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">(<i>R</i>)-<b>25</b></td><td class="colsep0 rowsep0" align="left">1.4/98.6</td><td class="colsep0 rowsep0" align="char" char=".">>4000</td></tr></tbody></table></div></div></div><div id="sec2_3_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i16" class="anchor-spacer"></div><h4 class="article-section__title" id="_i16"> Investigation of the Linker between the Hydantoin and Piperazine Moieties</h4><div class="NLM_p">As anticipated, increasing or decreasing the length of the linker reduced potency (compounds <b>26</b> and <b>27</b>), as did removing the carbonyl group (compound <b>56</b>) (<a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">Table <a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">6</a></a> and <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">2</a></a>). Substitution of the linker was investigated during the late lead optimization phase and will be presented later in the paper.</div><figure id="fig3" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-6/acs.jmedchem.0c02008/20210429/images/medium/jm0c02008_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-6/acs.jmedchem.0c02008/20210429/images/large/jm0c02008_0003.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Importance of the carbonyl group.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-6/acs.jmedchem.0c02008/20210429/images/large/jm0c02008_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c02008&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_table-wrap" id="tbl6"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 6. Linker Investigation</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-6/acs.jmedchem.0c02008/20210429/images/medium/jm0c02008_0013.gif" alt="" id="GRAPHIC-d7e1231-autogenerated" /></img><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compound</th><th class="colsep0 rowsep0" align="center" char="."><i>n</i></th><th class="colsep0 rowsep0" align="center" char=".">hs-ADAMTS-5, IC<sub>50</sub>, nM</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>26</b></td><td class="colsep0 rowsep0" align="char" char=".">0</td><td class="colsep0 rowsep0" align="char" char=".">>20 000</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>1</b></td><td class="colsep0 rowsep0" align="char" char=".">1</td><td class="colsep0 rowsep0" align="char" char=".">1530</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>27</b></td><td class="colsep0 rowsep0" align="char" char=".">2</td><td class="colsep0 rowsep0" align="char" char=".">>20 000</td></tr></tbody></table></div></div></div></div><div id="sec2_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i18" class="anchor-spacer"></div><h3 class="article-section__title" id="_i18"> Human AGC Neoepitope ELISA</h3><div class="NLM_p">To further evaluate the potency of the series, key compounds were tested in an ELISA assay which evaluates the cleavage of full-length AGC. The ELISA assay more accurately captures the activity of inhibitors on the target as it involves the full-length human ADAMTS-5 protein (vs truncated form for the fluorescent-based assay) and AGC, an endogenous substrate of ADAMTS-5.</div><div class="NLM_p">The activity of the hydantoin series in the human AGC neoepitope ELISA was confirmed and found to be comparable to the activity measured in our fluorescent-based assay. Thus, for compound <b>28</b>, an IC<sub>50</sub> of 29 nM was measured in the AGC ELISA assays. When the assay was performed in the presence of human serum, a limited decrease in activity was observed, which nicely reflects the moderate PPB of representative compounds <b>19</b>, <b>21</b>, and <b>28</b> (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">3</a></a> and <a class="ref showTableEvent internalNav" data-ID="tbl7" href="#tbl7">Table <a class="ref showTableEvent internalNav" data-ID="tbl7" href="#tbl7">7</a></a>).</div><figure id="fig4" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-6/acs.jmedchem.0c02008/20210429/images/medium/jm0c02008_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-6/acs.jmedchem.0c02008/20210429/images/large/jm0c02008_0004.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Dose–response curve in the human AGC neoepitope ELISA for compound <b>21</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-6/acs.jmedchem.0c02008/20210429/images/large/jm0c02008_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c02008&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_table-wrap" id="tbl7"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 7. Human AGC ELISA with and without Serum</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-6/acs.jmedchem.0c02008/20210429/images/medium/jm0c02008_0014.gif" alt="" id="gr9" /></img><div></div></div></div><div id="sec2_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i20" class="anchor-spacer"></div><h3 class="article-section__title" id="_i20"> Selectivity versus Other Proteases</h3><div class="NLM_p"><b>[<i>R</i>]-18</b> and <b>29</b>, two analogues with different substitutions on the C5 hydantoin and in the aryl region, were evaluated against a broad panel of proteases in a biochemical assay: ADAMTS-1, and −4; tumor necrosis factor-α-converting enzyme (TACE); and MMP-1, −2, −7, −9, −13, and −14. These proteases were selected to cover closely related, as well as various families of proteases (<a class="ref showTableEvent internalNav" data-ID="tbl8" href="#tbl8">Table <a class="ref showTableEvent internalNav" data-ID="tbl8" href="#tbl8">8</a></a>).</div><div class="NLM_table-wrap" id="tbl8"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 8. Activity of Two Representative Compounds across a Panel of Proteases</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-6/acs.jmedchem.0c02008/20210429/images/medium/jm0c02008_0015.gif" alt="" id="GRAPHIC-d7e1359-autogenerated" /></img><div></div></div><div class="NLM_p">The selectivity of these two compounds was moderate against ADAMTS-4 (2–12 fold) but excellent across the rest of the panel of proteases assessed. The selectivity ratio, defined as IC<sub>50</sub> against protease X divided by IC<sub>50</sub> against ADAMTS-5, for compound <b>29</b> was at least 12 against ADAMTS-4 and at least 19 against the other proteases tested. In addition, a larger set of compounds was assessed against ADAMTS-1, TACE, and MMP-2 (data not shown). Some of the compounds displayed moderate selectivity ratios (<10) against TACE and MMP-2. To optimize the selectivity, substitution and replacement of the piperazine moiety were explored because it occupies the entry of the S′<sub>1</sub> pocket, a region known to drive both potency and selectivity within the metalloproteinase family.<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> Of all the modifications investigated, only the replacement of the piperazine with an (<i>S</i>)-methyl-piperazine (compounds <b>37</b> and <b>39</b>) maintained potency, with the (<i>R</i>)-methyl enantiomer (compound <b>38</b>) being 5-fold less potent. Replacement of the piperazine with a piperidine (compounds <b>28</b> vs <b>40</b>) led to a slight decrease in potency (4-fold) against ADAMTS-5 (<a class="ref showTableEvent internalNav" data-ID="tbl9" href="#tbl9">Table <a class="ref showTableEvent internalNav" data-ID="tbl9" href="#tbl9">9</a></a>).</div><div class="NLM_table-wrap" id="tbl9"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 9. Substitution and Replacement of the Piperazine</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-6/acs.jmedchem.0c02008/20210429/images/medium/jm0c02008_0016.gif" alt="" id="GRAPHIC-d7e1409-autogenerated" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-6/acs.jmedchem.0c02008/20210429/images/medium/jm0c02008_0017.gif" alt="" id="gr10" /></img><div></div></div><div class="NLM_p">The selectivity of (<i>S</i>)-methyl-piperazine analogues was evaluated against ADAMTS-1, ADAMTS-4, MMP-2, and TACE using a biochemical assay and compared with their piperazine match pairs (<a class="ref showTableEvent internalNav" data-ID="tbl10" href="#tbl10">Table <a class="ref showTableEvent internalNav" data-ID="tbl10" href="#tbl10">10</a></a>). The introduction of the (<i>S</i>)-methyl group on the piperazine moiety further improved the selectivity profile over TACE (compound <b>44</b> vs <b>45</b>), ADAMTS-4, and MMP-2 (compound <b>21</b> vs <b>46</b>). It is worth mentioning that most of the (<i>S</i>)-methyl-piperazine analogues were selective against TACE and MMP2 (>10 fold) and moderately selective against ADAMTS-4 (5 fold).</div><div class="NLM_table-wrap" id="tbl10"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 10. Influence of the (<i>S</i>)-Methyl-piperazine Substitution on the Selectivity</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-6/acs.jmedchem.0c02008/20210429/images/medium/jm0c02008_0018.gif" alt="" id="gr11" /></img><div></div></div></div><div id="sec2_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i24" class="anchor-spacer"></div><h3 class="article-section__title" id="_i24"> Further Potency Optimization</h3><div class="NLM_p">One of the most effective ways to improve potency is to reduce the strain energy coming from the difference between the energy of unbound low-energy conformations and that of the bioactive conformation. With three consecutive carbon–carbon torsions, the linker between the hydantoin ring and the piperazine-amide offers a good opportunity to probe, control, and eventually reduce this strain. Consequently, substitutions on the linker were extensively explored, initially by adding small substituents to each carbon of the ethylene linker and evaluating the resulting diastereomers. In addition, substituents on the linker were connected with the C5-hydantoin carbon to generate the spiro analogues. From this endeavor, only substituents in the α position to the carbonyl group improved potency, and only one of the four possible diastereomers was active. Although the introduction of small substituents had a favorable impact on potency, it was in general accompanied by a decreased metabolic stability in rat liver microsomes, or reduced selectivity (<a class="ref showTableEvent internalNav" data-ID="tbl11" href="#tbl11">Table <a class="ref showTableEvent internalNav" data-ID="tbl11" href="#tbl11">11</a></a>). However, derivatives with alkoxy methyl substituents in the α position of the amide group displayed improved <i>in vitro</i> metabolic stability but showed unsatisfactory oral systemic exposures in rat.</div><div class="NLM_table-wrap" id="tbl11"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 11. Effect of Linker Substitution on Potency, Selectivity, and Metabolic Stability</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-6/acs.jmedchem.0c02008/20210429/images/medium/jm0c02008_0019.gif" alt="" id="GRAPHIC-d7e1467-autogenerated" /></img><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" char="." /></col><col align="left" char="." /></col><col align="left" char="." /></col><col align="left" char="." /></col><col align="left" char="." /></col><col align="left" char="." /></col><col align="left" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"><i>R</i> (compound)</th><th class="colsep0 rowsep0" align="center" char=".">hs-ADAMTS-5, IC<sub>50</sub>, nM</th><th class="colsep0 rowsep0" align="center" char=".">ADAMTS-4, IC<sub>50</sub>, nM</th><th class="colsep0 rowsep0" align="center" char=".">ADAMTS-1, IC<sub>50</sub>, nM</th><th class="colsep0 rowsep0" align="center" char=".">MMP-2, IC<sub>50</sub>, nM</th><th class="colsep0 rowsep0" align="center" char=".">TACE, IC<sub>50</sub>, nM</th><th class="colsep0 rowsep0" align="center" char=".">scaled Cl<sub>int</sub>, mic (L/(h kg)) rat</th><th class="colsep0 rowsep0" align="center" char=".">scaled Cl<sub>int</sub>, hep (L/(h kg)) rat</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">H (<b>49</b>)</td><td class="colsep0 rowsep0" align="left" char=".">164</td><td class="colsep0 rowsep0" align="left" char=".">478</td><td class="colsep0 rowsep0" align="left" char=".">>20 000</td><td class="colsep0 rowsep0" align="left" char=".">>4000</td><td class="colsep0 rowsep0" align="left" char=".">2709</td><td class="colsep0 rowsep0" align="left" char=".">2.64</td><td class="colsep0 rowsep0" align="left" char=".">ND</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Me (<b>50</b>)</td><td class="colsep0 rowsep0" align="left" char=".">22</td><td class="colsep0 rowsep0" align="left" char=".">15</td><td class="colsep0 rowsep0" align="left" char=".">>4000</td><td class="colsep0 rowsep0" align="left" char=".">>4000</td><td class="colsep0 rowsep0" align="left" char=".">170</td><td class="colsep0 rowsep0" align="left" char=".">12.4</td><td class="colsep0 rowsep0" align="left" char=".">5.56</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">i-Pr (<b>51</b>)</td><td class="colsep0 rowsep0" align="left" char=".">55</td><td class="colsep0 rowsep0" align="left" char=".">54</td><td class="colsep0 rowsep0" align="left" char=".">3247</td><td class="colsep0 rowsep0" align="left" char=".">3382</td><td class="colsep0 rowsep0" align="left" char=".">1275</td><td class="colsep0 rowsep0" align="left" char=".">21.2</td><td class="colsep0 rowsep0" align="left" char=".">16.2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">CH<sub>2</sub>OH (<b>52</b>)</td><td class="colsep0 rowsep0" align="left" char=".">18</td><td class="colsep0 rowsep0" align="left" char=".">30</td><td class="colsep0 rowsep0" align="left" char=".">>4000</td><td class="colsep0 rowsep0" align="left" char=".">2796</td><td class="colsep0 rowsep0" align="left" char=".">242</td><td class="colsep0 rowsep0" align="left" char=".">2.09</td><td class="colsep0 rowsep0" align="left" char="."><1.95</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">CH<sub>2</sub>OMe (<b>53</b>)</td><td class="colsep0 rowsep0" align="left" char=".">22</td><td class="colsep0 rowsep0" align="left" char=".">12</td><td class="colsep0 rowsep0" align="left" char=".">>4000</td><td class="colsep0 rowsep0" align="left" char=".">>4000</td><td class="colsep0 rowsep0" align="left" char=".">368</td><td class="colsep0 rowsep0" align="left" char=".">9.84</td><td class="colsep0 rowsep0" align="left" char=".">3.47</td></tr></tbody></table></div></div></div><div id="sec2_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i26" class="anchor-spacer"></div><h3 class="article-section__title" id="_i26"> Mouse Femoral Head Cartilage Explant Assay</h3><div class="NLM_p">Following evaluation of the various SAR combinations, the compounds with the highest potency and selectivity were assessed in mouse cartilage explants. Mouse femoral head cartilage was cultured as described by Stanton et al.<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> Femoral head cartilage was collected from C57BL/6 mice at 3 weeks of age (2 hips/animal). Hip cartilages (2 hips/well) were then stimulated with or without human IL-1α media in combination with different concentrations of the tested compounds. After 3 days of incubation, the GAG concentration was measured in the supernatant.</div><div class="NLM_p">There was a good correlation between inhibition of ADAMTS-5 activity in hs-ADAMTS-5 preparations and the mouse cartilage explant assays, although a 100-fold shift was observed (<a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">4</a></a>), most likely reflecting easier access of the compound to its soluble target in a biochemical assay than in a 3D matrix environment. An IC<sub>50</sub> below 50 nM against hs-ADAMTS-5 equated to an inhibition of over 50% at 10 μM in the mouse cartilage explant assay. These data also suggested that an IC<sub>50</sub> below 10–20 nM was required to achieve low μM activity in the mouse cartilage explant assay. ADMET and rat PK profiles were established for the most active and selective compounds, including GLPG1972 (<a class="ref showTableEvent internalNav" data-ID="tbl12" href="#tbl12">Table <a class="ref showTableEvent internalNav" data-ID="tbl12" href="#tbl12">12</a></a>).</div><figure id="fig5" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-6/acs.jmedchem.0c02008/20210429/images/medium/jm0c02008_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-6/acs.jmedchem.0c02008/20210429/images/large/jm0c02008_0005.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Correlation between inhibition of hs-ADAMTS-5 (IC<sub>50</sub>) and reduction of GAG production in mouse cartilage explants by compounds tested at (a) 10 μM and (b) 1 μM.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-6/acs.jmedchem.0c02008/20210429/images/large/jm0c02008_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c02008&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_table-wrap" id="tbl12"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 12. Potency, Selectivity, PK, and ADME Profiles of the Most Promising Compounds</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-6/acs.jmedchem.0c02008/20210429/images/medium/jm0c02008_0020.gif" alt="" id="gr12" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t12fn1"><div class="footnote" id="t12fn1"><sup><sup>a</sup></sup><p class="last">0.3 μM.</p></div><div class="footnote" id="t12fn2"><sup><sup>b</sup></sup><p class="last">3 μM.</p></div><div class="footnote" id="t12fn3"><sup><sup>c</sup></sup><p class="last">1 μM.</p></div><div class="footnote" id="t12fn4"><sup><sup>d</sup></sup><p class="last">For each compound, 3 male Sprague Dawley rats were used to generate the PK data.</p></div></div><div></div></div><div class="NLM_p last">Although <b>54</b> was one of the most potent compounds in both the biochemical and mouse explant assays, it was discontinued due to inhibition of cytochrome P450 enzymes and the intrinsic risk for drug–drug interactions. Compound <b>55</b> displayed a good overall profile but was only moderately potent in the mouse explant assay and had an unsatisfactory dose–exposure relationship in rat (data not shown). GLPG1972 displayed the best overall druglike profile and was one of the most selective compounds of the series.</div></div><div id="sec2_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i28" class="anchor-spacer"></div><h3 class="article-section__title" id="_i28"> Selectivity Profile of GLPG1972</h3><div class="NLM_p">GLPG1972 showed high selectivity, in a biochemical assay, over a range of metalloproteinases (<a class="ref showTableEvent internalNav" data-ID="tbl13" href="#tbl13">Table <a class="ref showTableEvent internalNav" data-ID="tbl13" href="#tbl13">13</a></a>) and had no inhibitory activity in a 114-target CEREP panel assay consisting of GPCRs, transporters, and ion channels.</div><div class="NLM_table-wrap" id="tbl13"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 13. Selectivity Profile of GLPG1972</div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">metalloproteinase</th><th class="colsep0 rowsep0" align="center" char=".">GLPG1972, IC<sub>50</sub> (nM)</th><th class="colsep0 rowsep0" align="center" char=".">fold selectivity</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">ADAMTS-5</td><td class="colsep0 rowsep0" align="char" char=".">19</td><td class="colsep0 rowsep0" align="char" char="."> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">ADAMTS-4</td><td class="colsep0 rowsep0" align="char" char=".">156</td><td class="colsep0 rowsep0" align="char" char=".">8</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">ADAMTS-1</td><td class="colsep0 rowsep0" align="char" char=".">>3460</td><td class="colsep0 rowsep0" align="char" char=".">>182</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">ADAMTS-13</td><td class="colsep0 rowsep0" align="char" char=".">>100 000</td><td class="colsep0 rowsep0" align="char" char=".">>5000</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">TACE (ADAM 17)</td><td class="colsep0 rowsep0" align="char" char=".">>20 000</td><td class="colsep0 rowsep0" align="char" char=".">>1000</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">MMP-1</td><td class="colsep0 rowsep0" align="char" char=".">>30 000</td><td class="colsep0 rowsep0" align="char" char=".">>1500</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">MMP-2</td><td class="colsep0 rowsep0" align="char" char=".">1158</td><td class="colsep0 rowsep0" align="char" char=".">60</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">MMP-7</td><td class="colsep0 rowsep0" align="char" char=".">>30 000</td><td class="colsep0 rowsep0" align="char" char=".">>1500</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">MMP-9</td><td class="colsep0 rowsep0" align="char" char=".">12 347</td><td class="colsep0 rowsep0" align="char" char=".">650</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">MMP-13</td><td class="colsep0 rowsep0" align="char" char=".">>20 000</td><td class="colsep0 rowsep0" align="char" char=".">>1000</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">MMP-14</td><td class="colsep0 rowsep0" align="char" char=".">>3198</td><td class="colsep0 rowsep0" align="char" char=".">>168</td></tr></tbody></table></div></div><div class="NLM_p last">ADAMTS-4 is the closest homologue to ADAMTS-5 with their metalloprotease domains exhibiting sequence identity and similarity of 48% and 70%, respectively (calculated on 221 residues). At the active site level, the main differences cluster rather deeply in the S′1 pocket (around the aromatic moiety) with 6 different residues out of the 22 that surround our inhibitor at less than 5 Å. Eventually, these differences enabled us to control the selectivity of ADAMTS-5 vs ADAMTS-4. In addition, GLPG1972 was inactive against a small panel of kinases (tested at 10 μM), which included Abl kinase, Akt1/PKBα, CaMK2α, CDC2/CDK1, EGFR kinase, FGFR1 kinase, Lyn A kinase, MEK1/MAP2K1, p38α kinase, PKA, PKCα, RAF-1/MEK1 kinase, and TRKB.</div></div><div id="sec2_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i30" class="anchor-spacer"></div><h3 class="article-section__title" id="_i30"> <i>In Vitro</i> ADME, <i>in Vivo</i> PK Profile, and Early Safety Assessment of GLPG1972</h3><div class="NLM_p">GLPG1972 displayed a favorable PK profile in mice, rats, and dogs. <i>In vivo</i> clearance data were largely in line with the data obtained <i>in vitro</i> in hepatocyte studies and showed a trend for lower plasma clearance in higher species (<a class="ref showTableEvent internalNav" data-ID="tbl14" href="#tbl14">Tables <a class="ref showTableEvent internalNav" data-ID="tbl14" href="#tbl14">14</a></a> and <a class="ref showTableEvent internalNav" data-ID="tbl15" href="#tbl15">15</a>).</div><div class="NLM_table-wrap" id="tbl14"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 14. <i>In Vitro</i> ADME Profile of GLPG1972</div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"><i>in vitro</i> ADME</th><th class="colsep0 rowsep0" align="center">GLPG1972</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Caco2 Papp(A2B) (10–6 cm/s)</td><td class="colsep0 rowsep0" align="left">9 (ER = 7)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">mouse/rat/dog/human liver microsomal stability, % remaining after 30 min at 0.1 μM</td><td class="colsep0 rowsep0" align="left">43/37/60/73</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">mouse/rat/dog/human hepatocyte stability, clearance expressed as % LBF at 0.1 μM</td><td class="colsep0 rowsep0" align="left">70/61/<30/<30</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">mouse/rat/dog/human plasma protein binding at 5 μM, % bound after 4 h</td><td class="colsep0 rowsep0" align="left">92.2/94.1/91.1/93.5</td></tr></tbody></table></div></div><div class="NLM_table-wrap" id="tbl15"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 15. PK Profile of GLPG1972 in Mouse, Rat, and Dog</div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">variable</th><th class="colsep0 rowsep0" align="center">mouse<a class="ref internalNav" href="#t15fn1" aria-label="a">a</a> (CD1)</th><th class="colsep0 rowsep0" align="center">rat<a class="ref internalNav" href="#t15fn2" aria-label="b">b</a> (SD)</th><th class="colsep0 rowsep0" align="center">dog<a class="ref internalNav" href="#t15fn3" aria-label="c">c</a> (beagle)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">doses (mg/kg)</td><td class="colsep0 rowsep0" align="left">1 i.v./5 p.o.</td><td class="colsep0 rowsep0" align="left">1 i.v./5 p.o.</td><td class="colsep0 rowsep0" align="left">1 i.v./5 p.o.</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Cl (L/(h kg))</td><td class="colsep0 rowsep0" align="left">4.29</td><td class="colsep0 rowsep0" align="left">1.65</td><td class="colsep0 rowsep0" align="left">0.12</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Cl (% LBF)</td><td class="colsep0 rowsep0" align="left">54.6</td><td class="colsep0 rowsep0" align="left">32.3</td><td class="colsep0 rowsep0" align="left">5.00</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Vss (L/kg)</td><td class="colsep0 rowsep0" align="left">0.968</td><td class="colsep0 rowsep0" align="left">1.38</td><td class="colsep0 rowsep0" align="left">0.567</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>T</i><sub>1/2</sub> (h) (i.v.)</td><td class="colsep0 rowsep0" align="left">0.158</td><td class="colsep0 rowsep0" align="left">0.630</td><td class="colsep0 rowsep0" align="left">3.94</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>F</i> (%)</td><td class="colsep0 rowsep0" align="left">25</td><td class="colsep0 rowsep0" align="left">58</td><td class="colsep0 rowsep0" align="left">97</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t15fn1"><div class="footnote" id="t15fn1"><sup><sup>a</sup></sup><p class="last">3 male CD1 mice were used to generate the PK data.</p></div><div class="footnote" id="t15fn2"><sup><sup>b</sup></sup><p class="last">3 male Sprague Dawley rats were used to generate the PK data.</p></div><div class="footnote" id="t15fn3"><sup><sup>c</sup></sup><p class="last">3 male Beagle dogs were used to generate the PK data.</p></div></div></div><div class="NLM_p last">GLPG1972 was considered to present a low risk of QT prolongation due to the absence of inhibitory activity observed on the amplitude of the IKr current in the <i>in vitro</i> hERG manual patch clamp assay up to 80 μM. GLPG1972 did not show any mutagenic potential when assessed in the full Ames test, up to concentrations of 5000 μg/plate, in the presence and absence of metabolic activation.</div></div><div id="sec2_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i33" class="anchor-spacer"></div><h3 class="article-section__title" id="_i33"> Cocrystallization of ADAMTS-5 with GLPG1972</h3><div class="NLM_p">The binding mode of GLPG1972 was resolved by cocrystallization with ADAMTS-5-(262–480)L282K followed by X-ray diffraction (resolution 2.25 Å, <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">5</a></a>). In agreement with the hypothesized binding mode, the hydantoin ring adopts a tautomeric form that enables its coordination with the zinc ion via the nitrogen of the N-acyl amide and the H-bonding with Glu<sup>411</sup>. Also, in line with interactions described above, three additional hydrogen bonds are preserved: the hydantoin amide nitrogen interacts with Gly<sup>380</sup> and the carbonyl oxygen of the piperazine amide with both backbone NHs of Leu<sup>379</sup> and Gly<sup>380</sup>. Interestingly, the methyl group is axial with respect to the piperazine ring and develops hydrophobic contacts with Leu<sup>443</sup>. Consequently, the slightly polarized hydrogen of its α carbon is equatorial and interacts with the carbonyl oxygen of Ser<sup>440</sup> with an almost ideal geometry. Hydrophobic contacts are observed between the cyclopropyl ring, which occupies the S<sub>1</sub> pocket, and Met<sup>381</sup>, between the piperazine ring and His<sup>410</sup>, and with the difluorophenyl ring embedded in the S′<sub>1</sub> pocket (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">5</a></a>).</div><figure id="fig2" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-6/acs.jmedchem.0c02008/20210429/images/medium/jm0c02008_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-6/acs.jmedchem.0c02008/20210429/images/large/jm0c02008_0002.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Cocrystal structure of GLPG1972 in ADAMTS-5 (PDB ID <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6YJM">6YJM</a>). The carbon atoms of the binding site and the local backbone structure of ADAMTS-5 are depicted in dark green. GLPG1972 is shown in sticks with light green carbons. The zinc of the catalytic site is magenta. Protein–ligand interactions are presented with dashed lines (hydrogen bond in green, metal interaction in gray, and hydrophobic contacts in pink). The surface is colored by hydrophobicity of the residue (from brown for hydrophobic to blue for hydrophilic).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-6/acs.jmedchem.0c02008/20210429/images/large/jm0c02008_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c02008&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_11" class="NLM_sec NLM_sec_level_2"><div id="ac_i34" class="anchor-spacer"></div><h3 class="article-section__title" id="_i34"> Chemistry</h3><div class="NLM_p">The synthetic discovery route used to prepare GLPG1972 is depicted in <a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>. It consisted of four linear steps and one chiral separation by supercritical fluid chromatography (SFC) to give GLPG1972 with an overall yield of 6%. Condensation of ketone <b>57</b> with <i>tert</i>-butyl-2-bromoacetate <b>58</b> gave γ-keto ester <b>59</b> that underwent a Bucherer–Bergs reaction to provide racemic hydantoin <b>60</b>. The <i>tert</i>-butyl ester group was removed under acidic conditions, affording the carboxylic acid intermediate <b>61</b>. Separation of enantiomers by chiral SFC was run on a 600 g scale, and <b>(</b><i>S</i><b>)-61</b> acid was isolated with high enantiomeric excess (ee = 99.1%). The phenyl-piperazine building block <b>(</b><i>S</i><b>)-65</b> was prepared in two steps (Buchwald cross coupling followed by Boc deprotection), starting from commercially available and enantiomerically pure (<i>S</i>)-3-methyl-piperazine-1-carboxylic acid <i>tert</i>-butyl ester. Finally, the two enantiomerically enriched intermediates <b>(</b><i>S</i><b>)-61</b> and <b>(</b><i>S</i><b>)-65</b> were coupled using EDC.HCl/HOBt to yield GLPG1972.</div><figure id="sch1" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-6/acs.jmedchem.0c02008/20210429/images/medium/jm0c02008_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-6/acs.jmedchem.0c02008/20210429/images/large/jm0c02008_0006.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthetic Route for GLPG1972<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-6/acs.jmedchem.0c02008/20210429/images/large/jm0c02008_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c02008&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) LDA, THF, −78 to 0 °C, 35%; (b) NaCN, (NH<sub>4</sub>)<sub>2</sub>CO<sub>3</sub>, EtOH/H<sub>2</sub>O, 60 °C, 68%; (c) HCl 4 M/dioxane, rt, 76%; (d) chiral SFC, AD-3 μm column; <b>(<i>R</i>)-61</b> 42%, <b>(<i>S</i>)-61</b> 43%; (e) Pd<sub>2</sub>(dba)<sub>3</sub>, BINAP, NaOtBu, toluene, 80 °C for 2.5 h then 110 °C, 93%; (f) HCl 4 M/dioxane, acetonitrile, rt, 88%; (g) EDC·HCl, HOBt, DIPEA, DMF, rt, 82%.</p></p></figure></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i36">Conclusion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_22387" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_22387" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">Following an HTS campaign, a hydantoin series was identified with modest potency against ADAMTS-5 but excellent ADME properties. Subsequent SAR optimization resulted in the discovery of GLPG1972, which displayed high potency against rn- and hs-ADAMTS-5 protein preparations as well as in a mouse cartilage explant assay. In addition, GLPG1972 featured an excellent selectivity profile versus metalloproteinases, with good plasma exposure in rats and dogs after oral administration, and high stability in dog and human liver microsomes and hepatocytes. Detailed pharmacology data on GLPG1972, including animal models with surgically induced OA, will be presented elsewhere (manuscript in preparation). GLPG1972 is a druglike small molecule with the potential to be a first-in-class disease-modifying therapy for the treatment of OA. It has been investigated in a phase 2 clinical trial (Roccella study; NCT03595618).</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i37">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_06188" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_06188" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec4_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i38" class="anchor-spacer"></div><h3 class="article-section__title" id="_i38"> Protein Purification</h3><div class="NLM_p">Coding sequences for ADAMTS proteins were cloned in fusion with a Ct thrombin cleavage site and a 6His tag in either the pTT5 vector (for human ADAMTS-5(1–567) and human ADAMTS-4(1–520)) or pYD7 vector (for rat ADAMTS-5(AA 1–564)) (pTT5 and pYD7 vectors were provided by the “Conseil National de Recherches Canada” (CNRC-NRC)).<a onclick="showRef(event, 'ref31 ref32'); return false;" href="javascript:void(0);" class="ref ref31 ref32">(31,32)</a></div><div class="NLM_p">The proteins were transiently expressed in 293-6E cells as previously described and recovered in the cell culture supernatant (conditioned medium [CM]).<a onclick="showRef(event, 'ref31 ref33'); return false;" href="javascript:void(0);" class="ref ref31 ref33">(31,33)</a></div><div class="NLM_p">The purification process was very similar for all proteins. For human ADAMTS-5 (262–567), mainly, CM was buffered by addition of 10× buffer (0.5 M Tris (pH 8), 4 M NaCl, 10 mM CaCl<sub>2</sub>, 10 μM ZnCl<sub>2</sub>, 200 mM imidazole) and then Tween20 (0.1% final concentration). The CM was clarified by filtration and loaded Ni<sup>2+</sup> affinity prepacked columns (HisTrap, GE Healthcare Life sciences 17-5248-02) pre-equilibrated with buffer A (50 mM Tris pH 8, 500 mM NaCl, 1 mM CaCl<sub>2</sub>, 1 μM ZnCl<sub>2</sub>, 0.1% Tween 20, and 20 mM Imidazole). After extensive washing, proteins were suspended in buffer A containing various concentrations of imidazole. Fractions containing purified ADAMTS-5 protein were pooled and centrifuged at 118 000<i>g</i> for 30 min at 4 °C (VTI50 rotor). Protein was then incubated overnight at room temperature with thrombin (Sigma RECOM-T) to remove the His tag. The final protein preparation was centrifuged at 210 000<i>g</i> for 30 min at 4 °C using the SW41 rotor and then dialyzed using Spectra Por 6–8 kDa cut off against 50 mM Tris, pH 8, 0.5 M NaCl, 10 mM CaCl<sub>2</sub>, 1 μM ZnCl<sub>2</sub>, and 0.1% Tween 20. The protein was centrifuged again before storage at −80 °C until use.</div><div class="NLM_p">The same process was used to purify the rat ADAMTS-5 and human ADAMTS-4 proteins with minor changes: clarification was achieved by centrifugation for 60 min @ 15 000<i>g</i> without cleavage of the His-tag. Also, for the human ADAMTS-4, the 10× buffer CM buffering was 0.5 M Tris (pH 8), 3.5 M NaCl, 50 mM CaCl<sub>2</sub>, 50 μM ZnCl<sub>2</sub>, and 200 mM imidazole, and no detergent was added.</div><div class="NLM_p">The construct used for the crystallographic studies had the same boundaries (1–480) and contained the L282K stabilizing mutation described by Shieh et al.; however, the expression was done in mammalian cells as opposed to inclusion bodies in bacteria.<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> A few modifications were made to the purification process to prepare this protein: CM was buffered by addition of 10× buffer (0.5 M Tris (pH 8), 4 M NaCl, 10 mM CaCl<sub>2</sub>, 10 μM ZnCl<sub>2</sub>, 200 mM imidazole, 1% Chaps). The CM was clarified by centrifugation for 60 min at 15 000<i>g</i> at 4 °C and loaded onto Ni<sup>2+</sup> affinity prepacked columns pre-equilibrated with buffer A (50 mM Tris pH 8, 500 mM NaCl, 1 mM CaCl<sub>2</sub>, 1 μM ZnCl<sub>2</sub>, 0.1% Chaps, and 20 mM imidazole). After the final centrifugation, protein was dialyzed using Spectra Por 10–12 kDa cut off against 50 mM Tris, pH 8, 0.25 M NaCl, 5 mM CaCl<sub>2</sub>, 1 μM ZnCl<sub>2</sub>, and 0.05% Tween 20.</div><div class="NLM_p last">Final preparation yields were as follows: 1.5 mg of highly active nonaggregated human and rat ADAMTS-5 protein per liter of CM (95% and ∼80% purity, respectively), >10 mg/L for human ADAMTS-4.</div></div><div id="sec4_1_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i39" class="anchor-spacer"></div><h3 class="article-section__title" id="_i39"> Biochemical Assays</h3><div class="NLM_p">The basis for the ADAMTS-5 biochemical assay is the cleavage of the fluorescent substrate TBIS-1 by rn- or hs-ADAMTS-5. Briefly, 25 ng of hs-ADAMTS-5 or 20 ng of rn-ADAMTS-5 was incubated with 4.5 μM FAM-TEGEARGSVILLK(5TAMRA)K-NH2 (FAM-TBIS-1) in 45 mM HEPES pH 7.5, 90 mM NaCl, 4.5 mM CaCl<sub>2</sub>, and 0.09% CHAPS at 37 °C in the presence or absence of compound at different concentrations. Cleavage of TBIS-1 was measured at 530 nm.</div><div class="NLM_p">The basis for the ADAMTS-1 selectivity biochemical assay is the cleavage of a fluorescent substrate by human recombinant ADAMTS-1. Briefly, 0.38 ng/μL hs-ADAMTS-1 (AA253–734, 2197-AD, R&D systems) was incubated with 7 μM 5(6)-fluorescein-NH-AELQGRPISIAK-5(6)-TAMRA (exc 485 nm/em 535 nm, custom-made, Anaspec) in 50 mM MOPS pH 7, 50 mM NaCl, 5 mM CaCl<sub>2</sub>, 0.05% CHAPS, and 5 μM ZnCl<sub>2</sub> at 37 °C for 120 min in the presence or absence of compound. Substrate cleavage was measured at 535 nm.</div><div class="NLM_p">The basis for the ADAMTS-4 selectivity biochemical assay is the cleavage of a fluorescent substrate by human recombinant ADAMTS-4. Briefly, 0.38 ng/μL hs-ADAMTS-4 (AA1–520, in house prepared) was incubated with 4.5 μM TBIS-1 (5 FAM-TEGEARGSVILLK (5TAMRA)K-NH2, exc 485 nm/em 530 nm, custom-made, Anaspec) in 45 mM Hepes pH 7.5, 90 mM NaCl, 4.5 mM CaCl<sub>2</sub>, and 0.09% CHAPS at 37 °C for 180 min in the presence or absence of compound. Substrate cleavage was measured at 530 nm.</div><div class="NLM_p">The basis for the MMP-2 selectivity biochemical assay is the cleavage of a fluorescent substrate by human recombinant MMP-2. Briefly, prior to substrate incubation, hs-MMP-2 (AA34–660, 902-MP-010, R&D Systems) was activated by 60 min of incubation with 1 mM 4-aminophenylmercuric acetate (APMA, A9563, SigmaAldrich) at 37 °C. 0.03 ng/μL activated hs-MMP-2 was incubated with 2.5 μM 390 MMP FRET substrate I (exc 320 nm/em 400 nm, 27076, Anaspec) in 45 mM Tris pH 7.5, 9 mMCaCl<sub>2</sub>, 135 mM NaCl, and 0.045% Brij-35 at room temperature for 30 min in the presence or absence of compound. Substrate cleavage was measured at 400 nm.</div><div class="NLM_p">The basis for the MMP-14 selectivity biochemical assay is the cleavage of a fluorescent substrate by human recombinant MMP-14. Briefly, 0.05 ng/μL hs-MMP-14 (AA112–298, SE-259-0010, Enzo) was incubated with 2.5 μM 390 MMP FRET substrate I (exc 320 nm/em 400 nm, 27076, Anaspec) in 45 mM MOPS pH7, 4.5 mM CaCl<sub>2</sub>, 0.9 μM ZnCl<sub>2</sub>, and 0.09% Brij-35 at room temperature for 60 min in the presence or absence of compound. Substrate cleavage was measured at 400 nm.</div><div class="NLM_p last">The basis for the TACE selectivity biochemical assay is the cleavage of a fluorescent substrate by human recombinant TACE. Briefly, 0.05 ng/μL hs-TACE (AA215–671, 930-ADB, R&D Systems) was incubated with 5 μM 5FAM-LAQAVRSSSRK-5TAMRA (exc 485 nm/em 530 nm, custom-made, Anaspec) in 22.5 mM Tris pH8.0, 2.25 μM ZnCl<sub>2</sub>, and 0.009% CHAPS at room temperature for 75 min in the presence or absence of compound. Substrate cleavage was measured at 530 nm.</div></div><div id="sec4_1_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i40" class="anchor-spacer"></div><h3 class="article-section__title" id="_i40"> Human AGC Neoepitope ELISA</h3><div class="NLM_p last">Human AGC, purified in-house, was treated with 1 mU/μL keratanase I (Seigakaku, Tokyo, Japan) at 37 °C, followed by incubation with 40% (v/v) CM from HEK293-6E cells expressing full-length human ADAMTS-5 in 50 mM Tris pH 7.5, 150 mM NaCl, 1 μM ZnCl<sub>2</sub>, 5 mM CaCl<sub>2</sub>, and 0.05% Brij-35, in the presence or absence of compound. After 50 min of incubation at 37 °C, the enzymatic reaction was stopped by the addition of 50 mM EDTA. The digests were then incubated for 2 h at 37 °C in plates coated with 5 μg/mL of a HABR antibody that binds both G1 and G2 domains.<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a> The ARGSVIL neoepitope was detected by incubation with 0.1 μg/mL biotinylated BC-3 antibody (1042001; MD Bioproducts, Zürich, Switzerland), followed by secondary detection with streptavidin–horseradish peroxidase and chemiluminescence.</div></div><div id="sec4_1_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i41" class="anchor-spacer"></div><h3 class="article-section__title" id="_i41"> Mouse Femoral Head Cartilage Explant Assay</h3><div class="NLM_p last">All animal experiments described in the paper were performed according to ethical guidelines approved by the Animal Institutional Care and Use Committee of Galapagos controlled by the French Authorities (Agreement C93-063-06, DDPP, Seine Saint Denis). Femoral head cartilage was collected from mice at 3 weeks of age (two hip heads/animal) into 48-well culture plates containing serum-free culture medium to provide three replicates/groups. The culture medium was removed, and the hip cartilage samples were stimulated by human interleukin-1α (ref 200-01A; PeproTech, London, UK) at 1 ng/mL in serum-free culture media in combination with different concentrations of each test compound. After 3 days of incubation, glycosaminoglycan (GAG) concentration in the supernatant was measured using 1,9-dimethylmethylene blue dye (cat. no. C7880; Sigma-Aldrich; Merck, Darmstadt, Germany), with chondroitin sulfate sodium salt from shark cartilage (Sigma-Aldrich; Merck, Darmstadt, Germany) as a standard.</div></div><div id="sec4_1_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i42" class="anchor-spacer"></div><h3 class="article-section__title" id="_i42"> Liver Microsomal Stability (LMS) Assay</h3><div class="NLM_p">The microsomal stability assay was performed by incubation of test compound at 1 μM, 0.2% DMSO in phosphate buffer with microsomes (0.5 mg/mL) from mouse, rat, dog, or human (Xeno-Tech), and cofactors with final concentrations as follows: 0.6 U/mL glucose-6-phosphate-dehydrogenase, 3.3 mM MgCl<sub>2</sub>, 3.3 mM glucose-6-phosphate, and 1.3 mM nicotinamide adenine dinucleotide phosphate (NADP)<sup>+</sup>. Before adding the microsomes (time zero), and after 30 min of incubation at 37 °C while shaking, the reaction was stopped, and proteins were precipitated with an excess of acetonitrile containing the internal standard. The samples were mixed, centrifuged, and filtered, and the supernatant was analyzed by liquid chromatography–mass spectrometry/mass spectrometry (LC-MS/MS). The instrument responses (analyte peak area/IS peak area) were referenced to the zero-time point samples (considered as 100%) in order to determine the percentage of compound remaining. Verapamil (1 μM) and warfarin (1 μM) were used as unstable and stable reference compounds, respectively.</div><div class="NLM_p"><i>In vitro</i> scaled intrinsic clearance (CL<sub>int</sub> scaled) was calculated from half-life using the following equations:</div><disp-formula-group><figcaption><strong></strong><span class="figure__caption hlFld-FigureCaption"><p>Intrinsic clearance equation</p></span></figcaption><span class="NLM_disp-formula" id="ueq1"><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-6/acs.jmedchem.0c02008/20210429/images/medium/jm0c02008_m001.gif" alt="" id="_i43" /></img><span class="labelSpan">(1)</span></span></disp-formula-group><disp-formula-group><figcaption><strong></strong><span class="figure__caption hlFld-FigureCaption"><p>Scaled intrinsic clearance equation</p></span></figcaption><span class="NLM_disp-formula" id="ueq2"><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-6/acs.jmedchem.0c02008/20210429/images/medium/jm0c02008_m002.gif" alt="" id="_i44" /></img><span class="labelSpan">(2)</span></span></disp-formula-group></div><div id="sec4_1_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i45" class="anchor-spacer"></div><h3 class="article-section__title" id="_i45"> Hepatocyte Stability Assay</h3><div class="NLM_p">The hepatocyte stability assay was performed by incubation of test compound at 1 μM, 0.03% DMSO in modified Krebs-Henseleit buffer with suspension of pooled cryopreserved hepatocytes (Bioreclamation IVT) from mouse, rat, dog, or human (Bioreclamation IVT) at 0.5 million viable hepatocytes/mL.</div><div class="NLM_p">Before adding the hepatocytes (time zero), and after 10, 20, 45, 90, 120, and 180 min of incubation (<i>n</i> = 2) at 37 °C while gently shaking, the reaction was stopped, and proteins were precipitated with an excess of acetonitrile containing the internal standard. The samples were mixed, centrifuged, and filtered, and the supernatant was analyzed by liquid chromatography–mass spectrometry/mass spectrometry (LC-MS/MS). The instrument responses (analyte peak areas/IS peak area) were referenced to the zero-time point samples (considered as 100%) in order to determine the percentage of compound remaining. Testosterone (1 μM) and 7-hydroxycoumarin (1 μM) were used as phase I and phase II reaction controls, while caffeine was used as a negative control.</div><div class="NLM_p last"><i>In vitro</i> intrinsic clearance (CL<sub>int</sub>) was calculated from half-life using the following equations:<span class="NLM_disp-formula" id="ueq3"><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-6/acs.jmedchem.0c02008/20210429/images/medium/jm0c02008_m003.gif" alt="" id="_i46" /></img></span><span class="NLM_disp-formula" id="ueq99"><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-6/acs.jmedchem.0c02008/20210429/images/medium/jm0c02008_m004.gif" alt="" id="_i47" /></img></span></div></div><div id="sec4_1_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i48" class="anchor-spacer"></div><h3 class="article-section__title" id="_i48"> Plasma Protein Binding Assay</h3><div class="NLM_p last">Plasma protein binding was determined by equilibrium dialysis using the Pierce Red Device plate with inserts (ThermoScientific). Test compound at 5 μM (0.5% DMSO) spiked in freshly thawed mouse, rat, dog, or human plasma (BioReclamation INC) was dialyzed against phosphate-buffered saline (PBS, pH 7.4) at 37 °C under shaking for 4 h. Proteins were precipitated with an excess of methanol, and samples were mixed and centrifuged; the supernatant was analyzed by liquid chromatography–mass spectrometry/mass spectrometry (LC-MS/MS). The percentage bound to plasma proteins was derived from these results with the following formula:<span class="NLM_disp-formula" id="ueq4"><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-6/acs.jmedchem.0c02008/20210429/images/medium/jm0c02008_m005.gif" alt="" id="_i49" /></img></span></div></div><div id="sec4_1_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i50" class="anchor-spacer"></div><h3 class="article-section__title" id="_i50"> Intestinal Permeability on Caco-2 Cells</h3><div class="NLM_p">Caco-2 cells were obtained from European Collection of Cell Cultures (ECACC) and used after a 21 day cell culture in 24-well transwell plates.</div><div class="NLM_p">Test compounds and references (vinblastine and propranolol) were prepared in protein-free Hanks’ balanced salt solution containing 25 mM HEPES (pH 7.4) at a concentration of 10 μM and added to either the apical or basolateral chambers of a transwell plate assembly.</div><div class="NLM_p">Before the experiment, the integrity of the monolayer was checked by measuring the transepithelial resistance. Lucifer Yellow (LY) was added to the donor buffer in all wells to assess integrity of the cell layers by monitoring LY permeation. As LY cannot freely permeate lipophilic barriers, a high degree of LY transport indicates poor integrity of the cell layer.</div><div class="NLM_p">After 1 h of incubation at 37 °C, aliquots were taken from both apical (A) and basolateral (B) chambers and added to acetonitrile containing internal standard (carbamazepine) in a 96-well plate. Concentrations of compound in the samples were measured by LC-MS/MS.</div><div class="NLM_p">Apparent permeability (<i>P</i><sub>app</sub>) values were calculated from the following relationship:<span class="NLM_disp-formula" id="ueq5"><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-6/acs.jmedchem.0c02008/20210429/images/medium/jm0c02008_m006.gif" alt="" id="_i51" /></img></span>where <i>V</i><sub>donor</sub> = volume apical chamber = 125 μL, <i>V</i><sub>acceptor</sub> = volume of the basolateral chamber = 600 μL, <i>T</i><sub>inc</sub> = incubation time = 3600 s, and the surface area for the 24-well transwell = 0.33 cm<sup>2</sup>.</div><div class="NLM_p last">The efflux ratios, as an indication of active efflux from the apical cell surface, were calculated using the ratio of <i>P</i><sub>app</sub><i>B</i> > <i>A</i>/<i>P</i><sub>app</sub><i>A</i> > <i>B</i>.</div></div><div id="sec4_1_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i52" class="anchor-spacer"></div><h3 class="article-section__title" id="_i52"> CYP Inhibition Assay</h3><div class="NLM_p">A 5 mM stock solution of compound was prepared in methanol. This stock was serially diluted 1:3 in methanol and then added in duplicates to a mixture containing 50 mM potassium phosphate buffer pH 7.4 and human liver microsomes (BD Gentest). A total of 7 different concentrations (0.14–100 μM in final reaction mixture; 2% methanol) of compound were prepared in duplicates.</div><div class="NLM_p">After prewarming for 5 min at 37 °C, the 20 min preincubation was started by adding a probe substrate to the first concentration range (first replica) and a cofactor mix (7. 65 mg/mL glucose-6-phosphate, 1.7 mg/mL NADP, and 6 U/mL of glucose-6-phosphate dehydrogenase) to the second replica. Final concentrations of cofactor mix components were as follows: 1.56 mg/mL glucose-6-phosphate, 0.34 mg/mL NADP, and 1.2 U/mL of glucose-6-phosphate dehydrogenase.</div><div class="NLM_p">After preincubation, the reaction was finally started by adding the cofactor mix to the first replica and probe substrate to the second replica (opposite from preincubation).</div><div class="NLM_p">After incubation at 37 °C, the reaction (aliquot of 50 μL) was terminated with 150 μL of acetonitrile:methanol (2:1) solution with internal standard (diclofenac). Samples were centrifuged and the supernatant fractions analyzed by LC-MS/MS.</div><div class="NLM_p">The instrument responses (ratio of compound and internal standard peak areas) were referenced to those for solvent controls (assumed as 100%) in order to determine the percentage reduction in probe metabolism.</div><div class="NLM_p last">Percent of control activity versus concentration plots were generated and fitted using GraphPad Prism software to determine IC<sub>50</sub> for both substrate and cofactor preincubations, as well as the IC<sub>50</sub> fold shift.</div></div><div id="sec4_1_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i53" class="anchor-spacer"></div><h3 class="article-section__title" id="_i53"> hERG Manual Patch Clamp Assay</h3><div class="NLM_p">Whole-cell patch-clamp recordings were performed using an EPC10 amplifier controlled by Pulse v8.77 software (HEKA). The external bathing solution contained 135 mM NaCl, 5 mM KCl, 1.8 mM CaCl<sub>2</sub>, 5 mM glucose, and 10 mM HEPES, pH 7.4. The internal patch pipet solution contained 100 mM K gluconate, 20 mM KCl, 1 mM CaCl<sub>2</sub>, 1 mM MgCl<sub>2</sub>, 5 mM Na<sub>2</sub>ATP, 2 mM glutathione, 11 mM EGTA, and 10 mM HEPES, pH 7.2. Compound was perfused using an Automate scientific pressurized superfusion system coupled to a Biologic micromanifold.</div><div class="NLM_p">All recordings were performed on HEK293 cells stably expressing hERG channels. Cells were cultured on 12 mm round coverslips (German glass, Bellco) anchored in the recording chamber using two platinum rods (Goodfellow). hERG currents were evoked using an activating pulse to +40 mV for 1000 ms followed by a tail current pulse to −50 mV for 2000 ms; holding potential was −80 mV. Pulses were applied every 15 s, and all experiments were performed at room temperature. For the concentration response, peak tail current amplitude was measured during the voltage step to −50 mV.</div><div class="NLM_p last">Acebutolol and nicardipine are included in the assay design as low and high binding controls.</div></div><div id="sec4_1_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i54" class="anchor-spacer"></div><h3 class="article-section__title" id="_i54"> Crystallization and Structure Determination of ADAMTS-5 in Complex with GLPG1972</h3><div class="NLM_p">A frozen aliquot of purified ADAMTS-5 (262–480; L282K) protein was thawed and concentrated to 8 mg/mL in preparation for cocrystallization. A 100 mM stock solution of inhibitor GLPG1972 in 100% DMSO was added to the protein, giving a final inhibitor concentration of 2.5 mM, and the complex was incubated at 4 °C for 2 h prior to cocrystallization. A 96-well Index HT crystallization screen (Hampton Research, Aliso Viejo, CA) was set up using a Mosquito crystallization robot (SPT Labtech, Melbourn, UK) employing the hanging drop method of vapor diffusion. Cocrystals appeared in several precipitant conditions after 24 h. The most promising cocrystals grew in precipitant solution containing 0.1 M HEPES pH 7.0 and 30% v/v Jeffamine ED-2001 pH 7.0. Cocrystals were removed from the growth drop using a nylon loop and flash cooled directly by plunging them into liquid nitrogen with no additional cryoprotectant solution.</div><div class="NLM_p">A complete data set was collected in-house on a Rigaku Saturn 944 charge-coupled device detector, and data were indexed, integrated, and scaled using MOSFLM and SCALA. Details of data collection and processing are given in <a href="/doi/suppl/10.1021/acs.jmedchem.0c02008/suppl_file/jm0c02008_si_001.pdf" class="ext-link">Table S1</a>. The X-ray cocrystal structure was solved by molecular replacement using chain A of PDB ID <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3B8Z">3B8Z</a> as a search ensemble in PHASER (CCP4, Didcot, UK). Indexing suggested that the crystals possessed primitive orthorhombic symmetry; however, refinement in REFMAC5 (CCP4) produced high <i>R</i>-values and poor-quality maps. The data set was then reprocessed as primitive monoclinic, with refinement producing lower <i>R</i>-values and improved maps, although still not consistent with a typical 2.25 Å data set. Further analysis of the diffraction data suggested that twinning was present. Subsequent refinement, using amplitude-based twin refinement in REFMAC5, produced <i>R</i>-values and electron density maps that were consistent with the maximum resolution of this data set and allowed automated model rebuilding using BUCCANEER (CCP4).</div><div class="NLM_p last">With the protein model complete, the difference electron density map was examined for peaks consistent with the presence of possible inhibitor. Once the inhibitor electron density was located, molecular structure and refinement library files were produced using JLIGAND (CCP4). The inhibitor was fitted into the electron density using COOT and refined using REFMAC5 (CCP4). Water molecules were then added using the water placement option in COOT and refined using REFMAC5 (CCP4). The structural geometry of the final protein model was checked using MOLPROBITY,<a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a> and the ligand was checked using Maestro and MOE.</div></div><div id="sec4_1_11" class="NLM_sec NLM_sec_level_2"><div id="ac_i55" class="anchor-spacer"></div><h3 class="article-section__title" id="_i55"> Synthetic Chemistry</h3><div id="sec4_1_11_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i56" class="anchor-spacer"></div><h4 class="article-section__title" id="_i56"> General Procedures</h4><div class="NLM_p last">All reagents were of commercial grade and were used as received, without further purification, unless otherwise stated. Commercially available anhydrous solvents were used for reactions conducted under an inert atmosphere. Reagent-grade solvents were used in all other cases, unless otherwise specified. Column chromatography was performed on silica gel 60 (thickness: 35–70 μm). Thin-layer chromatography was carried out using precoated silica gel 60F-254 plates (thickness: 0.25 mm). Celpure P65, a commercial product (CAS number 61790-53-2), was used as a filtration aid. <sup>1</sup>H NMR spectra were recorded on a 400 MHz Avance spectrometer (SEI probe) or a 300 MHz DPX Bruker spectrometer (QNP probe). Chemical shifts (δ) for <sup>1</sup>H NMR spectra are reported in ppm relative to tetramethylsilane (δ 0.00) or the appropriate residual solvent peak (i.e., CHCl<sub>3</sub> [δ 7.27], as internal reference). Multiplicities are given as singlet (s), doublet (d), triplet (t), quartet (q), quintuplet (quin), multiplet (m), and broad (br). Electrospray MS spectra were obtained with a Waters Acquity UPLC instrument equipped with a Waters Acquity photodiode array detector and single quad detector mass spectrometer. Columns used were UPLC ethylene-bridged hybrid (BEH) C18 1.7 μm, 2.1 × 5 mm VanGuard precolumn with Acquity UPLC BEH C18 1.7 μm, 2.1 × 30 mm column or Acquity UPLC BEH C18 1.7 μm, 2.1 × 50 mm column. All of the methods used MeCN/H<sub>2</sub>O gradients. MeCN and H<sub>2</sub>O contained either 0.1% formic acid or 0.05% NH<sub>3</sub>. All final compounds reported were analyzed using these analytical methods, and purities were greater than 95% unless otherwise indicated in the <a href="/doi/suppl/10.1021/acs.jmedchem.0c02008/suppl_file/jm0c02008_si_001.pdf" class="ext-link">Supporting Information</a>. An autopurification system from Waters was used for LC-MS purification. LC-MS columns used were Waters XBridge Prep C18 5 μm, ODB 30 mm inner diameter (ID) × 100 mm length (<i>L</i>) (preparative column); and Waters XBridge C18 5 μm, 4.6 mm ID × 100 mm <i>L</i> (analytical column). All of the methods used MeCN/H<sub>2</sub>O gradients. MeCN and H<sub>2</sub>O contained either 0.1% formic acid or 0.1% diethylamine. Chiral HPLC analyses were obtained from a Waters 2690 Alliance HPLC system. Chiral SFC preparative separation was performed on Thar350 preparative SFC, and chiral SFC analysis was performed on Waters analytical SFC. Optical rotation was determined on a Dr Kernchen Propol digital automatic polarimeter.</div></div><div id="sec4_1_11_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i57" class="anchor-spacer"></div><h4 class="article-section__title" id="_i57"> <i>tert</i>-Butyl (<i>S</i>)-4-(3,5-Difluorophenyl)-3-methylpiperazine-1-carboxylate ([<i>S</i>]-<b>64</b>)</h4><div class="NLM_p last">A solution of <i>tert</i>-butyl (<i>S</i>)-3-methylpiperazine-1-carboxylate (<i><b>S</b></i><b>-62</b>) (100 g, 499 mmol, 1 equiv) in toluene (500 mL) was degassed with argon for 15 min. To this solution, 1-bromo-3,5-difluorobenzene (<b>63</b>) (63 mL, 549 mmol, 1.1 equiv), NaO<i>t</i>-Bu (67 g, 699 mmol, 1.4 eq.; portion-wise over a period of 10 min), and BINAP (15.5 g, 25 mmol, 0.05 equiv) were added. The mixture was degassed with argon for 5 min before Pd<sub>2</sub>(dba)<sub>3</sub> (6.9 g, 7.5 mmol, 0.015 equiv) was added. The flask was equipped with a condenser, and the reaction mixture was stirred at 80 °C for 2.5 h and at reflux for 1 h. The mixture was diluted with water (650 mL) and EtOAc (600 mL). The aqueous layer was extracted with EtOAc (400 mL). Combined organic layers were washed with water (450 mL) and brine (450 mL), dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated <i>in vacuo</i>. The crude product was purified by filtration through a cake of SiO<sub>2</sub> (elution heptane/EtOAc: 100/0, 95/5, 80/20) to afford <i>tert</i>-butyl (<i>S</i>)-4-(3,5-difluorophenyl)-3-methylpiperazine-1-carboxylate (145 g, 93%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 6.62–6.50 (m, 2H), 6.45 (tt, <i>J</i> = 9.2, 2.2 Hz, 1H), 4.07 (br. s, 1H), 3.94 (br. s, 1H), 3.83–3.73 (m, 1H), 3.45–3.36 (m, 1H), 3.15 (br. s, 2H), 3.04–2.81 (m, 1H), 1.43 (s, 9H), 0.95 (d, <i>J</i> = 6.5 Hz, 3H). LC-MS: <i>m</i>/<i>z</i> = 313.4 [M + H].</div></div><div id="sec4_1_11_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i58" class="anchor-spacer"></div><h4 class="article-section__title" id="_i58"> (<i>S</i>)-1-(3,5-Difluorophenyl)-2-methylpiperazine (<b>[<i>S</i>]-65</b>)</h4><div class="NLM_p last">To a solution of <i>tert</i>-butyl (<i>S</i>)-4-(3,5-difluorophenyl)-3-methylpiperazine-1-carboxylate (<b><i>S</i>-64</b>) (145 g, 466 mmol, 1 equiv) in acetonitrile (580 mL), cooled in an ice bath, a 4 N HCl solution in dioxane (580 mL, 2320 mmol, 5 equiv) was added in five portions over a 20 min period. The reaction mixture was stirred at 0 °C for 20 min and then at rt for 3 h. The suspension was filtered, washed with acetonitrile (3 × 250 mL) and diethyl ether (2 × 300 mL), and dried under vacuum to afford (<i>S</i>)-1-(3,5-difluorophenyl)-2-methylpiperazine as dihydrochloride salt (117 g, 88%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 9.74 (br. s, 1H), 9.24 (br. s, 1H), 7.08 (br. s, 1H), 6.71–6.59 (m, 2H), 6.54 (tt, <i>J</i> = 9.2, 2.2 Hz, 1H), 4.38–4.12 (m, 1H), 3.62 (d, <i>J</i> = 13.7 Hz, 1H), 3.30–3.20 (m, 2H), 3.20–3.09 (m, 2H), 3.05–2.92 (m, 1H), 1.17 (d, <i>J</i> = 6.9 Hz, 3H). LC-MS: <i>m</i>/<i>z</i> = 213.4 [M + H].</div></div><div id="sec4_1_11_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i59" class="anchor-spacer"></div><h4 class="article-section__title" id="_i59"> <i>tert</i>-Butyl 4-Cyclopropyl-4-oxo-butanoate (<b>59</b>)</h4><div class="NLM_p last">A solution of LDA 2 M (3.0 L, 5.98 mol, 1.17 equiv) in THF (2.5 L) was cooled to −78 °C. A solution of 1-cyclopropylethanone (<b>57</b>) (460 g, 5.47 mol, 1.07 equiv) in THF (0.5 L) was added dropwise, then warmed to −20 °C, and stirred for 30 min. The reaction mixture was cooled to −78 °C, and <i>tert</i>-butyl bromoacetate (<b>58</b>) (997 g, 5.11 mol, 1 equiv) in THF (0.5 L) was added slowly. The reaction was: stirred at 0 °C overnight; quenched with saturated aqueous NH<sub>4</sub>Cl (3.3 L); extracted with EtOAc (3 × 0.5 L); washed with water (2 × 0.5 L), saturated aqueous NH<sub>4</sub>Cl (1 L), and brine (1 L); and dried over Na<sub>2</sub>SO<sub>4</sub>. Purification by distillation under reduced pressure (5 mbar, 95 °C) afforded <i>tert</i>-butyl 4-cyclopropyl-4-oxo-butanoate (350 g, 35%) as an oil. <sup>1</sup>H NMR (400 MHz, chloroform-<i>d</i>): δ 2.82 (td, <i>J</i> = 6.7, 1.7 Hz, 2H), 2.50 (td, <i>J</i> = 6.8, 1.7 Hz, 2H), 1.97–1.90 (m, 1H), 1.43 (m, 9H), 1.05–1.00 (m, 2H), 0.91–0.84 (m, 2H).</div></div><div id="sec4_1_11_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i60" class="anchor-spacer"></div><h4 class="article-section__title" id="_i60"> <i>tert</i>-Butyl 3-(4-Cyclopropyl-2,5-dioxo-imidazolidin-4-yl)propanoate (<b>60</b>)</h4><div class="NLM_p last">A mixture of <i>tert</i>-butyl 4-cyclopropyl-4-oxo-butanoate (<b>59</b>) (120 g, 605 mmol, 1 equiv), (NH<sub>4</sub>)<sub>2</sub>CO<sub>3</sub> (494 g, 5.15 mol, 8.5 equiv), NaCN (<i>CAUTION! Sodium cyanide is highly toxic</i>, 60 g, 1.45 mol, 2.4 equiv), water (600 mL), and EtOH (600 mL) was heated at 60 °C for 18 h in a sealed reactor. The reaction mixture was poured into a mixture of EtOAc (900 mL) and water (900 mL), and the aqueous layer was additionally extracted with EtOAc (3 × 600 mL). The organic layer was concentrated until there was only about 100 mL of EtOAc left, and petroleum ether (500 mL) was added dropwise to afford, after filtration, the expected <i>tert</i>-butyl 3-(4-cyclopropyl-2,5-dioxo-imidazolidin-4-yl)propanoate (110 g, 68%) as a white solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 10.62 (s, 1H), 7.66 (s, 1H), 2.30–2.20 (m, 1H), 2.17–2.09 (m, 1H), 1.96–1.88 (m, 2H), 1.39 (s, 9H), 1.10–1.03 (m, 1H), 0.48–0.40 (m, 1H), 0.39–0.27 (m, 2H), 0.14–0.05 (m, 1H). LC-MS: <i>m</i>/<i>z</i> = 269.3 [M + H].</div></div><div id="sec4_1_11_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i61" class="anchor-spacer"></div><h4 class="article-section__title" id="_i61"> 3-(4-Cyclopropyl-2,5-dioxo-imidazolidin-4-yl)propanoic Acid (<b>61</b>)</h4><div class="NLM_p last">A flask was charged with a solution of <i>tert</i>-butyl 3-(4-cyclopropyl-2,5-dioxo-imidazolidin-4-yl)propanoate (<b>60</b>) (200 g, 746 mmol, 1 equiv) in dioxane (100 mL) and was cooled in an ice bath; a 4 N HCl solution in dioxane (1 L) was added slowly. The reaction mixture was stirred at rt for 4 h and concentrated <i>in vacuo</i>. The resulting solid was suspended in 240 mL of acetonitrile, then stirred at reflux for 1 h, and allowed to cool down to rt under stirring. The resulting solid was separated by filtration, washed twice with acetonitrile (2 × 30 mL), and finally dried under vacuum at 45 °C to afford 3-(4-cyclopropyl-2,5-dioxo-imidazolidin-4-yl)propanoic acid (120 g, 76%) as a white solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 12.19 (br s, 1H), 10.61 (s, 1H), 7.70 (s, 1H), 2.33–2.22 (m, 1H), 2.18–2.09 (m, 1H), 1.99–1.87 (m, 2H), 1.10–1.04 (m, 1H), 0.47–0.41 (m, 1H), 0.39–0.28 (m, 2H), 0.13–0.06 (m, 1H). LC-MS: <i>m</i>/<i>z</i> = 213.2 [M + H].</div></div><div id="sec4_1_11_7" class="NLM_sec NLM_sec_level_3"><div id="ac_i62" class="anchor-spacer"></div><h4 class="article-section__title" id="_i62"> (<i>S</i>)-3-(4-Cyclopropyl-2,5-dioxoimidazolidin-4-yl)propanoic Acid (<b>[<i>S</i>]-61</b>)</h4><div class="NLM_p">The racemic 3-(4-cyclopropyl-2,5-dioxoimidazolidin-4-yl)propanoic acid (<b>61</b>) (600.0 g) was separated by chiral SFC to afford 253.33 g (42%) of the faster-eluting isomer and 258.92 g (43%) of the slower-eluting isomer. The slower-eluting isomer, (<i>S</i>)-3-(4-cyclopropyl-2,5-dioxoimidazolidin-4-yl)propanoic acid, was the isomer of interest. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 12.20 (s, 1H), 10.62 (s, 1H), 7.70 (s, 1H), 2.33–2.20 (m, 1H), 2.18–2.07 (m, 1H), 2.00–1.86 (m, 2H), 1.11–1.02 (m, 1H), 0.48–0.40 (m, 1H), 0.39–0.25 (m, 2H), 0.14–0.03 (m, 1H). LC-MS: <i>m</i>/<i>z</i> = 213.1 [M + H]. ee: 99.1% [ChiralPak AD-3 μm, 250 × 4.6 mm, CO<sub>2</sub> and ethanol (0.05% DEA) (gradient ethanol 5–40%), 35 °C, wavelength 210 nm].</div><div class="NLM_p">The purification was done in two stages.</div><div class="NLM_p">Conditions of the first separation were as follows: preparative SFC; column, ChiralPak AD-10 μm, 300 × 50 mm ID; mobile phase, CO<sub>2</sub>/EtOH (55/45) in isocratic mode; flow rate, 200 mL/min; column temperature, 38 °C; wavelength, 220 nm; cycle time, approximately 10.0 min; sample preparation, compound dissolved in MeOH to approximately 120 mg/mL; workup: fractions dried off via rotary evaporator to obtain the desired isomer, which was further upgraded by preparative HPLC to remove traces of ethyl ester formed.</div><div class="NLM_p last">Conditions of the second separation were as follows: preparative HPLC; column, C18, 250 × 50 mm ID; mobile phase, H<sub>2</sub>O and acetonitrile (5–20%) in 15 min linearly; flow rate, 80 mL/min; wavelength, 220 nm; sample preparation, compound dissolved in MeOH at approximately 100 mg/mL. Evaporation and lyophilization afforded the desired enantiomer.</div></div><div id="sec4_1_11_8" class="NLM_sec NLM_sec_level_3"><div id="ac_i63" class="anchor-spacer"></div><h4 class="article-section__title" id="_i63"> (<i>S</i>)-5-Cyclopropyl-5-(3-((<i>S</i>)-4-(3,5-difluorophenyl)-3-methylpiperazin-1-yl)-3-oxopropyl)imidazolidine-2,4-dione (GLPG1972)</h4><div class="NLM_p">The reaction was performed four times, starting with 50 g of (<i>S</i>)-3-(4-cyclopropyl-2,5-dioxoimidazolidin-4-yl)propanoic acid (<b>[</b><i><b>S</b></i><b>]-61</b>). The crude materials obtained were gathered before the purification step.</div><div class="NLM_p last">(<i>S</i>)-3-(4-Cyclopropyl-2,5-dioxoimidazolidin-4-yl)propanoic acid (<b>[</b><i><b>S</b></i><b>]-61</b>) (50 g, 0.24 mol, 1.1 equiv) was dissolved in DMF (360 mL). (<i>S</i>)-1-(3,5-Difluorophenyl)-2-methylpiperazine (<i><b>S</b></i><b>-65</b>) (61 g, 0.21 mol, 1 equiv) as a dihydrochloride salt, DIPEA (148 mL, 0.84 mol, 4 equiv; added through glass funnel over 2 min), EDC HCl (45 g, 0.24 mol, 1.1 equiv), and HOBt (4.95 g, 0.032 mol, 0.15 equiv) were added, and the reaction mixture was stirred at rt for 18 h. The reaction mixture was poured into cold, stirring water (1.8 L) and stirred for 45 min. A small precipitate was formed and filtered off. Filtrate was extracted with EtOAc (2 × 650 and 300 mL). Combined organic layers were washed with saturated aqueous NaHCO<sub>3</sub> (2 × 800 and 500 mL) and brine (2 × 500 mL), dried over Na<sub>2</sub>SO<sub>4</sub>, and concentrated <i>in vacuo</i>. Four separate batches of 50 g gave 321.8 g of crude material, which was purified by flash chromatography on silica gel (elution DCM/MeOH/NH<sub>3</sub>: 100/0/0 to 90/5/0.5) to afford (<i>S</i>)-5-cyclopropyl-5-(3-((<i>S</i>)-4-(3,5-difluorophenyl)-3-methylpiperazin-1-yl)-3-oxopropyl)imidazolidine-2,4-dione (285 g, 82%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>; mixture of rotamers was observed): δ 10.62 (s, 1H), 7.73 (d, <i>J</i> = 17.1 Hz, 1H), 6.66–6.50 (m, 2H), 6.46 (td, <i>J</i> = 9.2, 2.0 Hz, 1H), 4.41–4.26 (m, 0.5H), 4.26–4.00 (m, 1.5H), 3.81 (d, <i>J</i> = 13.1 Hz, 0.5H), 3.66 (d, <i>J</i> = 13.5 Hz, 0.5H), 3.52–3.36 (m, 1.5H), 3.32–3.15 (m, 0.5H), 3.16–2.72 (m, 2H), 2.49–2.12 (m, 2H), 2.09–1.77 (m, 2H), 1.36–1.01 (m, 1H), 0.95 (dd, <i>J</i> = 26.4, 6.5 Hz, 3H), 0.62–0.23 (m, 3H), 0.22 to −0.00 (m, 1H). <sup>13</sup>C NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>; mixture of rotamers was observed): δ −1.1, −1.0, 0.5, 0.6, 12.0, 12.4, 15.8, 16.0, 26.6, 26.9, 32.0, 32.1, 40.7, 41.2, 44.3, 45.1, 49.1, 49.38, 49.42, 63.8, 63.9, 92.4, 96.9, 97.3, 151.7, 156.9, 161.9, 162.1, 170.2, 170.3, 177.5, 177.6. LC-MS: <i>m</i>/<i>z</i> = 407.5 [M + H]. HRMS [M + H]<sup>+</sup> calcd for C<sub>20</sub>H<sub>25</sub>F<sub>2</sub>N<sub>4</sub>O<sub>3</sub>, 407.1895; found, 407.1937. [α]<sub>D</sub><sup>20</sup> = −15.2 (c 1, EtOH). ee ≥ 99.4% [Chiralpak IC (250 × 4.6 mm), 5 μm, heptane/EtOH/DEA (70/30/0.1, v/v/v), flow rate of 1 mL/min].</div></div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i64"><a href="/doi/suppl/10.1021/acs.jmedchem.0c02008" class="ext-link">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_78248" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_78248" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge at <a href="/doi/10.1021/acs.jmedchem.0c02008?goto=supporting-info" class="ext-link">https://pubs.acs.org/doi/10.1021/acs.jmedchem.0c02008</a>.<ul class="NLM_list-list_type-label" id="silist"><li><p class="inline">Details of data collection, processing, and structure-refinement statistics for the protein crystal structure of ADAMTS-5 in complex with inhibitor GLPG1972/S201086; correlation between inhibitory activity (IC<sub>50</sub>, nM) in rn- and hs-ADAMTS-5 preparations; synthetic procedures; and characterization of compounds (<a href="/doi/suppl/10.1021/acs.jmedchem.0c02008/suppl_file/jm0c02008_si_001.pdf" class="ext-link">PDF</a>)</p></li><li><p class="inline">Molecular formula string (<a href="/doi/suppl/10.1021/acs.jmedchem.0c02008/suppl_file/jm0c02008_si_002.csv" class="ext-link">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.0c02008/suppl_file/jm0c02008_si_001.pdf">jm0c02008_si_001.pdf (1.01 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.0c02008/suppl_file/jm0c02008_si_002.csv">jm0c02008_si_002.csv (8.12 kb)</a></li></ul></div></div></div><span class="author-information-subsection-header">Accession Codes</span><p class="last">PDB ID <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6YJM">6YJM</a>, GLPG1972 in ADAMTS-5; PDB ID <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3B8Z">3B8Z</a>: compound <b>1</b> in ADAMTS-5. Authors will release the atomic coordinates and experimental data upon article publication.</p><div class="testing" data-doi="10.1021/acs.jmedchem.0c02008" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_10642" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_10642" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Franck Brebion</span> - <span class="hlFld-Affiliation affiliation">Galapagos
SASU, 102 Avenue Gaston Roussel, 93230 Romainville, France</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-5293-0408" title="Orcid link">http://orcid.org/0000-0002-5293-0408</a>; 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#236551424d40480d615146414a4c4d63444f53440d404c4e"><span class="__cf_email__" data-cfemail="e5a397848b868ecba79780878c8a8ba582899582cb868a88">[email protected]</span></a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Romain Gosmini</span> - <span class="hlFld-Affiliation affiliation">Galapagos
SASU, 102 Avenue Gaston Roussel, 93230 Romainville, France</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#a4f6cbc9c5cdca8ae3cbd7c9cdcacde4c3c8d4c38ac7cbc9"><span class="__cf_email__" data-cfemail="87d5e8eae6eee9a9c0e8f4eaeee9eec7e0ebf7e0a9e4e8ea">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Pierre Deprez</span> - <span class="hlFld-Affiliation affiliation">Galapagos
SASU, 102 Avenue Gaston Roussel, 93230 Romainville, France</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Marie Varin</span> - <span class="hlFld-Affiliation affiliation">Galapagos
SASU, 102 Avenue Gaston Roussel, 93230 Romainville, France</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Christophe Peixoto</span> - <span class="hlFld-Affiliation affiliation">Galapagos
SASU, 102 Avenue Gaston Roussel, 93230 Romainville, France</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Luke Alvey</span> - <span class="hlFld-Affiliation affiliation">Galapagos
SASU, 102 Avenue Gaston Roussel, 93230 Romainville, France</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Hélène Jary</span> - <span class="hlFld-Affiliation affiliation">Galapagos
SASU, 102 Avenue Gaston Roussel, 93230 Romainville, France</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Natacha Bienvenu</span> - <span class="hlFld-Affiliation affiliation">Galapagos
SASU, 102 Avenue Gaston Roussel, 93230 Romainville, France</span>; 
    <span>Present Address:
                        N.B.: Evotec SAS, 195 route d‘Espagne, 31036 Toulouse CEDEX, France</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Nicolas Triballeau</span> - <span class="hlFld-Affiliation affiliation">Galapagos
SASU, 102 Avenue Gaston Roussel, 93230 Romainville, France</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Roland Blanque</span> - <span class="hlFld-Affiliation affiliation">Galapagos
SASU, 102 Avenue Gaston Roussel, 93230 Romainville, France</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Céline Cottereaux</span> - <span class="hlFld-Affiliation affiliation">Galapagos
SASU, 102 Avenue Gaston Roussel, 93230 Romainville, France</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Thierry Christophe</span> - <span class="hlFld-Affiliation affiliation">Galapagos
NV, Generaal De Wittelaan
L11 A3, 2800 Mechelen, Belgium</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Nele Vandervoort</span> - <span class="hlFld-Affiliation affiliation">Galapagos
NV, Generaal De Wittelaan
L11 A3, 2800 Mechelen, Belgium</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Patrick Mollat</span> - <span class="hlFld-Affiliation affiliation">Galapagos
SASU, 102 Avenue Gaston Roussel, 93230 Romainville, France</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Robert Touitou</span> - <span class="hlFld-Affiliation affiliation">Galapagos
SASU, 102 Avenue Gaston Roussel, 93230 Romainville, France</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Philip Leonard</span> - <span class="hlFld-Affiliation affiliation">Structural
Biology, Charles River, Chesterford Research Park, CB10 1XL Saffron Walden, United Kingdom</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Frédéric De Ceuninck</span> - <span class="hlFld-Affiliation affiliation">Institut
de Recherches Servier, Center for Therapeutic Innovation, Immuno-inflammatory
Disease, 78290 Croissy sur Seine, France</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Iuliana Botez</span> - <span class="hlFld-Affiliation affiliation">Institut
de Recherches Servier, Chemistry Center of Excellence, 78290 Croissy sur
Seine, France</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Alain Monjardet</span> - <span class="hlFld-Affiliation affiliation">Galapagos
SASU, 102 Avenue Gaston Roussel, 93230 Romainville, France</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ellen van der Aar</span> - <span class="hlFld-Affiliation affiliation">Galapagos
NV, Generaal De Wittelaan
L11 A3, 2800 Mechelen, Belgium</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">David Amantini</span> - <span class="hlFld-Affiliation affiliation">Galapagos
SASU, 102 Avenue Gaston Roussel, 93230 Romainville, France</span></div></li></ul></li><li></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare the following competing financial interest(s): F.B., R.G., P.D., M.V., C.P., L.A., H.J., N.T., R.B., C.C., T.C., N.V., P.M., R.T., P.L., A.M., E.v.d.A., and D.A. are employees of Galapagos. N.B. was an employee of Galapagos at the time of the work. F.D. and I.B. are employees of Servier. P.L. is an employee of Charles River.<br /></br></div></li></ul></div><div class="ack" id="ack1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i67">Acknowledgments</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_84728" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_84728" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">This study was funded by Galapagos. The authors would like to thank Philippe Delerive and Damien Fleury for fruitful discussions. The authors would also like to thank Pieter F. W. Stouten, Vivienne Allen, and Michael J. Lipkin who have actively contributed to the design and have built the statistical model (Naïve Bayes classifier) described in this paper. Medical writing support was provided by Dr. Nicolas Bertheleme of Oxford PharmaGenesis, Oxford, UK, with funding from Galapagos.</p></div><table summary="" class="NLM_def-list" id="dl1"><tr><td colspan="2" class="NLM_title">Abbreviations Used</td></tr><tr><td class="NLM_term">A2B</td><td class="NLM_def"><p class="first last">apical to basolateral</p></td></tr><tr><td class="NLM_term">ADAM</td><td class="NLM_def"><p class="first last">A disintegrin and metalloproteinase</p></td></tr><tr><td class="NLM_term">ADAMTS</td><td class="NLM_def"><p class="first last">A disintegrin and metalloproteinase with thrombospondin motifs</p></td></tr><tr><td class="NLM_term">ADAMTS-5</td><td class="NLM_def"><p class="first last">A disintegrin and metalloproteinase with thrombospondin motifs</p></td></tr><tr><td class="NLM_term">5AGC</td><td class="NLM_def"><p class="first last">aggrecan</p></td></tr><tr><td class="NLM_term">BEH</td><td class="NLM_def"><p class="first last">ethylene-bridged hybrid</p></td></tr><tr><td class="NLM_term">BFC</td><td class="NLM_def"><p class="first last">7-benzyloxy-4-trifluoromethylcoumarin</p></td></tr><tr><td class="NLM_term">CL</td><td class="NLM_def"><p class="first last">clearance</p></td></tr><tr><td class="NLM_term">CL<sub>int</sub></td><td class="NLM_def"><p class="first last">intrinsic clearance</p></td></tr><tr><td class="NLM_term">CM</td><td class="NLM_def"><p class="first last">conditioned medium</p></td></tr><tr><td class="NLM_term"><i>C</i><sub>max</sub></td><td class="NLM_def"><p class="first last">maximum plasma concentration</p></td></tr><tr><td class="NLM_term">DBF</td><td class="NLM_def"><p class="first last">dibenzylfluorescein</p></td></tr><tr><td class="NLM_term">DMOADs</td><td class="NLM_def"><p class="first last">disease-modifying osteoarthritis (OA) drugs</p></td></tr><tr><td class="NLM_term">DDP-IV</td><td class="NLM_def"><p class="first last">dipeptidyl peptidase-IV</p></td></tr><tr><td class="NLM_term">eq</td><td class="NLM_def"><p class="first last">equivalent</p></td></tr><tr><td class="NLM_term">ER</td><td class="NLM_def"><p class="first last">efflux ratio</p></td></tr><tr><td class="NLM_term"><i>F</i></td><td class="NLM_def"><p class="first last">oral bioavailability</p></td></tr><tr><td class="NLM_term">GAG</td><td class="NLM_def"><p class="first last">glycosaminoglycan</p></td></tr><tr><td class="NLM_term">HLM</td><td class="NLM_def"><p class="first last">human liver microsomes</p></td></tr><tr><td class="NLM_term">HSA</td><td class="NLM_def"><p class="first last">human serum albumin</p></td></tr><tr><td class="NLM_term">hs-ADAMTS-4/-5</td><td class="NLM_def"><p class="first last">human recombinant A disintegrin and metalloproteinase with thrombospondin motifs-4/-5</p></td></tr><tr><td class="NLM_term">H</td><td class="NLM_def"><p class="first last">human</p></td></tr><tr><td class="NLM_term">ID</td><td class="NLM_def"><p class="first last">inner diameter</p></td></tr><tr><td class="NLM_term">iv</td><td class="NLM_def"><p class="first last">intravenous</p></td></tr><tr><td class="NLM_term"><i>L</i></td><td class="NLM_def"><p class="first last">length</p></td></tr><tr><td class="NLM_term">MBI</td><td class="NLM_def"><p class="first last">mechanism-based inactivation</p></td></tr><tr><td class="NLM_term">MDCK</td><td class="NLM_def"><p class="first last">Madin–Darby canine kidney cell</p></td></tr><tr><td class="NLM_term">Me</td><td class="NLM_def"><p class="first last">methyl group</p></td></tr><tr><td class="NLM_term">min</td><td class="NLM_def"><p class="first last">minute</p></td></tr><tr><td class="NLM_term">ND</td><td class="NLM_def"><p class="first last">not disclosed</p></td></tr><tr><td class="NLM_term">OA</td><td class="NLM_def"><p class="first last">osteoarthritis</p></td></tr><tr><td class="NLM_term">P<sub>app</sub>A<sub>2</sub>B</td><td class="NLM_def"><p class="first last">apparent permeability from apical to basal chambers</p></td></tr><tr><td class="NLM_term">PBMC</td><td class="NLM_def"><p class="first last">peripheral blood mononuclear cell</p></td></tr><tr><td class="NLM_term">po</td><td class="NLM_def"><p class="first last"><i>per os</i></p></td></tr><tr><td class="NLM_term">R</td><td class="NLM_def"><p class="first last">rat</p></td></tr><tr><td class="NLM_term">rn-ADAMTS-4/-5</td><td class="NLM_def"><p class="first last">rat recombinant A disintegrin and metalloproteinase with thrombospondin motif-4/-5</p></td></tr><tr><td class="NLM_term">ROC</td><td class="NLM_def"><p class="first last">receiver operating characteristic</p></td></tr><tr><td class="NLM_term">TACE</td><td class="NLM_def"><p class="first last">tumor necrosis factor-α-converting enzyme</p></td></tr><tr><td class="NLM_term">UPLC</td><td class="NLM_def"><p class="first last">ultraperformance liquid chromatography</p></td></tr><tr><td class="NLM_term">Vss</td><td class="NLM_def"><p class="first last">apparent volume of distribution at steady state</p></td></tr><tr><td class="NLM_term">ZBG</td><td class="NLM_def"><p class="first last">zinc binding group</p></td></tr></table><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i69">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_33356" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_33356" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 36 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hunter, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schofield, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Callander, E.</span></span> <span> </span><span class="NLM_article-title">The individual and socioeconomic impact of osteoarthritis</span>. <i>Nat. Rev. Rheumatol.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">437</span>– <span class="NLM_lpage">441</span>, <span class="refDoi"> DOI: 10.1038/nrrheum.2014.44</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02008&amp;key=10.1038%2Fnrrheum.2014.44" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02008&amp;key=24662640" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02008&amp;key=1%3ACAS%3A280%3ADC%252BC2crmvVantQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2014&pages=437-441&author=D.+J.+Hunterauthor=D.+Schofieldauthor=E.+Callander&title=The+individual+and+socioeconomic+impact+of+osteoarthritis&doi=10.1038%2Fnrrheum.2014.44"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">The individual and socioeconomic impact of osteoarthritis</span></div><div class="casAuthors">Hunter David J; Schofield Deborah; Callander Emily</div><div class="citationInfo"><span class="NLM_cas:title">Nature reviews. Rheumatology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">437-41</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Osteoarthritis (OA) is a highly prevalent, disabling disease, with a commensurate tremendous individual and socioeconomic burden.  This Perspectives article focuses on the burden of OA for the individual, the health-care system and society, to draw attention to the magnitude of the current problem with some reference to projected figures.  We have an urgent opportunity to make fundamental changes to the way we care for individuals with OA that will have an effect upon the direct and indirect costs of this disease.  By focusing on the burden of this prevalent, disabling, and costly disease, we hope to highlight the opportunity for shifts in health-care policy towards prevention and chronic-disease management.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSzrLZQFrf-SsSzjBFCN0BJfW6udTcc2eYMWrN7ldYydrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2crmvVantQ%253D%253D&md5=2c735203ce3ca044913a7710502f69a7</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1038%2Fnrrheum.2014.44&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrrheum.2014.44%26sid%3Dliteratum%253Aachs%26aulast%3DHunter%26aufirst%3DD.%2BJ.%26aulast%3DSchofield%26aufirst%3DD.%26aulast%3DCallander%26aufirst%3DE.%26atitle%3DThe%2520individual%2520and%2520socioeconomic%2520impact%2520of%2520osteoarthritis%26jtitle%3DNat.%2520Rev.%2520Rheumatol.%26date%3D2014%26volume%3D10%26spage%3D437%26epage%3D441%26doi%3D10.1038%2Fnrrheum.2014.44" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">O’Neil, C. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hanlon, J. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marcum, Z. A.</span></span> <span> </span><span class="NLM_article-title">Adverse effects of analgesics commonly used by older adults with osteoarthritis: focus on non-opioid and opioid analgesics</span>. <i>Am. J. Geriatr Pharmacother</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">331</span>– <span class="NLM_lpage">342</span>, <span class="refDoi"> DOI: 10.1016/j.amjopharm.2012.09.004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02008&amp;key=10.1016%2Fj.amjopharm.2012.09.004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02008&amp;key=23036838" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02008&amp;key=1%3ACAS%3A528%3ADC%252BC3sXmtV2ns7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2012&pages=331-342&author=C.+K.+O%E2%80%99Neilauthor=J.+T.+Hanlonauthor=Z.+A.+Marcum&title=Adverse+effects+of+analgesics+commonly+used+by+older+adults+with+osteoarthritis%3A+focus+on+non-opioid+and+opioid+analgesics&doi=10.1016%2Fj.amjopharm.2012.09.004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Adverse Effects of Analgesics Commonly Used by Older Adults With Osteoarthritis: Focus on Non-Opioid and Opioid Analgesics</span></div><div class="casAuthors">O'Neil, Christine K.; Hanlon, Joseph T.; Marcum, Zachary A.</div><div class="citationInfo"><span class="NLM_cas:title">American Journal of Geriatric Pharmacotherapy</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">331-342</span>CODEN:
                <span class="NLM_cas:coden">AJGPB5</span>;
        ISSN:<span class="NLM_cas:issn">1876-7761</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Osteoarthritis (OA) is the most common cause of disability in older adults, and although analgesic use can be helpful, it can also result in adverse drug events.  To review the recent literature to describe potential adverse drug events assocd. with analgesics commonly used by older adults with OA.  To identify articles for this review, a systematic search of the English-language literature from Jan. 2001 to June 2012 was conducted using PubMed, MEDLINE, EBSCO, and the Cochrane Database of Systematic Reviews for publications related to the medical management of OA.  Search terms used were "analgesics," "acetaminophen," "nonsteroidal anti-inflammatory drugs" (NSAIDs), "opioids," "pharmacokinetics," "pharmacodynamics," and "adverse drug events." The search was restricted to those articles that concerned humans aged ≥65 years.  A manual search of the ref. lists from identified articles and the authors' article files, book chapters, and recent reviews was conducted to identify addnl. articles.  From these, the authors identified those studies that examd. analgesic use in older adults.  There are limited data to suggest that non-frail elders are more likely than their younger counterparts to develop acetaminophen-induced hepatotoxicity.  However, decreased hepatic phase II metab. in frail elders may result in increased risk of hepatotoxicity.  It is now well established that older adults are at higher risk of NSAID-induced gastrointestinal toxicity and renal insufficiency.  Insofar as opioids, the data that suggest an increased risk of falls, fractures, or delirium need to be tempered by the potential risk of inadequately treating severe chronic OA-related pain.  Acetaminophen is the mainstay frontline analgesic for treating OA-related pain in older adults.  NSAIDs should be limited to short-term use only, and for moderate to severe OA-related pain, opioids may be preferable in individuals without substance abuse or dependence issues.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoRlmkGVxFgL7Vg90H21EOLACvtfcHk0lj9hJdv_oFtvw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXmtV2ns7c%253D&md5=6f22f392d17a5f4faa03bbad6e370481</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1016%2Fj.amjopharm.2012.09.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.amjopharm.2012.09.004%26sid%3Dliteratum%253Aachs%26aulast%3DO%25E2%2580%2599Neil%26aufirst%3DC.%2BK.%26aulast%3DHanlon%26aufirst%3DJ.%2BT.%26aulast%3DMarcum%26aufirst%3DZ.%2BA.%26atitle%3DAdverse%2520effects%2520of%2520analgesics%2520commonly%2520used%2520by%2520older%2520adults%2520with%2520osteoarthritis%253A%2520focus%2520on%2520non-opioid%2520and%2520opioid%2520analgesics%26jtitle%3DAm.%2520J.%2520Geriatr%2520Pharmacother%26date%3D2012%26volume%3D10%26spage%3D331%26epage%3D342%26doi%3D10.1016%2Fj.amjopharm.2012.09.004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Teichtahl, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cicuttini, F. M.</span></span> <span> </span><span class="NLM_article-title">Osteoarthritis year in review 2015: imaging</span>. <i>Osteoarthritis and cartilage</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>24</i></span>,  <span class="NLM_fpage">49</span>– <span class="NLM_lpage">57</span>, <span class="refDoi"> DOI: 10.1016/j.joca.2015.07.027</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02008&amp;key=10.1016%2Fj.joca.2015.07.027" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02008&amp;key=26707992" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02008&amp;key=1%3ACAS%3A280%3ADC%252BC28rlt1Gjsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2016&pages=49-57&author=Y.+Wangauthor=A.+J.+Teichtahlauthor=F.+M.+Cicuttini&title=Osteoarthritis+year+in+review+2015%3A+imaging&doi=10.1016%2Fj.joca.2015.07.027"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Osteoarthritis year in review 2015: imaging</span></div><div class="casAuthors">Wang Y; Teichtahl A J; Cicuttini F M</div><div class="citationInfo"><span class="NLM_cas:title">Osteoarthritis and cartilage</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">49-57</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">PURPOSE:  This narrative review covers original publications related to imaging in osteoarthritis (OA) published in English between 1 April 2014 and 30 April 2015.  Novel lessons relating to imaging are described.  METHODS:  An extensive PubMed database search was performed based on, but not limited to the terms "OA" in combination with "Magnetic resonance imaging (MRI)", "Imaging", "Radiography", "Ultrasound", "Computed tomography (CT)" and "Nuclear medicine" to extract relevant studies.  In vitro data and animal studies were excluded.  This review focuses on the new developments and observations based on the aforementioned imaging modalities, as well as a 'whole-organ' approach by presenting findings from different tissues (bone, meniscus, synovium, muscle and fat) and joints (hip, lumbar spine and hand).  RESULTS AND CONCLUSIONS:  Over the past year, studies using imagine have made a major contribution to the understanding of the pathogenesis of OA.  Significant work has continued at the knee, with MRI now being increasingly used to assess structural endpoints in clinical trials.  This offers the exciting opportunity to explore potential disease modifying OA therapies.  There has been a clear interest in the role of bone in the pathogenesis of OA.  There is now a growing body of literature examining the pathogenesis of OA at the hip, lumbar spine and hand.  The future of imaging in OA offers the exciting potential to better understand the disease process across all joints and develop more effective preventive and therapeutic interventions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSnG-xUyVai4BWfpMXQLRstfW6udTcc2eauOlV6cyd5MLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC28rlt1Gjsg%253D%253D&md5=d101c7a60f2d40903d34be8b73c9a894</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1016%2Fj.joca.2015.07.027&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.joca.2015.07.027%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DY.%26aulast%3DTeichtahl%26aufirst%3DA.%2BJ.%26aulast%3DCicuttini%26aufirst%3DF.%2BM.%26atitle%3DOsteoarthritis%2520year%2520in%2520review%25202015%253A%2520imaging%26jtitle%3DOsteoarthritis%2520and%2520cartilage%26date%3D2016%26volume%3D24%26spage%3D49%26epage%3D57%26doi%3D10.1016%2Fj.joca.2015.07.027" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yang, C. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chanalaris, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Troeberg, L.</span></span> <span> </span><span class="NLM_article-title">ADAMTS and ADAM metalloproteinases in osteoarthritis - looking beyond the ‘usual suspects’</span>. <i>Osteoarthritis and cartilage</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>25</i></span>,  <span class="NLM_fpage">1000</span>– <span class="NLM_lpage">1009</span>, <span class="refDoi"> DOI: 10.1016/j.joca.2017.02.791</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02008&amp;key=10.1016%2Fj.joca.2017.02.791" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02008&amp;key=28216310" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02008&amp;key=1%3ACAS%3A280%3ADC%252BC1c3osV2gtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2017&pages=1000-1009&author=C.+Y.+Yangauthor=A.+Chanalarisauthor=L.+Troeberg&title=ADAMTS+and+ADAM+metalloproteinases+in+osteoarthritis+-+looking+beyond+the+%E2%80%98usual+suspects%E2%80%99&doi=10.1016%2Fj.joca.2017.02.791"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">ADAMTS and ADAM metalloproteinases in osteoarthritis - looking beyond the 'usual suspects'</span></div><div class="casAuthors">Yang C-Y; Chanalaris A; Troeberg L</div><div class="citationInfo"><span class="NLM_cas:title">Osteoarthritis and cartilage</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1000-1009</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">INTRODUCTION:  Matrix metalloproteinases (MMPs) and 'aggrecanase' a disintegrin and metalloproteinase with thrombospondin motifs (ADAMTSs) are well established to play key roles in osteoarthritis (OA) through degradation of extracellular matrix (ECM) type II collagen and aggrecan, and are thus potential targets for development of OA therapies.  OBJECTIVE:  This paper aims to provide a comprehensive review of the expression and potential roles of other, lesser-known ADAMTSs and related adamalysins (or a disintegrin and metalloproteinases (ADAMs)) in cartilage, with a view to identifying potentially protective or homeostatic metalloproteinases in the joint and informing consequent selective inhibitor design.  DESIGN:  A comprehensive literature search was performed using PubMed terms 'osteoarthritis' and 'ADAMTS' or 'ADAM'.  RESULTS:  Several ADAMTSs and ADAMs were identified as having reportedly increased expression in OA.  These include enzymes likely to play roles in cartilage matrix anabolism (e.g., the procollagen N-proteinases ADAMTS-2, ADAMTS-3 and ADAMTS-14), chondrocyte differentiation and proliferation (e.g., ADAM9, ADAM10, ADAM12), as well as enzymes contributing to cartilage catabolism (e.g., Cartilage oligomeric protein (COMP)-degrading ADAMTS-7 and ADAMTS-12).  CONCLUSIONS:  In addition to the well-characterised MMPs, ADAMTS-4 and ADAMTS-5, many other ADAMTSs and ADAMs are expressed in cartilage and several show significantly altered expression in OA.  Studies aimed at elucidating the pathophysiological roles of these enzymes in cartilage will contribute to our understanding of OA pathogenesis and enable design of targeted inhibitors that effectively target metalloproteinase-mediated cartilage degradation while sparing cartilage repair pathways.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTGxTBW1-m5KGhHGZei4OW9fW6udTcc2eauOlV6cyd5MLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1c3osV2gtg%253D%253D&md5=90d9865793e24f56742bfd2495061996</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1016%2Fj.joca.2017.02.791&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.joca.2017.02.791%26sid%3Dliteratum%253Aachs%26aulast%3DYang%26aufirst%3DC.%2BY.%26aulast%3DChanalaris%26aufirst%3DA.%26aulast%3DTroeberg%26aufirst%3DL.%26atitle%3DADAMTS%2520and%2520ADAM%2520metalloproteinases%2520in%2520osteoarthritis%2520-%2520looking%2520beyond%2520the%2520%25E2%2580%2598usual%2520suspects%25E2%2580%2599%26jtitle%3DOsteoarthritis%2520and%2520cartilage%26date%3D2017%26volume%3D25%26spage%3D1000%26epage%3D1009%26doi%3D10.1016%2Fj.joca.2017.02.791" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wojtowicz-Praga, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dickson, R. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hawkins, M. J.</span></span> <span> </span><span class="NLM_article-title">Matrix metalloproteinase inhibitors</span>. <i>Invest. New Drugs</i> <span class="NLM_year" style="font-weight: bold;">1997</span>,  <span class="NLM_volume"><i>15</i></span>,  <span class="NLM_fpage">61</span>– <span class="NLM_lpage">75</span>, <span class="refDoi"> DOI: 10.1023/A:1005722729132</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02008&amp;key=10.1023%2FA%3A1005722729132" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02008&amp;key=9195290" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02008&amp;key=1%3ACAS%3A528%3ADyaK2sXktlOls7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=1997&pages=61-75&author=S.+M.+Wojtowicz-Pragaauthor=R.+B.+Dicksonauthor=M.+J.+Hawkins&title=Matrix+metalloproteinase+inhibitors&doi=10.1023%2FA%3A1005722729132"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Matrix metalloproteinase inhibitors</span></div><div class="casAuthors">Wojtowicz-Praga, Slawomir M.; Dickson, Robert B.; Hawkins, Michael J.</div><div class="citationInfo"><span class="NLM_cas:title">Investigational New Drugs</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">61-75</span>CODEN:
                <span class="NLM_cas:coden">INNDDK</span>;
        ISSN:<span class="NLM_cas:issn">0167-6997</span>.
    
            (<span class="NLM_cas:orgname">Kluwer</span>)
        </div><div class="casAbstract">A review with 94 refs.  The matrix metalloproteinases (MMPs) are a family of at least fifteen secreted and membrane-bound zinc-endopeptidases.  Collectively, these enzymes can degrade all of the components of the extracellular matrix, including fibrillar and non-fibrillar collagens, fibronectin, laminin and basement membrane glycoproteins.  MMPs are thought to be essential for the diverse invasive processes of angiogenesis and tumor metastasis.  Numerous studies have shown that there is a close assocn. between expression of various members of the MMP family by tumors and their proliferative and invasive behavior and metastatic potential.  In some of human cancers a pos. correlation has also been demonstrated between the intensity of new blood vessel growth (angiogenesis) and the likelihood of developing metastases.  Thus, control of MMP activity in these two different contexts has generated considerable interest as a possible therapeutic target.  The tissue inhibitors of metalloproteinases (TIMPs) are naturally occurring proteins that specifically inhibit matrix metalloproteinases, thus maintaining balance between matrix destruction and formation.  An imbalance between MMPs and the assocd. TIMPs may play a significant role in the invasive phenotype of malignant tumors.  TIMP-1 has been shown to inhibit tumor-induced angiogenesis in exptl. systems.  These findings raised the possibility of using an agent that affects expression or activity of MMPs as an anti-cancer therapy.  TIMPs are probably not suitable for pharmacol. applications due to their short half-life in vivo.  Batimastat (BB-94) and marimastat (BB-2516) are synthetic, low-mol. wt. MMP inhibitors.  They have a collagen-mimicking hydroxamate structure, which facilitates chelation of the zinc ion in the active site of the MMPs.  These compds. inhibit MMPs potently and specifically.  Batimastat was the first synthetic MMP inhibitor studied in humans with advanced malignancies, but its usefulness has been limited by extremely poor water soly., which required i.p. administration of the drug as a detergent emulsion.  Marimastat belongs to a second generation of MMP inhibitors.  In contrast to batimastat, marimastat is orally available.  Both of these agents are currently in Phase I/II trials in US, Europe and Canada.  Some other new agents, currently in clin. trials, have been shown to inhibit MMP prodn.  Bryostatins, naturally occurring macrocyclic lactones, have both in vitro and in vivo activity in numerous murine and human tumors.  In culture, bryostatin-1 has been shown to induce differentiation and halt the growth of several malignant cell lines.  While the exact mechanism responsible for anti-tumor activity is unclear, an initial event in the action of bryostatin-1 is activation of protein kinase C (PKC), followed by its down regulation.  Bryostatin-1 does not directly affect the activity of MMPs, but it can inhibit the prodn. of MMP-1, 3, 9, 10 and 11 by inhibiting PKC.  TIMP-1 levels could also be modulated by bryostatin-1, as it is encoded by a PKC responsive gene.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpFfjYPPsjV67Vg90H21EOLACvtfcHk0lj9hJdv_oFtvw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXktlOls7s%253D&md5=e3dda291df34d418d5e6f4cf97786f6c</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1023%2FA%3A1005722729132&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1023%252FA%253A1005722729132%26sid%3Dliteratum%253Aachs%26aulast%3DWojtowicz-Praga%26aufirst%3DS.%2BM.%26aulast%3DDickson%26aufirst%3DR.%2BB.%26aulast%3DHawkins%26aufirst%3DM.%2BJ.%26atitle%3DMatrix%2520metalloproteinase%2520inhibitors%26jtitle%3DInvest.%2520New%2520Drugs%26date%3D1997%26volume%3D15%26spage%3D61%26epage%3D75%26doi%3D10.1023%2FA%3A1005722729132" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Malemud, C. J.</span></span> <span> </span><span class="NLM_article-title">Inhibition of MMPs and ADAM/ADAMTS</span>. <i>Biochem. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>165</i></span>,  <span class="NLM_fpage">33</span>– <span class="NLM_lpage">40</span>, <span class="refDoi"> DOI: 10.1016/j.bcp.2019.02.033</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02008&amp;key=10.1016%2Fj.bcp.2019.02.033" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02008&amp;key=30826330" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02008&amp;key=1%3ACAS%3A528%3ADC%252BC1MXks1eks78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=165&publication_year=2019&pages=33-40&author=C.+J.+Malemud&title=Inhibition+of+MMPs+and+ADAM%2FADAMTS&doi=10.1016%2Fj.bcp.2019.02.033"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of MMPs and ADAM/ADAMTS</span></div><div class="casAuthors">Malemud, Charles J.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Pharmacology (Amsterdam, Netherlands)</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">165</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">33-40</span>CODEN:
                <span class="NLM_cas:coden">BCPCA6</span>;
        ISSN:<span class="NLM_cas:issn">0006-2952</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Matrix metalloproteinases (MMPs), A Disintegrin and Metalloproteinase (ADAM) and Disintegrin and Metalloproteinase with Thrombospondin Motif (ADAMTS) are zinc-dependent endopeptidases that play a crit. role in the destruction of extracellular matrix proteins and, the shedding of membrane-bound receptor mols. in various forms of arthritis and other diseases.  Under normal conditions, MMP, ADAM and ADAMTS gene expression aids in the maintenance of homeostasis.  However, in inflamed synovial joints characteristic of rheumatoid arthritis and osteoarthritis.  MMP, ADAM and ADAMTS prodn. is greatly increased under the influence of pro-inflammatory cytokines.  Analyses based on medicinal chem. strategies designed to directly inhibit the activity of MMPs have been largely unsuccessful when these MMP inhibitors were employed in animal models of rheumatoid arthritis and osteoarthritis.  This is despite the fact that these MMP inhibitors were largely able to suppress pro-inflammatory cytokine-induced MMP prodn. in vitro.  A focus on ADAM and ADAMTS inhibitors has also been pursued.  Thus, recent progress has identified the "sheddase" activity of ADAMs as a viable target and the development of GW280264X is an exptl. ADAM17 inhibitor.  Of note, a monoclonal antibody, GLPG1972, developed as an ADAMTS-5 inhibitor, entered a Phase I OA clin. trial.  However, the failure of many of these previously developed inhibitors to move beyond the preclin. testing phase has required that novel strategies be developed that are designed to suppress both MMP, ADAM and ADAMTS prodn. and activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpodUTdsK4strVg90H21EOLACvtfcHk0li8zpHd7XmupQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXks1eks78%253D&md5=8aa04cc97bafeec7f028531fd9e9a3fc</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1016%2Fj.bcp.2019.02.033&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bcp.2019.02.033%26sid%3Dliteratum%253Aachs%26aulast%3DMalemud%26aufirst%3DC.%2BJ.%26atitle%3DInhibition%2520of%2520MMPs%2520and%2520ADAM%252FADAMTS%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D2019%26volume%3D165%26spage%3D33%26epage%3D40%26doi%3D10.1016%2Fj.bcp.2019.02.033" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Glasson, S. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Askew, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sheppard, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carito, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blanchet, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, H. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Flannery, C. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peluso, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kanki, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Majumdar, M. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morris, E. A.</span></span> <span> </span><span class="NLM_article-title">Deletion of active ADAMTS5 prevents cartilage degradation in a murine model of osteoarthritis</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>434</i></span>,  <span class="NLM_fpage">644</span>– <span class="NLM_lpage">648</span>, <span class="refDoi"> DOI: 10.1038/nature03369</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02008&amp;key=10.1038%2Fnature03369" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02008&amp;key=15800624" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02008&amp;key=1%3ACAS%3A528%3ADC%252BD2MXislCmsr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=434&publication_year=2005&pages=644-648&author=S.+S.+Glassonauthor=R.+Askewauthor=B.+Sheppardauthor=B.+Caritoauthor=T.+Blanchetauthor=H.+L.+Maauthor=C.+R.+Flanneryauthor=D.+Pelusoauthor=K.+Kankiauthor=Z.+Yangauthor=M.+K.+Majumdarauthor=E.+A.+Morris&title=Deletion+of+active+ADAMTS5+prevents+cartilage+degradation+in+a+murine+model+of+osteoarthritis&doi=10.1038%2Fnature03369"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Deletion of active ADAMTS5 prevents cartilage degradation in a murine model of osteoarthritis</span></div><div class="casAuthors">Glasson, Sonya S.; Askew, Roger; Sheppard, Barbara; Carito, Brenda; Blanchet, Tracey; Ma, Hak-Ling; Flannery, Carl R.; Peluso, Diane; Kanki, Kim; Yang, Zhiyong; Majumdar, Manas K.; Morris, Elisabeth A.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">434</span>
        (<span class="NLM_cas:issue">7033</span>),
    <span class="NLM_cas:pages">644-648</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Human osteoarthritis is a progressive disease of the joints characterized by degrdn. of articular cartilage.  Although disease initiation may be multifactorial, the cartilage destruction appears to be a result of uncontrolled proteolytic extracellular matrix destruction.  A major component of the cartilage extracellular matrix is aggrecan, a proteoglycan that imparts compressive resistance to the tissue.  Aggrecan is cleaved at a specific 'aggrecanase' site in human osteoarthritic cartilage; this cleavage can be performed by several members of ADAMTS family of metalloproteases.  The relative contribution of individual ADAMTS proteases to cartilage destruction during osteoarthritis has not been resolved.  Here we describe expts. with a genetically modified mouse in which the catalytic domain of ADAMTS5 (aggrecanase-2) was deleted.  After surgically induced joint instability, there was significant redn. in the severity of cartilage destruction in the ADAMTS5 knockout mice compared with wild-type mice.  This is the first report of a single gene deletion capable of abrogating the course of cartilage destruction in an animal model of osteoarthritis.  These results demonstrate that ADAMTS5 is the primary 'aggrecanase' responsible for aggrecan degrdn. in a murine model of osteoarthritis, and suggest rational strategies for therapeutic intervention in osteoarthritis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoN65ylxfcWq7Vg90H21EOLACvtfcHk0li8zpHd7XmupQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXislCmsr8%253D&md5=1bb0c5c0faeb0591976c84852bebc026</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1038%2Fnature03369&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature03369%26sid%3Dliteratum%253Aachs%26aulast%3DGlasson%26aufirst%3DS.%2BS.%26aulast%3DAskew%26aufirst%3DR.%26aulast%3DSheppard%26aufirst%3DB.%26aulast%3DCarito%26aufirst%3DB.%26aulast%3DBlanchet%26aufirst%3DT.%26aulast%3DMa%26aufirst%3DH.%2BL.%26aulast%3DFlannery%26aufirst%3DC.%2BR.%26aulast%3DPeluso%26aufirst%3DD.%26aulast%3DKanki%26aufirst%3DK.%26aulast%3DYang%26aufirst%3DZ.%26aulast%3DMajumdar%26aufirst%3DM.%2BK.%26aulast%3DMorris%26aufirst%3DE.%2BA.%26atitle%3DDeletion%2520of%2520active%2520ADAMTS5%2520prevents%2520cartilage%2520degradation%2520in%2520a%2520murine%2520model%2520of%2520osteoarthritis%26jtitle%3DNature%26date%3D2005%26volume%3D434%26spage%3D644%26epage%3D648%26doi%3D10.1038%2Fnature03369" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Stanton, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rogerson, F. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">East, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Golub, S. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lawlor, K. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meeker, C. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Little, C. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Last, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Farmer, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Campbell, I. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fourie, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fosang, A. J.</span></span> <span> </span><span class="NLM_article-title">ADAMTS5 is the major aggrecanase in mouse cartilage in vivo and in vitro</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>434</i></span>,  <span class="NLM_fpage">648</span>– <span class="NLM_lpage">652</span>, <span class="refDoi"> DOI: 10.1038/nature03417</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02008&amp;key=10.1038%2Fnature03417" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02008&amp;key=15800625" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02008&amp;key=1%3ACAS%3A528%3ADC%252BD2MXislCmsrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=434&publication_year=2005&pages=648-652&author=H.+Stantonauthor=F.+M.+Rogersonauthor=C.+J.+Eastauthor=S.+B.+Golubauthor=K.+E.+Lawlorauthor=C.+T.+Meekerauthor=C.+B.+Littleauthor=K.+Lastauthor=P.+J.+Farmerauthor=I.+K.+Campbellauthor=A.+M.+Fourieauthor=A.+J.+Fosang&title=ADAMTS5+is+the+major+aggrecanase+in+mouse+cartilage+in+vivo+and+in+vitro&doi=10.1038%2Fnature03417"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">ADAMTS5 is the major aggrecanase in mouse cartilage in vivo and in vitro</span></div><div class="casAuthors">Stanton, Heather; Rogerson, Fraser M.; East, Charlotte J.; Golub, Suzanne B.; Lawlor, Kate E.; Meeker, Clare T.; Little, Christopher B.; Last, Karena; Farmer, Pamela J.; Campbell, Ian K.; Fourie, Anne M.; Fosang, Amanda J.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">434</span>
        (<span class="NLM_cas:issue">7033</span>),
    <span class="NLM_cas:pages">648-652</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Aggrecan is the major proteoglycan in cartilage, endowing this tissue with the unique capacity to bear load and resist compression.  In arthritic cartilage, aggrecan is degraded by one or more 'aggrecanases' from the ADAMTS (a disintegrin and metalloproteinase with thrombospondin motifs) family of proteinases.  ADAMTS1, 8 and 9 have weak aggrecan-degrading activity.  However, they are not thought to be the primary aggrecanases because ADAMTS1 null mice are not protected from exptl. arthritis, and cleavage by ADAMTS8 and 9 is highly inefficient.  Although ADAMTS4 and 5 are expressed in joint tissues, and are known to be efficient aggrecanases in vitro, the exact contribution of these two enzymes to cartilage pathol. is unknown.  Here we show that ADAMTS5 is the major aggrecanase in mouse cartilage, both in vitro and in a mouse model of inflammatory arthritis.  Our data suggest that ADAMTS5 may be a suitable target for the development of new drugs designed to inhibit cartilage destruction in arthritis, although further work will be required to det. whether ADAMTS5 is also the major aggrecanase in human arthritis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqjJz-6pKyUPLVg90H21EOLACvtfcHk0li8zpHd7XmupQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXislCmsrg%253D&md5=7fd3127cfffec334d18c07aec84e8b83</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1038%2Fnature03417&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature03417%26sid%3Dliteratum%253Aachs%26aulast%3DStanton%26aufirst%3DH.%26aulast%3DRogerson%26aufirst%3DF.%2BM.%26aulast%3DEast%26aufirst%3DC.%2BJ.%26aulast%3DGolub%26aufirst%3DS.%2BB.%26aulast%3DLawlor%26aufirst%3DK.%2BE.%26aulast%3DMeeker%26aufirst%3DC.%2BT.%26aulast%3DLittle%26aufirst%3DC.%2BB.%26aulast%3DLast%26aufirst%3DK.%26aulast%3DFarmer%26aufirst%3DP.%2BJ.%26aulast%3DCampbell%26aufirst%3DI.%2BK.%26aulast%3DFourie%26aufirst%3DA.%2BM.%26aulast%3DFosang%26aufirst%3DA.%2BJ.%26atitle%3DADAMTS5%2520is%2520the%2520major%2520aggrecanase%2520in%2520mouse%2520cartilage%2520in%2520vivo%2520and%2520in%2520vitro%26jtitle%3DNature%26date%3D2005%26volume%3D434%26spage%3D648%26epage%3D652%26doi%3D10.1038%2Fnature03417" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Botter, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Glasson, S. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hopkins, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clockaerts, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weinans, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van Leeuwen, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van Osch, G. J.</span></span> <span> </span><span class="NLM_article-title">ADAMTS5–/– mice have less subchondral bone changes after induction of osteoarthritis through surgical instability: implications for a link between cartilage and subchondral bone changes</span>. <i>Osteoarthritis and cartilage</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">636</span>– <span class="NLM_lpage">645</span>, <span class="refDoi"> DOI: 10.1016/j.joca.2008.09.018</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02008&amp;key=10.1016%2Fj.joca.2008.09.018" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02008&amp;key=19010693" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02008&amp;key=1%3ACAS%3A280%3ADC%252BD1M3pvFWitA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2009&pages=636-645&author=S.+M.+Botterauthor=S.+S.+Glassonauthor=B.+Hopkinsauthor=S.+Clockaertsauthor=H.+Weinansauthor=J.+P.+van+Leeuwenauthor=G.+J.+van+Osch&title=ADAMTS5%E2%80%93%2F%E2%80%93+mice+have+less+subchondral+bone+changes+after+induction+of+osteoarthritis+through+surgical+instability%3A+implications+for+a+link+between+cartilage+and+subchondral+bone+changes&doi=10.1016%2Fj.joca.2008.09.018"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">ADAMTS5-/- mice have less subchondral bone changes after induction of osteoarthritis through surgical instability: implications for a link between cartilage and subchondral bone changes</span></div><div class="casAuthors">Botter S M; Glasson S S; Hopkins B; Clockaerts S; Weinans H; van Leeuwen J P T M; van Osch G J V M</div><div class="citationInfo"><span class="NLM_cas:title">Osteoarthritis and cartilage</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">636-45</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">OBJECTIVE:  Osteoarthritis (OA) is characterized by damaged articular cartilage and changes in subchondral bone.  Previous work demonstrated aggrecanase-2 deficient (ADAMTS5-/-) mice to be protected from cartilage damage induced by joint instability.  This study analyzed whether this protective effect on cartilage is also reflected in the subchondral bone structure.  METHODS:  Right knee joints from 10-week old male wild type (WT) and ADAMTS5-/- mice received transection of the medial meniscotibial ligament to induce OA, whereas left knees were left unoperated.  After 8 weeks knee joints were scanned by micro-CT.  The proximal tibia was selected for further analysis.  Histology was performed to evaluate cartilage damage and osteoclast presence.  RESULTS:  ADAMTS5-/- joints had a significantly thinner subchondral plate and less epiphyseal trabecular bone compared to WT joints.  Histology confirmed previous findings that ADAMTS5-/- mice have significantly less cartilage damage than WT in the instability-induced OA model.  Although the subchondral bone plate became significantly thicker at the medial tibial plateau in operated joints of both genotypes, the percentage increase was significantly smaller in ADAMTS5-/- mice (WT: 20.7+/-4.7%, ADAMTS5-/-: 8.3+/-1.2% compared to the left unoperated control joint).  In ADAMTS5-/- animals a significant decrease was found in both Oc.N./BS and Oc.S./BS.  Finally, in WT but not in ADAMTS5-/- mice a significant correlation was found between medial subchondral bone plate thickness and cartilage damage at the medial tibial plateau.  CONCLUSION:  ADAMTS5-/- joints that were protected from cartilage damage showed minor changes in the subchondral bone structure, in contrast to WT mice where substantial changes were found.  This finding suggests links between the process of cartilage damage and subchondral bone changes in instability-induced OA.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRNHrHVpZU4PyO2kE7krGOBfW6udTcc2eaA_5WUrthBBbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD1M3pvFWitA%253D%253D&md5=222a243320db13dd6f62e46278d20900</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1016%2Fj.joca.2008.09.018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.joca.2008.09.018%26sid%3Dliteratum%253Aachs%26aulast%3DBotter%26aufirst%3DS.%2BM.%26aulast%3DGlasson%26aufirst%3DS.%2BS.%26aulast%3DHopkins%26aufirst%3DB.%26aulast%3DClockaerts%26aufirst%3DS.%26aulast%3DWeinans%26aufirst%3DH.%26aulast%3Dvan%2BLeeuwen%26aufirst%3DJ.%2BP.%26aulast%3Dvan%2BOsch%26aufirst%3DG.%2BJ.%26atitle%3DADAMTS5%25E2%2580%2593%252F%25E2%2580%2593%2520mice%2520have%2520less%2520subchondral%2520bone%2520changes%2520after%2520induction%2520of%2520osteoarthritis%2520through%2520surgical%2520instability%253A%2520implications%2520for%2520a%2520link%2520between%2520cartilage%2520and%2520subchondral%2520bone%2520changes%26jtitle%3DOsteoarthritis%2520and%2520cartilage%26date%3D2009%26volume%3D17%26spage%3D636%26epage%3D645%26doi%3D10.1016%2Fj.joca.2008.09.018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Malfait, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ritchie, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gil, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Austin, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hartke, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qin, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tortorella, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mogil, J. S.</span></span> <span> </span><span class="NLM_article-title">ADAMTS-5 deficient mice do not develop mechanical allodynia associated with osteoarthritis following medial meniscal destabilization</span>. <i>Osteoarthritis and cartilage</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>18</i></span>,  <span class="NLM_fpage">572</span>– <span class="NLM_lpage">580</span>, <span class="refDoi"> DOI: 10.1016/j.joca.2009.11.013</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02008&amp;key=10.1016%2Fj.joca.2009.11.013" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02008&amp;key=20036347" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02008&amp;key=1%3ACAS%3A280%3ADC%252BC3c3itFOrsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2010&pages=572-580&author=A.+M.+Malfaitauthor=J.+Ritchieauthor=A.+S.+Gilauthor=J.+S.+Austinauthor=J.+Hartkeauthor=W.+Qinauthor=M.+D.+Tortorellaauthor=J.+S.+Mogil&title=ADAMTS-5+deficient+mice+do+not+develop+mechanical+allodynia+associated+with+osteoarthritis+following+medial+meniscal+destabilization&doi=10.1016%2Fj.joca.2009.11.013"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">ADAMTS-5 deficient mice do not develop mechanical allodynia associated with osteoarthritis following medial meniscal destabilization</span></div><div class="casAuthors">Malfait A M; Ritchie J; Gil A S; Austin J-S; Hartke J; Qin W; Tortorella M D; Mogil J S</div><div class="citationInfo"><span class="NLM_cas:title">Osteoarthritis and cartilage</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">572-80</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">OBJECTIVE:  To characterize pain-related behavior during the course of knee osteoarthritis (OA) induced by destabilization of the medial meniscus (DMM) in wild type (WT) and in ADAMTS-5 null mice.  METHODS:  DMM surgery was performed in the right knee of CD-1 mice.  At regular intervals up to 8 weeks after surgery, mice were assessed for the following parameters: mechanical allodynia (via withdrawal thresholds to von Frey filaments applied to the plantar surface of both hind paws or to the tail), thermal hyperalgesia, locomotor activity and gait analysis.  In addition, mechanical allodynia was tested in C57BL/6 WT or ADAMTS-5 null mice following DMM surgery.  RESULTS:  In CD-1 mice, a robust and progressive decrease in withdrawal threshold was observed in both hind paws after DMM but not sham surgery.  Allodynia was apparent as early as 14 days postoperatively.  Both sexes developed OA changes after surgery with concurrent mechanical allodynia.  No other pain-related behavioral changes were detected up to 8 weeks post-surgery.  In C57BL/6 mice, a genetic background in which only males develop OA changes after DMM, males but not females developed allodynia in the ipsilateral hind paw.  In contrast, C57BL/6 ADAMTS-5 null mice did not develop OA changes or mechanical allodynia up to 8 weeks post-surgery.  CONCLUSION:  Joint pathology following DMM surgery in mice is associated with progressive mechanical allodynia.  ADAMTS-5 null mice are resistant to DMM-induced OA-like lesions and to the associated mechanical allodynia.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcThJCmZtCkVsENHe_gFldTbfW6udTcc2eaA_5WUrthBBbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3c3itFOrsw%253D%253D&md5=5929be92d57f0b58ebe16578ac99a303</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1016%2Fj.joca.2009.11.013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.joca.2009.11.013%26sid%3Dliteratum%253Aachs%26aulast%3DMalfait%26aufirst%3DA.%2BM.%26aulast%3DRitchie%26aufirst%3DJ.%26aulast%3DGil%26aufirst%3DA.%2BS.%26aulast%3DAustin%26aufirst%3DJ.%2BS.%26aulast%3DHartke%26aufirst%3DJ.%26aulast%3DQin%26aufirst%3DW.%26aulast%3DTortorella%26aufirst%3DM.%2BD.%26aulast%3DMogil%26aufirst%3DJ.%2BS.%26atitle%3DADAMTS-5%2520deficient%2520mice%2520do%2520not%2520develop%2520mechanical%2520allodynia%2520associated%2520with%2520osteoarthritis%2520following%2520medial%2520meniscal%2520destabilization%26jtitle%3DOsteoarthritis%2520and%2520cartilage%26date%3D2010%26volume%3D18%26spage%3D572%26epage%3D580%26doi%3D10.1016%2Fj.joca.2009.11.013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rong, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guan, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tao, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guan, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tao, T.</span></span> <span> </span><span class="NLM_article-title">Association of ADAMTS5 gene polymorphisms with osteoarthritis in Chinese Han population: a community-based case-control study</span>. <i>Rheumatol. Int.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>33</i></span>,  <span class="NLM_fpage">2893</span>– <span class="NLM_lpage">2897</span>, <span class="refDoi"> DOI: 10.1007/s00296-012-2506-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02008&amp;key=10.1007%2Fs00296-012-2506-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02008&amp;key=22961118" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02008&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhs1KqsL%252FF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2013&pages=2893-2897&author=J.+Guauthor=J.+Rongauthor=F.+Guanauthor=L.+Jiangauthor=T.+Zhangauthor=S.+Taoauthor=G.+Guanauthor=L.+Xuauthor=T.+Tao&title=Association+of+ADAMTS5+gene+polymorphisms+with+osteoarthritis+in+Chinese+Han+population%3A+a+community-based+case-control+study&doi=10.1007%2Fs00296-012-2506-1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Association of ADAMTS5 gene polymorphisms with osteoarthritis in Chinese Han population: a community-based case-control study</span></div><div class="casAuthors">Gu, Jiaao; Rong, Jiesheng; Guan, Fulin; Jiang, Liying; Zhang, Ting; Tao, Shuqing; Guan, Guofa; Xu, Liang; Tao, Tianzun</div><div class="citationInfo"><span class="NLM_cas:title">Rheumatology International</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">33</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">2893-2897</span>CODEN:
                <span class="NLM_cas:coden">RHINDE</span>;
        ISSN:<span class="NLM_cas:issn">0172-8172</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Aggrecanase-2 (ADAMTS5) is reported to play essential roles in the pathophysiol. of osteoarthritis (OA).  To explore the relationship between ADAMTS5 gene polymorphisms and primary OA, we conducted a community-based case-control study.  A total of 732 community residents aged 40-84 years participated in the community-based study in Northeast China.  After taking phys. examn. and radiog. examn., 420 persons of the residents were diagnosed OA (216 women and 204 men).  The other 312 individuals without any symptoms of osteoarthritis or signs in the radiographs (156 women and 156 men) were considered as healthy controls.  After obtaining the DNA of patients and control group, genotypes of the ADAMTS5 gene polymorphisms were detd. by polymerase chain reaction (PCR) followed by restriction enzyme digestion (HAEIII for P692L in exon 7 and BSRBI for R614H in exon 5).  The nos. of patients with different OA subtypes were also calcd.  The genotype and allele frequency of for the exon 5C/T BSRBI polymorphism was significantly different between OA patients and control individuals (P = 0.001, OR = 0.701, 95% CI = 0.569-0.863).  This difference was more obvious in cervical OA patients (P = 0.001, OR = 0.664, 95% CI = 0.521-0.847).  The mutation type of exon 5C/T BSRBI polymorphism would be a protective factor for OA esp. for cervical OA.  Our results suggest that the ADAMTS5 gene polymorphisms may contribute to the susceptibility of osteoarthritis in the Chinese Han population.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqW6-pfC7YaLLVg90H21EOLACvtfcHk0lgM7SQuI3Cx9w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhs1KqsL%252FF&md5=97d36af4b3a97fad680d51bae2a11649</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1007%2Fs00296-012-2506-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00296-012-2506-1%26sid%3Dliteratum%253Aachs%26aulast%3DGu%26aufirst%3DJ.%26aulast%3DRong%26aufirst%3DJ.%26aulast%3DGuan%26aufirst%3DF.%26aulast%3DJiang%26aufirst%3DL.%26aulast%3DZhang%26aufirst%3DT.%26aulast%3DTao%26aufirst%3DS.%26aulast%3DGuan%26aufirst%3DG.%26aulast%3DXu%26aufirst%3DL.%26aulast%3DTao%26aufirst%3DT.%26atitle%3DAssociation%2520of%2520ADAMTS5%2520gene%2520polymorphisms%2520with%2520osteoarthritis%2520in%2520Chinese%2520Han%2520population%253A%2520a%2520community-based%2520case-control%2520study%26jtitle%3DRheumatol.%2520Int.%26date%3D2013%26volume%3D33%26spage%3D2893%26epage%3D2897%26doi%3D10.1007%2Fs00296-012-2506-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Song, R. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tortorella, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Malfait, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alston, J. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arner, E. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Griggs, D. W.</span></span> <span> </span><span class="NLM_article-title">Aggrecan degradation in human articular cartilage explants is mediated by both ADAMTS-4 and ADAMTS-5</span>. <i>Arthritis Rheum.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>56</i></span>,  <span class="NLM_fpage">575</span>– <span class="NLM_lpage">585</span>, <span class="refDoi"> DOI: 10.1002/art.22334</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02008&amp;key=10.1002%2Fart.22334" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02008&amp;key=17265492" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02008&amp;key=1%3ACAS%3A528%3ADC%252BD2sXislShurw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2007&pages=575-585&author=R.+H.+Songauthor=M.+D.+Tortorellaauthor=A.+M.+Malfaitauthor=J.+T.+Alstonauthor=Z.+Yangauthor=E.+C.+Arnerauthor=D.+W.+Griggs&title=Aggrecan+degradation+in+human+articular+cartilage+explants+is+mediated+by+both+ADAMTS-4+and+ADAMTS-5&doi=10.1002%2Fart.22334"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Aggrecan degradation in human articular cartilage explants is mediated by both ADAMTS-4 and ADAMTS-5</span></div><div class="casAuthors">Song, Ruo-Hua; Tortorella, Micky D.; Malfait, Anne-Marie; Alston, James T.; Yang, Zhiyong; Arner, Elizabeth C.; Griggs, David W.</div><div class="citationInfo"><span class="NLM_cas:title">Arthritis & Rheumatism</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">575-585</span>CODEN:
                <span class="NLM_cas:coden">ARHEAW</span>;
        ISSN:<span class="NLM_cas:issn">0004-3591</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">Objective. Recent published studies have shown that cartilage from ADAMTS-5-knockout mice, but not ADAMTS-4- or ADAMTS-1-knockout mice, is significantly protected from degrdn.  The present study was undertaken to evaluate the resp. roles of these enzymes in human cartilage breakdown, using a small interfering RNA (siRNA) approach to assess the effects of inhibition of each enzyme in normal and osteoarthritic (OA) explants.  Methods. The activities of siRNA specifically targeting ADAMTS-1, -4, and -5 were assessed by transfection into primary human chondrocytes and cultured human cartilage explants.  At 24 h, a cytokine stimulus was applied to normal, but not OA, samples to initiate a catabolic response.  At designated times, total RNA was isolated and gene expression was measured by quant. real-time reverse transcription-polymerase chain reaction.  Aggrecan release and aggrecanase-generated neoepitope formation were detd. by dye binding anal. and Western blotting, resp.  Results. Human chondrocytes and explants were efficiently transfected with siRNA that specifically decreased the expression of each targeted gene.  Suppression of ADAMTS-4 and ADAMTS-5, individually or in combination, attenuated the degrdn. of aggrecan in cytokine-stimulated normal cartilage.  A redn. in aggrecan degrdn. was also obsd. following siRNA-mediated knockdown of either gene in unstimulated OA cartilage.  In contrast, knockdown of ADAMTS-1 failed to inhibit aggrecan loss.  Conclusion. Despite the apparent dominant role of ADAMTS-5 in genetically modified mice, our data suggest that both ADAMTS-4 and ADAMTS-5 contribute to the structural damage that characterizes human OA.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrWjonvxEQIv7Vg90H21EOLACvtfcHk0liL-Fi6U3ykDg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXislShurw%253D&md5=46b9d8f073555353d2b4a70428a2db8a</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1002%2Fart.22334&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fart.22334%26sid%3Dliteratum%253Aachs%26aulast%3DSong%26aufirst%3DR.%2BH.%26aulast%3DTortorella%26aufirst%3DM.%2BD.%26aulast%3DMalfait%26aufirst%3DA.%2BM.%26aulast%3DAlston%26aufirst%3DJ.%2BT.%26aulast%3DYang%26aufirst%3DZ.%26aulast%3DArner%26aufirst%3DE.%2BC.%26aulast%3DGriggs%26aufirst%3DD.%2BW.%26atitle%3DAggrecan%2520degradation%2520in%2520human%2520articular%2520cartilage%2520explants%2520is%2520mediated%2520by%2520both%2520ADAMTS-4%2520and%2520ADAMTS-5%26jtitle%3DArthritis%2520Rheum.%26date%3D2007%26volume%3D56%26spage%3D575%26epage%3D585%26doi%3D10.1002%2Fart.22334" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chockalingam, P. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rivera-Bermudez, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zeng, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dufield, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Larsson, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lohmander, L. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Flannery, C. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Glasson, S. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Georgiadis, K. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morris, E. A.</span></span> <span> </span><span class="NLM_article-title">Elevated aggrecanase activity in a rat model of joint injury is attenuated by an aggrecanase specific inhibitor</span>. <i>Osteoarthritis and cartilage</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>19</i></span>,  <span class="NLM_fpage">315</span>– <span class="NLM_lpage">323</span>, <span class="refDoi"> DOI: 10.1016/j.joca.2010.12.004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02008&amp;key=10.1016%2Fj.joca.2010.12.004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02008&amp;key=21163358" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02008&amp;key=1%3ACAS%3A280%3ADC%252BC3M3hvFyjtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2011&pages=315-323&author=P.+S.+Chockalingamauthor=W.+Sunauthor=M.+A.+Rivera-Bermudezauthor=W.+Zengauthor=D.+R.+Dufieldauthor=S.+Larssonauthor=L.+S.+Lohmanderauthor=C.+R.+Flanneryauthor=S.+S.+Glassonauthor=K.+E.+Georgiadisauthor=E.+A.+Morris&title=Elevated+aggrecanase+activity+in+a+rat+model+of+joint+injury+is+attenuated+by+an+aggrecanase+specific+inhibitor&doi=10.1016%2Fj.joca.2010.12.004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Elevated aggrecanase activity in a rat model of joint injury is attenuated by an aggrecanase specific inhibitor</span></div><div class="casAuthors">Chockalingam P S; Sun W; Rivera-Bermudez M A; Zeng W; Dufield D R; Larsson S; Lohmander L S; Flannery C R; Glasson S S; Georgiadis K E; Morris E A</div><div class="citationInfo"><span class="NLM_cas:title">Osteoarthritis and cartilage</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">315-23</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">OBJECTIVE:  To evaluate aggrecanase activity after traumatic knee injury in a rat model by measuring the level of aggrecanase-generated Ala-Arg-Gly-aggrecan (ARG-aggrecan) fragments in synovial fluid, and compare with ARG-aggrecan release into joint fluid following human knee injury.  To evaluate the effect of small molecule inhibitors on induced aggrecanase activity in the rat model.  METHOD:  An enzyme-linked immunosorbent assay (ELISA) was developed to measure ARG-aggrecan levels in animal and human joint fluids.  A rat model of meniscal tear (MT)-induced joint instability was used to assess ARG-aggrecan release into joint fluid and the effects of aggrecanase inhibition.  Synovial fluids were also obtained from patients with acute joint injury or osteoarthritis and assayed for ARG-aggrecan.  RESULTS:  Joint fluids from human patients after knee injury showed significantly enhanced levels of ARG-aggrecan compared to uninjured reference subjects.  Similarly, synovial fluid ARG-aggrecan levels increased following surgically-induced joint instability in the rat MT model, which was significantly attenuated by orally dosing the animals with AGG-523, an aggrecanase specific inhibitor.  CONCLUSIONS:  Aggrecanase-generated aggrecan fragments were rapidly released into human and rat joint fluids after injury to the knee and remained elevated over a prolonged period.  Our findings in human and preclinical models strengthen the connection between aggrecanase activity in joints and knee injury and disease.  The ability of a small molecule aggrecanase inhibitor to reduce the release of aggrecanase-generated aggrecan fragments into rat joints suggests that pharmacologic inhibition of aggrecanase activity in humans may be an effective treatment for slowing cartilage degradation following joint injury.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTSEJ86GtNp_UkUaC_kzhvyfW6udTcc2eakC6K3ZHRb57ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3M3hvFyjtA%253D%253D&md5=202a8e1850e72fcddd1a4772c37672cc</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1016%2Fj.joca.2010.12.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.joca.2010.12.004%26sid%3Dliteratum%253Aachs%26aulast%3DChockalingam%26aufirst%3DP.%2BS.%26aulast%3DSun%26aufirst%3DW.%26aulast%3DRivera-Bermudez%26aufirst%3DM.%2BA.%26aulast%3DZeng%26aufirst%3DW.%26aulast%3DDufield%26aufirst%3DD.%2BR.%26aulast%3DLarsson%26aufirst%3DS.%26aulast%3DLohmander%26aufirst%3DL.%2BS.%26aulast%3DFlannery%26aufirst%3DC.%2BR.%26aulast%3DGlasson%26aufirst%3DS.%2BS.%26aulast%3DGeorgiadis%26aufirst%3DK.%2BE.%26aulast%3DMorris%26aufirst%3DE.%2BA.%26atitle%3DElevated%2520aggrecanase%2520activity%2520in%2520a%2520rat%2520model%2520of%2520joint%2520injury%2520is%2520attenuated%2520by%2520an%2520aggrecanase%2520specific%2520inhibitor%26jtitle%3DOsteoarthritis%2520and%2520cartilage%26date%3D2011%26volume%3D19%26spage%3D315%26epage%3D323%26doi%3D10.1016%2Fj.joca.2010.12.004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shiozaki, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maeda, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miura, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kotoku, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamasaki, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matsuda, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aoki, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yasue, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Imai, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ubukata, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suma, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yokota, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hotta, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tanaka, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hase, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haas, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fryer, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Laird, E. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Littmann, N. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Andrews, S. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Josey, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mimura, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shinozaki, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yoshiuchi, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Inaba, T.</span></span> <span> </span><span class="NLM_article-title">Discovery of (1S,2R,3R)-2,3-dimethyl-2-phenyl-1-sulfamidocyclopropanecarboxylates: novel and highly selective aggrecanase inhibitors</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>54</i></span>,  <span class="NLM_fpage">2839</span>– <span class="NLM_lpage">2863</span>, <span class="refDoi"> DOI: 10.1021/jm101609j</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm101609j" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02008&amp;key=1%3ACAS%3A528%3ADC%252BC3MXjsFKnsb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=2839-2863&author=M.+Shiozakiauthor=K.+Maedaauthor=T.+Miuraauthor=M.+Kotokuauthor=T.+Yamasakiauthor=I.+Matsudaauthor=K.+Aokiauthor=K.+Yasueauthor=H.+Imaiauthor=M.+Ubukataauthor=A.+Sumaauthor=M.+Yokotaauthor=T.+Hottaauthor=M.+Tanakaauthor=Y.+Haseauthor=J.+Haasauthor=A.+M.+Fryerauthor=E.+R.+Lairdauthor=N.+M.+Littmannauthor=S.+W.+Andrewsauthor=J.+A.+Joseyauthor=T.+Mimuraauthor=Y.+Shinozakiauthor=H.+Yoshiuchiauthor=T.+Inaba&title=Discovery+of+%281S%2C2R%2C3R%29-2%2C3-dimethyl-2-phenyl-1-sulfamidocyclopropanecarboxylates%3A+novel+and+highly+selective+aggrecanase+inhibitors&doi=10.1021%2Fjm101609j"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of (1S,2R,3R)-2,3-Dimethyl-2-phenyl-1-sulfamidocyclopropanecarboxylates: Novel and Highly Selective Aggrecanase Inhibitors</span></div><div class="casAuthors">Shiozaki, Makoto; Maeda, Katsuya; Miura, Tomoya; Kotoku, Masayuki; Yamazaki, Takayuki; Matsuda, Isamu; Aoki, Kenta; Yasue, Katsutaka; Imai, Hiroto; Ubukata, Minoru; Suma, Akira; Yokota, Masahiro; Hotta, Takahiro; Tanaka, Masahiro; Hase, Yasunori; Haas, Julia; Fryer, Andrew M.; Laird, Ellen R.; Littmann, Nicole M.; Andrews, Steven W.; Josey, John A.; Mimura, Takayuki; Shinozaki, Yuichi; Yoshiuchi, Hiromi; Inaba, Takashi</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">2839-2863</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Aggrecanases, particularly aggrecanase-1 (ADAMTS-4) and aggrecanase-2 (ADAMTS-5), are believed to be key enzymes involved in the articular cartilage breakdown that leads to osteoarthritis.  Thus, aggrecanases are considered to be viable drug targets for the treatment of this debilitating disease.  A series of (1S,2R,3R)-2,3-dimethyl-2-phenyl-1-sulfamidocyclopropanecarboxylates was discovered to be potent, highly selective, and orally bioavailable aggrecanase inhibitors.  These compds. have unique P1' groups comprising novel piperidine- or piperazine-based heterocycles that are connected to a cyclopropane amino acid scaffold via a sulfamido linkage.  These P1' groups are quite effective in imparting selectivity over other MMPs, and this selectivity was further increased by incorporation of a Me substituent in the 2-position of the cyclopropane ring.  In contrast to classical hydroxamate-based inhibitors that tend to lack metabolic stability, our aggrecanase inhibitors bear a carboxylate zinc-binding group and have good oral bioavailability.  Lead compd. 13b (I), characterized by the novel P1' portion of 1,2,3,4-tetrahydropyrido[3',4':4,5]imidazo[1,2-a]pyridine ring, is a potent and selective aggrecanse inhibitor with excellent pharmacokinetic profiles.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpa2g_2zxHrX7Vg90H21EOLACvtfcHk0liL-Fi6U3ykDg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXjsFKnsb8%253D&md5=d4d5fee4292c93129a83ea22ab0a8964</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1021%2Fjm101609j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm101609j%26sid%3Dliteratum%253Aachs%26aulast%3DShiozaki%26aufirst%3DM.%26aulast%3DMaeda%26aufirst%3DK.%26aulast%3DMiura%26aufirst%3DT.%26aulast%3DKotoku%26aufirst%3DM.%26aulast%3DYamasaki%26aufirst%3DT.%26aulast%3DMatsuda%26aufirst%3DI.%26aulast%3DAoki%26aufirst%3DK.%26aulast%3DYasue%26aufirst%3DK.%26aulast%3DImai%26aufirst%3DH.%26aulast%3DUbukata%26aufirst%3DM.%26aulast%3DSuma%26aufirst%3DA.%26aulast%3DYokota%26aufirst%3DM.%26aulast%3DHotta%26aufirst%3DT.%26aulast%3DTanaka%26aufirst%3DM.%26aulast%3DHase%26aufirst%3DY.%26aulast%3DHaas%26aufirst%3DJ.%26aulast%3DFryer%26aufirst%3DA.%2BM.%26aulast%3DLaird%26aufirst%3DE.%2BR.%26aulast%3DLittmann%26aufirst%3DN.%2BM.%26aulast%3DAndrews%26aufirst%3DS.%2BW.%26aulast%3DJosey%26aufirst%3DJ.%2BA.%26aulast%3DMimura%26aufirst%3DT.%26aulast%3DShinozaki%26aufirst%3DY.%26aulast%3DYoshiuchi%26aufirst%3DH.%26aulast%3DInaba%26aufirst%3DT.%26atitle%3DDiscovery%2520of%2520%25281S%252C2R%252C3R%2529-2%252C3-dimethyl-2-phenyl-1-sulfamidocyclopropanecarboxylates%253A%2520novel%2520and%2520highly%2520selective%2520aggrecanase%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D2839%26epage%3D2863%26doi%3D10.1021%2Fjm101609j" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Deng, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Keefe, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davie, C. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lind, K. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Acharya, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Franklin, G. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Larkin, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matico, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neeb, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thompson, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lohr, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gross, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Centrella, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Donovan, G. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bedard, K. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van Vloten, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mataruse, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Skinner, S. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Belyanskaya, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carpenter, T. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shearer, T. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clark, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cuozzo, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arico-Muendel, C. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morgan, B. A.</span></span> <span> </span><span class="NLM_article-title">Discovery of highly potent and selective small molecule ADAMTS-5 inhibitors that inhibit human cartilage degradation via encoded library technology (ELT)</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">7061</span>– <span class="NLM_lpage">7079</span>, <span class="refDoi"> DOI: 10.1021/jm300449x</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm300449x" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02008&amp;key=1%3ACAS%3A528%3ADC%252BC38Xht1Smu7bM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=7061-7079&author=H.+Dengauthor=H.+O%E2%80%99Keefeauthor=C.+P.+Davieauthor=K.+E.+Lindauthor=R.+A.+Acharyaauthor=G.+J.+Franklinauthor=J.+Larkinauthor=R.+Maticoauthor=M.+Neebauthor=M.+M.+Thompsonauthor=T.+Lohrauthor=J.+W.+Grossauthor=P.+A.+Centrellaauthor=G.+K.+O%E2%80%99Donovanauthor=K.+L.+Bedardauthor=K.+van+Vlotenauthor=S.+Mataruseauthor=S.+R.+Skinnerauthor=S.+L.+Belyanskayaauthor=T.+Y.+Carpenterauthor=T.+W.+Shearerauthor=M.+A.+Clarkauthor=J.+W.+Cuozzoauthor=C.+C.+Arico-Muendelauthor=B.+A.+Morgan&title=Discovery+of+highly+potent+and+selective+small+molecule+ADAMTS-5+inhibitors+that+inhibit+human+cartilage+degradation+via+encoded+library+technology+%28ELT%29&doi=10.1021%2Fjm300449x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of Highly Potent and Selective Small Molecule ADAMTS-5 Inhibitors That Inhibit Human Cartilage Degradation via Encoded Library Technology (ELT)</span></div><div class="casAuthors">Deng, Hongfeng; O'Keefe, Heather; Davie, Christopher P.; Lind, Kenneth E.; Acharya, Raksha A.; Franklin, G. Joseph; Larkin, Jonathan; Matico, Rosalie; Neeb, Michael; Thompson, Monique M.; Lohr, Thomas; Gross, Jeffrey W.; Centrella, Paolo A.; O'Donovan, Gary K.; Bedard, Katie L.; van Vloten, Kurt; Mataruse, Sibongile; Skinner, Steven R.; Belyanskaya, Svetlana L.; Carpenter, Tiffany Y.; Shearer, Todd W.; Clark, Matthew A.; Cuozzo, John W.; Arico-Muendel, Christopher C.; Morgan, Barry A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">7061-7079</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The metalloprotease ADAMTS-5 is considered a potential target for the treatment of osteoarthritis.  To identify selective inhibitors of ADAMTS-5, the authors employed encoded library technol. (ELT), which enables affinity selection of small mol. binders from complex mixts. by DNA tagging.  Selection of ADAMTS-5 against a four-billion member ELT library led to a novel inhibitor scaffold not contg. a classical zinc-binding functionality.  One exemplar, (R)-N-((1-(4-(but-3-en-1-ylamino)-6-(((2-(thiophen-2-yl)thiazol-4-yl)methyl)amino)-1,3,5-triazin-2-yl)pyrrolidin-2-yl)methyl)-4-propylbenzenesulfonamide (I), inhibited ADAMTS-5 with IC50 = 30 nM, showing >50-fold selectivity against ADAMTS-4 and >1000-fold selectivity against ADAMTS-1, ADAMTS-13, MMP-13, and TACE.  Extensive SAR studies showed that potency and physicochem. properties of the scaffold could be further improved.  Furthermore, in a human osteoarthritis cartilage explant study, compds. I and II inhibited aggrecanase-mediated 374ARGS neoepitope release from aggrecan and glycosaminoglycan in response to IL-1β/OSM stimulation.  This study provides the first small mol. evidence for the crit. role of ADAMTS-5 in human cartilage degrdn.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoMOEaetEOSWLVg90H21EOLACvtfcHk0lhIHyby7yYXiA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xht1Smu7bM&md5=9f7d1a265c7f8089f9fa505f9974483e</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1021%2Fjm300449x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm300449x%26sid%3Dliteratum%253Aachs%26aulast%3DDeng%26aufirst%3DH.%26aulast%3DO%25E2%2580%2599Keefe%26aufirst%3DH.%26aulast%3DDavie%26aufirst%3DC.%2BP.%26aulast%3DLind%26aufirst%3DK.%2BE.%26aulast%3DAcharya%26aufirst%3DR.%2BA.%26aulast%3DFranklin%26aufirst%3DG.%2BJ.%26aulast%3DLarkin%26aufirst%3DJ.%26aulast%3DMatico%26aufirst%3DR.%26aulast%3DNeeb%26aufirst%3DM.%26aulast%3DThompson%26aufirst%3DM.%2BM.%26aulast%3DLohr%26aufirst%3DT.%26aulast%3DGross%26aufirst%3DJ.%2BW.%26aulast%3DCentrella%26aufirst%3DP.%2BA.%26aulast%3DO%25E2%2580%2599Donovan%26aufirst%3DG.%2BK.%26aulast%3DBedard%26aufirst%3DK.%2BL.%26aulast%3Dvan%2BVloten%26aufirst%3DK.%26aulast%3DMataruse%26aufirst%3DS.%26aulast%3DSkinner%26aufirst%3DS.%2BR.%26aulast%3DBelyanskaya%26aufirst%3DS.%2BL.%26aulast%3DCarpenter%26aufirst%3DT.%2BY.%26aulast%3DShearer%26aufirst%3DT.%2BW.%26aulast%3DClark%26aufirst%3DM.%2BA.%26aulast%3DCuozzo%26aufirst%3DJ.%2BW.%26aulast%3DArico-Muendel%26aufirst%3DC.%2BC.%26aulast%3DMorgan%26aufirst%3DB.%2BA.%26atitle%3DDiscovery%2520of%2520highly%2520potent%2520and%2520selective%2520small%2520molecule%2520ADAMTS-5%2520inhibitors%2520that%2520inhibit%2520human%2520cartilage%2520degradation%2520via%2520encoded%2520library%2520technology%2520%2528ELT%2529%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D7061%26epage%3D7079%26doi%3D10.1021%2Fjm300449x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Durham, T. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marimuthu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Toth, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adams, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mudra, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Swearingen, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chambers, M. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thirunavukkarasu, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wiley, M. R.</span></span> <span> </span><span class="NLM_article-title">A highly selective hydantoin inhibitor of aggrecanase-1 and aggrecanase-2 with a low projected human dose</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">5933</span>– <span class="NLM_lpage">5939</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.7b00650</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b00650" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02008&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhtVSjtrrP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=5933-5939&author=T.+B.+Durhamauthor=J.+Marimuthuauthor=J.+L.+Tothauthor=C.+Liuauthor=L.+Adamsauthor=D.+R.+Mudraauthor=C.+Swearingenauthor=C.+Linauthor=M.+G.+Chambersauthor=K.+Thirunavukkarasuauthor=M.+R.+Wiley&title=A+highly+selective+hydantoin+inhibitor+of+aggrecanase-1+and+aggrecanase-2+with+a+low+projected+human+dose&doi=10.1021%2Facs.jmedchem.7b00650"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">A Highly Selective Hydantoin Inhibitor of Aggrecanase-1 and Aggrecanase-2 with a Low Projected Human Dose</span></div><div class="casAuthors">Durham, Timothy B.; Marimuthu, Jothirajah; Toth, James L.; Liu, Chin; Adams, Lisa; Mudra, Daniel R.; Swearingen, Craig; Lin, Chaohua; Chambers, Mark G.; Thirunavukkarasu, Kannan; Wiley, Michael R.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">5933-5939</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Aggrecanase-1 and -2 (ADAMTS-4 and ADAMTS-5) are zinc metalloproteases involved in the degrdn. of aggrecan in cartilage.  Inhibitors could provide a means of altering the progression of osteoarthritis.  We report the identification of 7 which had good oral pharmacokinetics in rats and showed efficacy in a rat chem. model of osteoarthritis.  The projected human dose required to achieve sustained plasma levels ≥10 times the hADAMTS-5 IC50 is 5 mg q.d.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpUR6nsVIkmMLVg90H21EOLACvtfcHk0lhIHyby7yYXiA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhtVSjtrrP&md5=2797b44e0f9ce99664405758353167d2</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b00650&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b00650%26sid%3Dliteratum%253Aachs%26aulast%3DDurham%26aufirst%3DT.%2BB.%26aulast%3DMarimuthu%26aufirst%3DJ.%26aulast%3DToth%26aufirst%3DJ.%2BL.%26aulast%3DLiu%26aufirst%3DC.%26aulast%3DAdams%26aufirst%3DL.%26aulast%3DMudra%26aufirst%3DD.%2BR.%26aulast%3DSwearingen%26aufirst%3DC.%26aulast%3DLin%26aufirst%3DC.%26aulast%3DChambers%26aufirst%3DM.%2BG.%26aulast%3DThirunavukkarasu%26aufirst%3DK.%26aulast%3DWiley%26aufirst%3DM.%2BR.%26atitle%3DA%2520highly%2520selective%2520hydantoin%2520inhibitor%2520of%2520aggrecanase-1%2520and%2520aggrecanase-2%2520with%2520a%2520low%2520projected%2520human%2520dose%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26spage%3D5933%26epage%3D5939%26doi%3D10.1021%2Facs.jmedchem.7b00650" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liang, J.</span>; <span class="NLM_string-name">Wang, Q. T.</span>; <span class="NLM_string-name">Ku, M. S.</span>; <span class="NLM_string-name">Michalak, R. S.</span>; <span class="NLM_string-name">Huang, J. W.</span></span> <i>Polymorphs of N2-(l, l’-Biphenyl-4-ylcarbonyl)-N 1-[2-(4-Fluorophenyl)-l,l-Dimethylethyl]-L-α-Glutamine</i>. U.S. Patent <span class="NLM_patent">20100216886</span>, November 9, <span class="NLM_year">2007</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2007&author=J.+Liang&author=Q.+T.+Wang&author=M.+S.+Ku&author=R.+S.+Michalak&author=J.+W.+Huang&title=Polymorphs+of+N2-%28l%2C+l%E2%80%99-Biphenyl-4-ylcarbonyl%29-N+1-%5B2-%284-Fluorophenyl%29-l%2Cl-Dimethylethyl%5D-L-%CE%B1-Glutamine"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DLiang%26aufirst%3DJ.%26jtitle%3DPolymorphs%2520of%2520N2-%2528l%252C%2520l%25E2%2580%2599-Biphenyl-4-ylcarbonyl%2529-N%25201-%255B2-%25284-Fluorophenyl%2529-l%252Cl-Dimethylethyl%255D-L-%25CE%25B1-Glutamine%26date%3D2007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sum, P.-E.</span>; <span class="NLM_string-name">How, D. B.</span>; <span class="NLM_string-name">Sabatini, J. J.</span>; <span class="NLM_string-name">Xiang, J. S.</span>; <span class="NLM_string-name">Feyfant, E.</span>; <span class="NLM_string-name">Tam, S. Y.</span>; <span class="NLM_string-name">Skotnicki, J. S.</span>; <span class="NLM_string-name">Mansour, T. S.</span></span> <i>Glutamate Aggrecanase Inhibitors</i>. U.S. Patent <span class="NLM_patent">20070043066A1</span>, July 11, <span class="NLM_year">2006</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2006&author=P.-E.+Sum&author=D.+B.+How&author=J.+J.+Sabatini&author=J.+S.+Xiang&author=E.+Feyfant&author=S.+Y.+Tam&author=J.+S.+Skotnicki&author=T.+S.+Mansour&title=Glutamate+Aggrecanase+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DSum%26aufirst%3DP.-E.%26jtitle%3DGlutamate%2520Aggrecanase%2520Inhibitors%26date%3D2006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Inaba, T.</span>; <span class="NLM_string-name">Haas, J.</span>; <span class="NLM_string-name">Shiozaki, M.</span>; <span class="NLM_string-name">Littman, N. M.</span>; <span class="NLM_string-name">Yasue, K.</span>; <span class="NLM_string-name">Andrews, S. W.</span>; <span class="NLM_string-name">Sakai, A.</span>; <span class="NLM_string-name">Fryer, A. M.</span>; <span class="NLM_string-name">Matsuo, T.</span>; <span class="NLM_string-name">Laird, E. R.</span>; <span class="NLM_string-name">Suma, A.</span>; <span class="NLM_string-name">Shinozaki, Y.</span>; <span class="NLM_string-name">Hori, Y.</span>; <span class="NLM_string-name">Imai, H.</span>; <span class="NLM_string-name">Negoro, T.</span></span> <i>Cyclopropane Compounds and Pharmaceutical Use Thereof</i>. U.S. Patent <span class="NLM_patent">20080306258A1</span>, May 6, <span class="NLM_year">2008</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2008&author=T.+Inaba&author=J.+Haas&author=M.+Shiozaki&author=N.+M.+Littman&author=K.+Yasue&author=S.+W.+Andrews&author=A.+Sakai&author=A.+M.+Fryer&author=T.+Matsuo&author=E.+R.+Laird&author=A.+Suma&author=Y.+Shinozaki&author=Y.+Hori&author=H.+Imai&author=T.+Negoro&title=Cyclopropane+Compounds+and+Pharmaceutical+Use+Thereof"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DInaba%26aufirst%3DT.%26jtitle%3DCyclopropane%2520Compounds%2520and%2520Pharmaceutical%2520Use%2520Thereof%26date%3D2008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Durham, T. B.</span>; <span class="NLM_string-name">Marimuthu, J.</span>; <span class="NLM_string-name">Wiley, R. M.</span></span> <i>Aggrecanase inhibitors</i>. U.S. Patent <span class="NLM_patent">9206139B2</span>, October 18, <span class="NLM_year">2013</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2013&author=T.+B.+Durham&author=J.+Marimuthu&author=R.+M.+Wiley&title=Aggrecanase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DDurham%26aufirst%3DT.%2BB.%26jtitle%3DAggrecanase%2520inhibitors%26date%3D2013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Larkin, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lohr, T. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Elefante, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shearin, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matico, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Su, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xue, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Genell, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miller, R. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tran, P. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Malfait, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maier, C. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matheny, C. J.</span></span> <span> </span><span class="NLM_article-title">Translational development of an ADAMTS-5 antibody for osteoarthritis disease modification</span>. <i>Osteoarthritis and cartilage</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>23</i></span>,  <span class="NLM_fpage">1254</span>– <span class="NLM_lpage">1266</span>, <span class="refDoi"> DOI: 10.1016/j.joca.2015.02.778</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02008&amp;key=10.1016%2Fj.joca.2015.02.778" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02008&amp;key=25800415" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02008&amp;key=1%3ACAS%3A280%3ADC%252BC2MnmvF2ntQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2015&pages=1254-1266&author=J.+Larkinauthor=T.+A.+Lohrauthor=L.+Elefanteauthor=J.+Shearinauthor=R.+Maticoauthor=J.+L.+Suauthor=Y.+Xueauthor=F.+Liuauthor=C.+Genellauthor=R.+E.+Millerauthor=P.+B.+Tranauthor=A.+M.+Malfaitauthor=C.+C.+Maierauthor=C.+J.+Matheny&title=Translational+development+of+an+ADAMTS-5+antibody+for+osteoarthritis+disease+modification&doi=10.1016%2Fj.joca.2015.02.778"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Translational development of an ADAMTS-5 antibody for osteoarthritis disease modification</span></div><div class="casAuthors">Larkin J; Lohr T A; Elefante L; Xue Y; Shearin J; Matico R; Su J-L; Liu F; Genell C; Maier C C; Miller R E; Tran P B; Malfait A-M; Matheny C J</div><div class="citationInfo"><span class="NLM_cas:title">Osteoarthritis and cartilage</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1254-66</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">OBJECTIVE/METHOD:  Aggrecanase activity, most notably ADAMTS-5, is implicated in pathogenic cartilage degradation.  Selective monoclonal antibodies (mAbs) to both ADAMTS-5 and ADAMTS-4 were generated and in vitro, ex vivo and in vivo systems were utilized to assess target engagement, aggrecanase inhibition and modulation of disease-related endpoints with the intent of selecting a candidate for clinical development in osteoarthritis (OA).  RESULTS:  Structural mapping predicts the most potent mAbs employ a unique mode of inhibition by cross-linking the catalytic and disintegrin domains.  In a surgical mouse model of OA, both ADAMTS-5 and ADAMTS-4-specific mAbs penetrate cartilage following systemic administration, demonstrating access to the anticipated site of action.  Structural disease modification and associated alleviation of pain-related behavior were observed with ADAMTS-5 mAb treatment.  Treatment of human OA cartilage demonstrated a preferential role for ADAMTS-5 inhibition over ADAMTS-4, as measured by ARGS neoepitope release in explant cultures.  ADAMTS-5 mAb activity was most evident in a subset of patient-derived tissues and suppression of ARGS neoepitope release was sustained for weeks after a single treatment in human explants and in cynomolgus monkeys, consistent with high affinity target engagement and slow ADAMTS-5 turnover.  CONCLUSION:  This data supports a hypothesis set forth from knockout mouse studies that ADAMTS-5 is the major aggrecanase involved in cartilage degradation and provides a link between a biological pathway and pharmacology which translates to human tissues, non-human primate models and points to a target OA patient population.  Therefore, a humanized ADAMTS-5-selective monoclonal antibody (GSK2394002) was progressed as a potential OA disease modifying therapeutic.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcT56eBi4fPFqhfKb6ELK8t0fW6udTcc2ebZrqoFGTL-0rntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2MnmvF2ntQ%253D%253D&md5=1bf194a9b106bfcfc4e454f41b615e88</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1016%2Fj.joca.2015.02.778&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.joca.2015.02.778%26sid%3Dliteratum%253Aachs%26aulast%3DLarkin%26aufirst%3DJ.%26aulast%3DLohr%26aufirst%3DT.%2BA.%26aulast%3DElefante%26aufirst%3DL.%26aulast%3DShearin%26aufirst%3DJ.%26aulast%3DMatico%26aufirst%3DR.%26aulast%3DSu%26aufirst%3DJ.%2BL.%26aulast%3DXue%26aufirst%3DY.%26aulast%3DLiu%26aufirst%3DF.%26aulast%3DGenell%26aufirst%3DC.%26aulast%3DMiller%26aufirst%3DR.%2BE.%26aulast%3DTran%26aufirst%3DP.%2BB.%26aulast%3DMalfait%26aufirst%3DA.%2BM.%26aulast%3DMaier%26aufirst%3DC.%2BC.%26aulast%3DMatheny%26aufirst%3DC.%2BJ.%26atitle%3DTranslational%2520development%2520of%2520an%2520ADAMTS-5%2520antibody%2520for%2520osteoarthritis%2520disease%2520modification%26jtitle%3DOsteoarthritis%2520and%2520cartilage%26date%3D2015%26volume%3D23%26spage%3D1254%26epage%3D1266%26doi%3D10.1016%2Fj.joca.2015.02.778" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fields, G. B.</span></span> <span> </span><span class="NLM_article-title">The rebirth of matrix metalloproteinase inhibitors: moving beyond the dogma</span>. <i>Cells</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">984</span>, <span class="refDoi"> DOI: 10.3390/cells8090984</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02008&amp;key=10.3390%2Fcells8090984" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02008&amp;key=1%3ACAS%3A528%3ADC%252BB3cXmtVSltrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2019&pages=984&author=G.+B.+Fields&title=The+rebirth+of+matrix+metalloproteinase+inhibitors%3A+moving+beyond+the+dogma&doi=10.3390%2Fcells8090984"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">The rebirth of matrix metalloproteinase inhibitors: moving beyond the dogma</span></div><div class="casAuthors">Fields, Gregg B.</div><div class="citationInfo"><span class="NLM_cas:title">Cells</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">984</span>CODEN:
                <span class="NLM_cas:coden">CELLC6</span>;
        ISSN:<span class="NLM_cas:issn">2073-4409</span>.
    
            (<span class="NLM_cas:orgname">MDPI AG</span>)
        </div><div class="casAbstract">The pursuit of matrix metalloproteinase (MMP) inhibitors began in earnest over three decades ago.  Initial clin. trials were disappointing, resulting in a neg. view of MMPs as therapeutic targets.  As a better understanding of MMP biol. and inhibitor pharmacokinetic properties emerged, it became clear that initial MMP inhibitor clin. trials were held prematurely.  Further complicating matters were problematic conclusions drawn from animal model studies.  The most recent generation of MMP inhibitors have desirable selectivities and improved pharmacokinetics, resulting in improved toxicity profiles.  Application of selective MMP inhibitors led to the conclusion that MMP-2, MMP-9, MMP-13, and MT1-MMP are not involved in musculoskeletal syndrome, a common side effect obsd. with broad spectrum MMP inhibitors.  Specific activities within a single MMP can now be inhibited.  Better definition of the roles of MMPs in immunol. responses and inflammation will help inform clinic trials, and multiple studies indicate that modulating MMP activity can improve immunotherapy.  There is a U.S.  Food and Drug Administration (FDA)-approved MMP inhibitor for periodontal disease, and several MMP inhibitors are in clinic trials, targeting a variety of maladies including gastric cancer, diabetic foot ulcers, and multiple sclerosis.  It is clearly time to move on from the dogma of viewing MMP inhibition as intractable.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpY8YcT4Rj5RLVg90H21EOLACvtfcHk0lguvYy7eKiLdw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXmtVSltrY%253D&md5=4ff4b435717c123cd5043df32587c853</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.3390%2Fcells8090984&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fcells8090984%26sid%3Dliteratum%253Aachs%26aulast%3DFields%26aufirst%3DG.%2BB.%26atitle%3DThe%2520rebirth%2520of%2520matrix%2520metalloproteinase%2520inhibitors%253A%2520moving%2520beyond%2520the%2520dogma%26jtitle%3DCells%26date%3D2019%26volume%3D8%26spage%3D984%26doi%3D10.3390%2Fcells8090984" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Song, W.</span></span> <span> </span><span class="NLM_article-title">Zinc binding groups for histone deacetylase inhibitors</span>. <i>J. Enzyme Inhib. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>33</i></span>,  <span class="NLM_fpage">714</span>– <span class="NLM_lpage">721</span>, <span class="refDoi"> DOI: 10.1080/14756366.2017.1417274</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02008&amp;key=10.1080%2F14756366.2017.1417274" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02008&amp;key=29616828" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02008&amp;key=1%3ACAS%3A528%3ADC%252BC1cXntVGhtrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2018&pages=714-721&author=L.+Zhangauthor=J.+Zhangauthor=Q.+Jiangauthor=L.+Zhangauthor=W.+Song&title=Zinc+binding+groups+for+histone+deacetylase+inhibitors&doi=10.1080%2F14756366.2017.1417274"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Zinc binding groups for histone deacetylase inhibitors</span></div><div class="casAuthors">Zhang, Lei; Zhang, Jian; Jiang, Qixiao; Zhang, Li; Song, Weiguo</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Enzyme Inhibition and Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">33</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">714-721</span>CODEN:
                <span class="NLM_cas:coden">JEIMAZ</span>;
        ISSN:<span class="NLM_cas:issn">1475-6366</span>.
    
            (<span class="NLM_cas:orgname">Taylor & Francis Ltd.</span>)
        </div><div class="casAbstract">Zinc binding groups (ZBGs) play a crucial role in targeting histone deacetylase inhibitors (HDACIs) to the active site of histone deacetylases (HDACs), thus detg. the potency of HDACIs.  Due to the high affinity to the zinc ion, hydroxamic acid is the most commonly used ZBG in the structure of HDACs.  An alternative ZBG is benzamide group, which features excellent inhibitory selectivity for class I HDACs.  Various ZBGs have been designed and tested to improve the activity and selectivity of HDACIs, and to overcome the pharmacokinetic limitations of current HDACIs.  Herein, different kinds of ZBGs are reviewed and their features have been discussed for further design of HDACIs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqXFywPdICZVrVg90H21EOLACvtfcHk0liZEAPmnoyt7Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXntVGhtrc%253D&md5=771d801a575618430f1cdcd03044dbdc</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1080%2F14756366.2017.1417274&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F14756366.2017.1417274%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DJiang%26aufirst%3DQ.%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DSong%26aufirst%3DW.%26atitle%3DZinc%2520binding%2520groups%2520for%2520histone%2520deacetylase%2520inhibitors%26jtitle%3DJ.%2520Enzyme%2520Inhib.%2520Med.%2520Chem.%26date%3D2018%26volume%3D33%26spage%3D714%26epage%3D721%26doi%3D10.1080%2F14756366.2017.1417274" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rogers, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hahn, M.</span></span> <span> </span><span class="NLM_article-title">Extended-connectivity fingerprints</span>. <i>J. Chem. Inf. Model.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>50</i></span>,  <span class="NLM_fpage">742</span>– <span class="NLM_lpage">754</span>, <span class="refDoi"> DOI: 10.1021/ci100050t</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ci100050t" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02008&amp;key=1%3ACAS%3A528%3ADC%252BC3cXlt1Onsbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2010&pages=742-754&author=D.+Rogersauthor=M.+Hahn&title=Extended-connectivity+fingerprints&doi=10.1021%2Fci100050t"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Extended-Connectivity Fingerprints</span></div><div class="casAuthors">Rogers, David; Hahn, Mathew</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Chemical Information and Modeling</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">50</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">742-754</span>CODEN:
                <span class="NLM_cas:coden">JCISD8</span>;
        ISSN:<span class="NLM_cas:issn">1549-9596</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Extended-connectivity fingerprints (ECFPs) are a novel class of topol. fingerprints for mol. characterization.  Historically, topol. fingerprints were developed for substructure and similarity searching.  ECFPs were developed specifically for structure-activity modeling.  ECFPs are circular fingerprints with a no. of useful qualities: they can be very rapidly calcd.; they are not predefined and can represent an essentially infinite no. of different mol. features (including stereochem. information); their features represent the presence of particular substructures, allowing easier interpretation of anal. results; and the ECFP algorithm can be tailored to generate different types of circular fingerprints, optimized for different uses.  While the use of ECFPs has been widely adopted and validated, a description of their implementation has not previously been presented in the literature.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGra43orI-Y7lbVg90H21EOLACvtfcHk0liZEAPmnoyt7Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXlt1Onsbg%253D&md5=cd6c736cd7a3d280b67f5316acce8006</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1021%2Fci100050t&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fci100050t%26sid%3Dliteratum%253Aachs%26aulast%3DRogers%26aufirst%3DD.%26aulast%3DHahn%26aufirst%3DM.%26atitle%3DExtended-connectivity%2520fingerprints%26jtitle%3DJ.%2520Chem.%2520Inf.%2520Model.%26date%3D2010%26volume%3D50%26spage%3D742%26epage%3D754%26doi%3D10.1021%2Fci100050t" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Triballeau, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Acher, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brabet, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pin, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bertrand, H. O.</span></span> <span> </span><span class="NLM_article-title">Virtual screening workflow development guided by the “receiver operating characteristic” curve approach. Application to high-throughput docking on metabotropic glutamate receptor subtype 4</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>48</i></span>,  <span class="NLM_fpage">2534</span>– <span class="NLM_lpage">2547</span>, <span class="refDoi"> DOI: 10.1021/jm049092j</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm049092j" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02008&amp;key=1%3ACAS%3A528%3ADC%252BD2MXitVWrtLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2005&pages=2534-2547&author=N.+Triballeauauthor=F.+Acherauthor=I.+Brabetauthor=J.+P.+Pinauthor=H.+O.+Bertrand&title=Virtual+screening+workflow+development+guided+by+the+%E2%80%9Creceiver+operating+characteristic%E2%80%9D+curve+approach.+Application+to+high-throughput+docking+on+metabotropic+glutamate+receptor+subtype+4&doi=10.1021%2Fjm049092j"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Virtual Screening Workflow Development Guided by the "Receiver Operating Characteristic" Curve Approach. Application to High-Throughput Docking on Metabotropic Glutamate Receptor Subtype 4</span></div><div class="casAuthors">Triballeau, Nicolas; Acher, Francine; Brabet, Isabelle; Pin, Jean-Philippe; Bertrand, Hugues-Olivier</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">48</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">2534-2547</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The "receiver operating characteristic" (ROC) curve method is a well-recognized metric used as an objective way to evaluate the ability of a given test to discriminate between two populations.  This facilitates decision-making in a plethora of fields in which a wrong judgment may have serious consequences including clin. diagnosis, public safety, travel security, and economic strategies.  When virtual screening is used to speed-up the drug discovery process in pharmaceutical research, taking the right decision upon selecting or discarding a mol. prior to in vitro evaluation is of paramount importance.  Characterizing both the ability of a virtual screening workflow to select active mols. and the ability to discard inactive ones, the ROC curve approach is well suited for this crit. decision gate.  As a case study, the first virtual screening workflow focused on metabotropic glutamate receptor subtype 4 (mGlu4R) agonists is reported here.  Six compds. out of 38 selected and tested in vitro were shown to have agonist activity on this target of therapeutic interest.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrUSadKBJXUTbVg90H21EOLACvtfcHk0liZEAPmnoyt7Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXitVWrtLw%253D&md5=b9ea8c34ae0133f8416700e0fab9a17d</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1021%2Fjm049092j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm049092j%26sid%3Dliteratum%253Aachs%26aulast%3DTriballeau%26aufirst%3DN.%26aulast%3DAcher%26aufirst%3DF.%26aulast%3DBrabet%26aufirst%3DI.%26aulast%3DPin%26aufirst%3DJ.%2BP.%26aulast%3DBertrand%26aufirst%3DH.%2BO.%26atitle%3DVirtual%2520screening%2520workflow%2520development%2520guided%2520by%2520the%2520%25E2%2580%259Creceiver%2520operating%2520characteristic%25E2%2580%259D%2520curve%2520approach.%2520Application%2520to%2520high-throughput%2520docking%2520on%2520metabotropic%2520glutamate%2520receptor%2520subtype%25204%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2005%26volume%3D48%26spage%3D2534%26epage%3D2547%26doi%3D10.1021%2Fjm049092j" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sheppeck, J. E.,  2nd</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gilmore, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tebben, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xue, C. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, R. Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Decicco, C. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duan, J. J.</span></span> <span> </span><span class="NLM_article-title">Hydantoins, triazolones, and imidazolones as selective non-hydroxamate inhibitors of tumor necrosis factor-alpha converting enzyme (TACE)</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">2769</span>– <span class="NLM_lpage">2774</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2007.02.076</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02008&amp;key=10.1016%2Fj.bmcl.2007.02.076" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02008&amp;key=17368021" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02008&amp;key=1%3ACAS%3A528%3ADC%252BD2sXkslOqurc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2007&pages=2769-2774&author=J.+E.+Sheppeckauthor=J.+L.+Gilmoreauthor=A.+Tebbenauthor=C.+B.+Xueauthor=R.+Q.+Liuauthor=C.+P.+Deciccoauthor=J.+J.+Duan&title=Hydantoins%2C+triazolones%2C+and+imidazolones+as+selective+non-hydroxamate+inhibitors+of+tumor+necrosis+factor-alpha+converting+enzyme+%28TACE%29&doi=10.1016%2Fj.bmcl.2007.02.076"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Hydantoins, triazolones, and imidazolones as selective non-hydroxamate inhibitors of tumor necrosis factor-α converting enzyme (TACE)</span></div><div class="casAuthors">Sheppeck, James E., II; Gilmore, John L.; Tebben, Andrew; Xue, Chu-Biao; Liu, Rui-Qin; Decicco, Carl P.; Duan, James J.-W.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">2769-2774</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">We have discovered selective and potent inhibitors of TACE that replace the common hydroxamate zinc binding group with a hydantoin, triazolone, and imidazolone heterocycle.  These novel heterocyclic inhibitors of a zinc metalloprotease were designed using a pharmacophore model that we previously described while developing hydantoin and pyrimidinetrione (barbiturate) inhibitors of TACE.  The potency and binding orientation of these inhibitors is discussed and they are modeled into the X-ray crystal structure of TACE and compared to hydroxamate and earlier hydantoin TACE inhibitors which share the same 4-[(2-methyl-4-quinolinyl)methoxy]benzoyl P1' group.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpZyj_difdnHrVg90H21EOLACvtfcHk0lhKP9lYzXjcSA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXkslOqurc%253D&md5=2f03480cea9a5e1c3acffa62c4361f91</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2007.02.076&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2007.02.076%26sid%3Dliteratum%253Aachs%26aulast%3DSheppeck%26aufirst%3DJ.%2BE.%26aulast%3DGilmore%26aufirst%3DJ.%2BL.%26aulast%3DTebben%26aufirst%3DA.%26aulast%3DXue%26aufirst%3DC.%2BB.%26aulast%3DLiu%26aufirst%3DR.%2BQ.%26aulast%3DDecicco%26aufirst%3DC.%2BP.%26aulast%3DDuan%26aufirst%3DJ.%2BJ.%26atitle%3DHydantoins%252C%2520triazolones%252C%2520and%2520imidazolones%2520as%2520selective%2520non-hydroxamate%2520inhibitors%2520of%2520tumor%2520necrosis%2520factor-alpha%2520converting%2520enzyme%2520%2528TACE%2529%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2007%26volume%3D17%26spage%3D2769%26epage%3D2774%26doi%3D10.1016%2Fj.bmcl.2007.02.076" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guo, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Orth, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Madison, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dai, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feltz, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Girijavallabhan, V. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kozlowski, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lavey, B. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lundell, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Niu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Piwinski, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Popovici-Muller, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rizvi, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rosner, K. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shankar, B. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shih, N. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Siddiqui, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tong, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Umland, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wong, M. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, D. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, G.</span></span> <span> </span><span class="NLM_article-title">Discovery and SAR of hydantoin TACE inhibitors</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>20</i></span>,  <span class="NLM_fpage">1877</span>– <span class="NLM_lpage">1880</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2010.01.148</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02008&amp;key=10.1016%2Fj.bmcl.2010.01.148" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02008&amp;key=20172725" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02008&amp;key=1%3ACAS%3A528%3ADC%252BC3cXivFGltLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2010&pages=1877-1880&author=W.+Yuauthor=Z.+Guoauthor=P.+Orthauthor=V.+Madisonauthor=L.+Chenauthor=C.+Daiauthor=R.+J.+Feltzauthor=V.+M.+Girijavallabhanauthor=S.+H.+Kimauthor=J.+A.+Kozlowskiauthor=B.+J.+Laveyauthor=D.+Liauthor=D.+Lundellauthor=X.+Niuauthor=J.+J.+Piwinskiauthor=J.+Popovici-Mullerauthor=R.+Rizviauthor=K.+E.+Rosnerauthor=B.+B.+Shankarauthor=N.+Y.+Shihauthor=M.+A.+Siddiquiauthor=J.+Sunauthor=L.+Tongauthor=S.+Umlandauthor=M.+K.+Wongauthor=D.+Y.+Yangauthor=G.+Zhou&title=Discovery+and+SAR+of+hydantoin+TACE+inhibitors&doi=10.1016%2Fj.bmcl.2010.01.148"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery and SAR of hydantoin TACE inhibitors</span></div><div class="casAuthors">Yu, Wensheng; Guo, Zhuyan; Orth, Peter; Madison, Vincent; Chen, Lei; Dai, Chaoyang; Feltz, Robert J.; Girijavallabhan, Vinay M.; Kim, Seong Heon; Kozlowski, Joseph A.; Lavey, Brian J.; Li, Dansu; Lundell, Daniel; Niu, Xiaoda; Piwinski, John J.; Popovici-Muller, Janeta; Rizvi, Razia; Rosner, Kristin E.; Shankar, Bandarpalle B.; Shih, Neng-Yang; Arshad Siddiqui, M.; Sun, Jing; Tong, Ling; Umland, Shelby; Wong, Michael K. C.; Yang, De-yi; Zhou, Guowei</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1877-1880</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">We disclose inhibitors of TNF-α converting enzyme (TACE) designed around a hydantoin zinc binding moiety.  Crystal structures of inhibitors bound to TACE revealed monodentate coordination of the hydantoin to the zinc.  SAR, X-ray, and modeling designs are described.  To our knowledge, these are the first reported X-ray structures of TACE with a hydantoin zinc ligand.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGri6B5mp14eEbVg90H21EOLACvtfcHk0lhKP9lYzXjcSA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXivFGltLc%253D&md5=242b5a605e75157211d5917968a5ecb8</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2010.01.148&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2010.01.148%26sid%3Dliteratum%253Aachs%26aulast%3DYu%26aufirst%3DW.%26aulast%3DGuo%26aufirst%3DZ.%26aulast%3DOrth%26aufirst%3DP.%26aulast%3DMadison%26aufirst%3DV.%26aulast%3DChen%26aufirst%3DL.%26aulast%3DDai%26aufirst%3DC.%26aulast%3DFeltz%26aufirst%3DR.%2BJ.%26aulast%3DGirijavallabhan%26aufirst%3DV.%2BM.%26aulast%3DKim%26aufirst%3DS.%2BH.%26aulast%3DKozlowski%26aufirst%3DJ.%2BA.%26aulast%3DLavey%26aufirst%3DB.%2BJ.%26aulast%3DLi%26aufirst%3DD.%26aulast%3DLundell%26aufirst%3DD.%26aulast%3DNiu%26aufirst%3DX.%26aulast%3DPiwinski%26aufirst%3DJ.%2BJ.%26aulast%3DPopovici-Muller%26aufirst%3DJ.%26aulast%3DRizvi%26aufirst%3DR.%26aulast%3DRosner%26aufirst%3DK.%2BE.%26aulast%3DShankar%26aufirst%3DB.%2BB.%26aulast%3DShih%26aufirst%3DN.%2BY.%26aulast%3DSiddiqui%26aufirst%3DM.%2BA.%26aulast%3DSun%26aufirst%3DJ.%26aulast%3DTong%26aufirst%3DL.%26aulast%3DUmland%26aufirst%3DS.%26aulast%3DWong%26aufirst%3DM.%2BK.%26aulast%3DYang%26aufirst%3DD.%2BY.%26aulast%3DZhou%26aufirst%3DG.%26atitle%3DDiscovery%2520and%2520SAR%2520of%2520hydantoin%2520TACE%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2010%26volume%3D20%26spage%3D1877%26epage%3D1880%26doi%3D10.1016%2Fj.bmcl.2010.01.148" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shieh, H. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mathis, K. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Williams, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hills, R. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wiese, J. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Benson, T. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kiefer, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marino, M. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carroll, J. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leone, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Malfait, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arner, E. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tortorella, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tomasselli, A.</span></span> <span> </span><span class="NLM_article-title">High resolution crystal structure of the catalytic domain of ADAMTS-5 (aggrecanase-2)</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>283</i></span>,  <span class="NLM_fpage">1501</span>– <span class="NLM_lpage">1507</span>, <span class="refDoi"> DOI: 10.1074/jbc.M705879200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02008&amp;key=10.1074%2Fjbc.M705879200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02008&amp;key=17991750" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02008&amp;key=1%3ACAS%3A528%3ADC%252BD1cXks1eqsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=283&publication_year=2008&pages=1501-1507&author=H.+S.+Shiehauthor=K.+J.+Mathisauthor=J.+M.+Williamsauthor=R.+L.+Hillsauthor=J.+F.+Wieseauthor=T.+E.+Bensonauthor=J.+R.+Kieferauthor=M.+H.+Marinoauthor=J.+N.+Carrollauthor=J.+W.+Leoneauthor=A.+M.+Malfaitauthor=E.+C.+Arnerauthor=M.+D.+Tortorellaauthor=A.+Tomasselli&title=High+resolution+crystal+structure+of+the+catalytic+domain+of+ADAMTS-5+%28aggrecanase-2%29&doi=10.1074%2Fjbc.M705879200"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">High resolution crystal structure of the catalytic domain of ADAMTS-5 (aggrecanase-2)</span></div><div class="casAuthors">Shieh, Huey-Sheng; Mathis, Karl J.; Williams, Jennifer M.; Hills, Robert L.; Wiese, Joe F.; Benson, Timothy E.; Kiefer, James R.; Marino, Margaret H.; Carroll, Jeffery N.; Leone, Joseph W.; Malfait, Anne-Marie; Arner, Elizabeth C.; Tortorella, Micky D.; Tomasselli, Alfredo</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">283</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1501-1507</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Aggrecanase-2 [a disintegrin and metalloproteinase with thrombospondin motifs-5 (ADAMTS-5)], a member of the ADAMTS protein family, is critically involved in arthritic diseases because of its direct role in cleaving the cartilage component, aggrecan.  Here, the catalytic domain of human recombinant aggrecanase-2/ADAMTS-5 was refolded, purified, and crystd., and its 3-dimensional structure detd. to 1.4 Å resoln. in the presence of an inhibitor.  A high-resoln. structure of an aggrecanase/ADAMTS protein provides an opportunity for the development of therapeutics to treat osteoarthritis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr1HlBpxGGpr7Vg90H21EOLACvtfcHk0lhKP9lYzXjcSA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXks1eqsg%253D%253D&md5=7ccfa1927dfb72cb4c7fc4b6a2c62317</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M705879200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M705879200%26sid%3Dliteratum%253Aachs%26aulast%3DShieh%26aufirst%3DH.%2BS.%26aulast%3DMathis%26aufirst%3DK.%2BJ.%26aulast%3DWilliams%26aufirst%3DJ.%2BM.%26aulast%3DHills%26aufirst%3DR.%2BL.%26aulast%3DWiese%26aufirst%3DJ.%2BF.%26aulast%3DBenson%26aufirst%3DT.%2BE.%26aulast%3DKiefer%26aufirst%3DJ.%2BR.%26aulast%3DMarino%26aufirst%3DM.%2BH.%26aulast%3DCarroll%26aufirst%3DJ.%2BN.%26aulast%3DLeone%26aufirst%3DJ.%2BW.%26aulast%3DMalfait%26aufirst%3DA.%2BM.%26aulast%3DArner%26aufirst%3DE.%2BC.%26aulast%3DTortorella%26aufirst%3DM.%2BD.%26aulast%3DTomasselli%26aufirst%3DA.%26atitle%3DHigh%2520resolution%2520crystal%2520structure%2520of%2520the%2520catalytic%2520domain%2520of%2520ADAMTS-5%2520%2528aggrecanase-2%2529%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2008%26volume%3D283%26spage%3D1501%26epage%3D1507%26doi%3D10.1074%2Fjbc.M705879200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tortorella, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tomasselli, A. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mathis, K. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schnute, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Woodard, S. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Munie, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Williams, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Caspers, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wittwer, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Malfait, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shieh, H. S.</span></span> <span> </span><span class="NLM_article-title">Structural and inhibition analysis reveals the mechanism of selectivity of a series of aggrecanase inhibitors</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>284</i></span>,  <span class="NLM_fpage">24185</span>– <span class="NLM_lpage">24191</span>, <span class="refDoi"> DOI: 10.1074/jbc.M109.029116</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02008&amp;key=10.1074%2Fjbc.M109.029116" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02008&amp;key=19586907" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02008&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtVGgsr%252FP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=284&publication_year=2009&pages=24185-24191&author=M.+D.+Tortorellaauthor=A.+G.+Tomasselliauthor=K.+J.+Mathisauthor=M.+E.+Schnuteauthor=S.+S.+Woodardauthor=G.+Munieauthor=J.+M.+Williamsauthor=N.+Caspersauthor=A.+J.+Wittwerauthor=A.+M.+Malfaitauthor=H.+S.+Shieh&title=Structural+and+inhibition+analysis+reveals+the+mechanism+of+selectivity+of+a+series+of+aggrecanase+inhibitors&doi=10.1074%2Fjbc.M109.029116"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Structural and Inhibition Analysis Reveals the Mechanism of Selectivity of a Series of Aggrecanase Inhibitors</span></div><div class="casAuthors">Tortorella, Micky D.; Tomasselli, Alfredo G.; Mathis, Karl J.; Schnute, Mark E.; Woodard, Scott S.; Munie, Grace; Williams, Jennifer M.; Caspers, Nicole; Wittwer, Arthur J.; Malfait, Anne-Marie; Shieh, Huey-Sheng</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">284</span>
        (<span class="NLM_cas:issue">36</span>),
    <span class="NLM_cas:pages">24185-24191</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Several inhibitors of a series of cis-1(S)2(R)-amino-2-indanol-based compds. were reported to be selective for the aggrecanases, ADAMTS-4 and -5 over other metalloproteinases.  To understand the nature of this selectivity for aggrecanases, the inhibitors, along with the broad spectrum metalloproteinase inhibitor marimastat, were independently bound to the catalytic domain of ADAMTS-5, and the corresponding crystal structures were detd.  By comparing the structures, it was detd. that the specificity of the relative inhibitors for ADAMTS-5 was not driven by a specific interaction, such as zinc chelation, hydrogen bonding, or charge interactions, but rather by subtle and indirect factors, such as water bridging, ring rigidity, pocket size, and shape, as well as protein conformation flexibility.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoI39fzCSuJerVg90H21EOLACvtfcHk0lgx5OTVIovFfA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtVGgsr%252FP&md5=86e9879fb3359bc2ad78e2ce653ea0de</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M109.029116&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M109.029116%26sid%3Dliteratum%253Aachs%26aulast%3DTortorella%26aufirst%3DM.%2BD.%26aulast%3DTomasselli%26aufirst%3DA.%2BG.%26aulast%3DMathis%26aufirst%3DK.%2BJ.%26aulast%3DSchnute%26aufirst%3DM.%2BE.%26aulast%3DWoodard%26aufirst%3DS.%2BS.%26aulast%3DMunie%26aufirst%3DG.%26aulast%3DWilliams%26aufirst%3DJ.%2BM.%26aulast%3DCaspers%26aufirst%3DN.%26aulast%3DWittwer%26aufirst%3DA.%2BJ.%26aulast%3DMalfait%26aufirst%3DA.%2BM.%26aulast%3DShieh%26aufirst%3DH.%2BS.%26atitle%3DStructural%2520and%2520inhibition%2520analysis%2520reveals%2520the%2520mechanism%2520of%2520selectivity%2520of%2520a%2520series%2520of%2520aggrecanase%2520inhibitors%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2009%26volume%3D284%26spage%3D24185%26epage%3D24191%26doi%3D10.1074%2Fjbc.M109.029116" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mosyak, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Georgiadis, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shane, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Svenson, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hebert, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McDonagh, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mackie, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olland, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhong, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kriz, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reifenberg, E. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Collins-Racie, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Corcoran, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Freeman, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zollner, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marvell, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vera, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sum, P. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lavallie, E. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stahl, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Somers, W.</span></span> <span> </span><span class="NLM_article-title">Crystal structures of the two major aggrecan degrading enzymes, ADAMTS4 and ADAMTS5</span>. <i>Protein Sci.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">16</span>– <span class="NLM_lpage">21</span>, <span class="refDoi"> DOI: 10.1110/ps.073287008</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02008&amp;key=10.1110%2Fps.073287008" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02008&amp;key=18042673" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02008&amp;key=1%3ACAS%3A528%3ADC%252BD1cXmt1CrtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2008&pages=16-21&author=L.+Mosyakauthor=K.+Georgiadisauthor=T.+Shaneauthor=K.+Svensonauthor=T.+Hebertauthor=T.+McDonaghauthor=S.+Mackieauthor=S.+Ollandauthor=L.+Linauthor=X.+Zhongauthor=R.+Krizauthor=E.+L.+Reifenbergauthor=L.+A.+Collins-Racieauthor=C.+Corcoranauthor=B.+Freemanauthor=R.+Zollnerauthor=T.+Marvellauthor=M.+Veraauthor=P.+E.+Sumauthor=E.+R.+Lavallieauthor=M.+Stahlauthor=W.+Somers&title=Crystal+structures+of+the+two+major+aggrecan+degrading+enzymes%2C+ADAMTS4+and+ADAMTS5&doi=10.1110%2Fps.073287008"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Crystal structures of the two major aggrecan degrading enzymes, ADAMTS4 and ADAMTS5</span></div><div class="casAuthors">Mosyak, Lidia; Georgiadis, Katy; Shane, Tania; Svenson, Kristine; Hebert, Tracy; Mcdonagh, Thomas; Mackie, Stewart; Olland, Stephane; Lin, Laura; Zhong, Xiaotian; Kriz, Ronald; Reifenberg, Erica L.; Collins-Racie, Lisa A.; Corcoran, Christopher; Freeman, Bethany; Zollner, Richard; Marvell, Tod; Vera, Matthew; Sum, Phaik-Eng; Lavallie, Edward R.; Stahl, Mark; Somers, William</div><div class="citationInfo"><span class="NLM_cas:title">Protein Science</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">16-21</span>CODEN:
                <span class="NLM_cas:coden">PRCIEI</span>;
        ISSN:<span class="NLM_cas:issn">0961-8368</span>.
    
            (<span class="NLM_cas:orgname">Cold Spring Harbor Laboratory Press</span>)
        </div><div class="casAbstract">Aggrecanases are now believed to be the principal proteinases responsible for aggrecan degrdn. in osteoarthritis.  Given their potential as a drug target, we solved crystal structures of the two most active human aggrecanase isoforms, ADAMTS4 and ADAMTS5, each in complex with bound inhibitor and one wherein the enzyme is in apo form.  These structures show that the unliganded and inhibitor-bound enzymes exhibit two essentially different catalytic-site configurations: an autoinhibited, nonbinding, closed form and an open, binding form.  On this basis, we propose that mature aggrecanases exist as an ensemble of at least two isomers, only one of which is proteolytically active.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoS55VRlPEB4bVg90H21EOLACvtfcHk0lgx5OTVIovFfA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXmt1CrtA%253D%253D&md5=1cb25cc6bd0043a1881b600eb9f191be</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1110%2Fps.073287008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1110%252Fps.073287008%26sid%3Dliteratum%253Aachs%26aulast%3DMosyak%26aufirst%3DL.%26aulast%3DGeorgiadis%26aufirst%3DK.%26aulast%3DShane%26aufirst%3DT.%26aulast%3DSvenson%26aufirst%3DK.%26aulast%3DHebert%26aufirst%3DT.%26aulast%3DMcDonagh%26aufirst%3DT.%26aulast%3DMackie%26aufirst%3DS.%26aulast%3DOlland%26aufirst%3DS.%26aulast%3DLin%26aufirst%3DL.%26aulast%3DZhong%26aufirst%3DX.%26aulast%3DKriz%26aufirst%3DR.%26aulast%3DReifenberg%26aufirst%3DE.%2BL.%26aulast%3DCollins-Racie%26aufirst%3DL.%2BA.%26aulast%3DCorcoran%26aufirst%3DC.%26aulast%3DFreeman%26aufirst%3DB.%26aulast%3DZollner%26aufirst%3DR.%26aulast%3DMarvell%26aufirst%3DT.%26aulast%3DVera%26aufirst%3DM.%26aulast%3DSum%26aufirst%3DP.%2BE.%26aulast%3DLavallie%26aufirst%3DE.%2BR.%26aulast%3DStahl%26aufirst%3DM.%26aulast%3DSomers%26aufirst%3DW.%26atitle%3DCrystal%2520structures%2520of%2520the%2520two%2520major%2520aggrecan%2520degrading%2520enzymes%252C%2520ADAMTS4%2520and%2520ADAMTS5%26jtitle%3DProtein%2520Sci.%26date%3D2008%26volume%3D17%26spage%3D16%26epage%3D21%26doi%3D10.1110%2Fps.073287008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tom, R.</span>; <span class="NLM_string-name">Bisson, L.</span>; <span class="NLM_string-name">Durocher, Y.</span></span> <span> </span><span class="NLM_article-title">Transient Expression in HEK293-EBNA1 Cells</span>. In  <i>Methods Express: Expression Systems</i>, <span class="NLM_edition">1st</span> ed.; <span class="NLM_contrib-group"><span class="NLM_string-name">Dyson, M.</span>, <span class="NLM_string-name">Durocher, Y.</span></span>, Eds.; <span class="NLM_publisher-name">Scion Publishing Ltd</span>, <span class="NLM_year">2007</span>; pp  <span class="NLM_fpage">203</span>– <span class="NLM_lpage">223</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2007&pages=203-223&author=R.+Tom&author=L.+Bisson&author=Y.+Durocherauthor=M.+Dyson&author=Y.+Durocher&title=Methods+Express%3A+Expression+Systems"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DTom%26aufirst%3DR.%26atitle%3DTransient%2520Expression%2520in%2520HEK293-EBNA1%2520Cells%26btitle%3DMethods%2520Express%253A%2520Expression%2520Systems%26aulast%3DDyson%26aufirst%3DM.%26pub%3DScion%2520Publishing%2520Ltd%26date%3D2007%26spage%3D203%26epage%3D223" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Durocher, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perret, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kamen, A.</span></span> <span> </span><span class="NLM_article-title">High-Level and High-Throughput Recombinant Protein Production by Transient Transfection of Suspension-Growing Human 293-EBNA1 Cells</span>. <i>Nucleic acids research</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>30</i></span>,  <span class="NLM_fpage">9e</span>, <span class="refDoi"> DOI: 10.1093/nar/30.2.e9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02008&amp;key=10.1093%2Fnar%2F30.2.e9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02008&amp;key=1%3ACAS%3A528%3ADC%252BD38XhtFCktb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2002&pages=9e&author=Y.+Durocherauthor=S.+Perretauthor=A.+Kamen&title=High-Level+and+High-Throughput+Recombinant+Protein+Production+by+Transient+Transfection+of+Suspension-Growing+Human+293-EBNA1+Cells&doi=10.1093%2Fnar%2F30.2.e9"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">High-level and high-throughput recombinant protein production by transient transfection of suspension-growing human 293-EBNA1 cells</span></div><div class="casAuthors">Durocher, Yves; Perret, Sylvie; Kamen, Amine</div><div class="citationInfo"><span class="NLM_cas:title">Nucleic Acids Research</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">30</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">e9/1-e9/9</span>CODEN:
                <span class="NLM_cas:coden">NARHAD</span>;
        ISSN:<span class="NLM_cas:issn">0305-1048</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">A scalable transfection procedure using polyethylenimine (PEI) is described for the human embryonic kidney 293 cell line grown in suspension.  Green fluorescent protein (GFP) and human placental secreted alk. phosphatase (SEAP) were used as reporter genes to monitor transfection efficiency and productivity.  Up to 75% of GFP-pos. cells were obtained using linear or branched 25 kDa PEI.  The 293 cell line and two genetic variants, either expressing the SV40 large T-antigen (293T) or the Epstein-Barr virus (EBV) EBNA1 protein (293E), were tested for protein expression.  The highest expression level was obtained with 293E cells using the EBV oriP-contg. plasmid pCEP4.  We designed the pTT vector, an oriP-based vector having an improved cytomegalovirus expression cassette.  Using this vector, 10- and 3-fold increases in SEAP expression was obtained In 293E cells compared with pcDNA3.1 and pCEP4 vectors, resp.  The presence of serum had a pos. effect on gene transfer and expression.  Transfection of suspension-growing cells was more efficient with linear PEI and was not affected by the presence of medium conditioned for 24 h.  Using the pTT vector, >20 mg/l of purified His-tagged SEAP was recovered from a 3.5 I bioreactor.  Intracellular proteins were also produced at levels as high as 50 mg/l, representing up to 20% of total cell proteins.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrU-3OCtMsZRLVg90H21EOLACvtfcHk0liGTyrCk9xX1w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XhtFCktb4%253D&md5=feb0b6451bdc147622a7017b7ed65efd</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1093%2Fnar%2F30.2.e9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fnar%252F30.2.e9%26sid%3Dliteratum%253Aachs%26aulast%3DDurocher%26aufirst%3DY.%26aulast%3DPerret%26aufirst%3DS.%26aulast%3DKamen%26aufirst%3DA.%26atitle%3DHigh-Level%2520and%2520High-Throughput%2520Recombinant%2520Protein%2520Production%2520by%2520Transient%2520Transfection%2520of%2520Suspension-Growing%2520Human%2520293-EBNA1%2520Cells%26jtitle%3DNucleic%2520acids%2520research%26date%3D2002%26volume%3D30%26spage%3D9e%26doi%3D10.1093%2Fnar%2F30.2.e9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Joncour, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Desroy, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Housseman, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bock, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bienvenu, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cherel, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Labeguere, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peixoto, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Annoot, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lepissier, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heiermann, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hengeveld, W. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pilzak, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Monjardet, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wakselman, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roncoroni, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Le Tallec, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Galien, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">David, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vandervoort, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Christophe, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Conrath, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jans, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wohlkonig, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Soror, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Steyaert, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Touitou, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fleury, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vercheval, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mollat, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Triballeau, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van der Aar, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brys, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heckmann, B.</span></span> <span> </span><span class="NLM_article-title">Discovery, structure-activity relationship, and binding mode of an imidazo[1,2-a]pyridine series of autotaxin inhibitors</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">7371</span>– <span class="NLM_lpage">7392</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.7b00647</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b00647" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02008&amp;key=1%3ACAS%3A528%3ADC%252BC2sXht1WitLvN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=7371-7392&author=A.+Joncourauthor=N.+Desroyauthor=C.+Houssemanauthor=X.+Bockauthor=N.+Bienvenuauthor=L.+Cherelauthor=V.+Labeguereauthor=C.+Peixotoauthor=D.+Annootauthor=L.+Lepissierauthor=J.+Heiermannauthor=W.+J.+Hengeveldauthor=G.+Pilzakauthor=A.+Monjardetauthor=E.+Wakselmanauthor=V.+Roncoroniauthor=S.+Le+Tallecauthor=R.+Galienauthor=C.+Davidauthor=N.+Vandervoortauthor=T.+Christopheauthor=K.+Conrathauthor=M.+Jansauthor=A.+Wohlkonigauthor=S.+Sororauthor=J.+Steyaertauthor=R.+Touitouauthor=D.+Fleuryauthor=L.+Verchevalauthor=P.+Mollatauthor=N.+Triballeauauthor=E.+van+der+Aarauthor=R.+Brysauthor=B.+Heckmann&title=Discovery%2C+structure-activity+relationship%2C+and+binding+mode+of+an+imidazo%5B1%2C2-a%5Dpyridine+series+of+autotaxin+inhibitors&doi=10.1021%2Facs.jmedchem.7b00647"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery, Structure-Activity Relationship, and Binding Mode of an Imidazo[1,2-a]pyridine Series of Autotaxin Inhibitors</span></div><div class="casAuthors">Joncour, Agnes; Desroy, Nicolas; Housseman, Christopher; Bock, Xavier; Bienvenu, Natacha; Cherel, Laetitia; Labeguere, Virginie; Peixoto, Christophe; Annoot, Denis; Lepissier, Luce; Heiermann, Jorg; Hengeveld, Willem Jan; Pilzak, Gregor; Monjardet, Alain; Wakselman, Emanuelle; Roncoroni, Veronique; Le Tallec, Sandrine; Galien, Rene; David, Christelle; Vandervoort, Nele; Christophe, Thierry; Conrath, Katja; Jans, Mia; Wohlkonig, Alexandre; Soror, Sameh; Steyaert, Jan; Touitou, Robert; Fleury, Damien; Vercheval, Lionel; Mollat, Patrick; Triballeau, Nicolas; van der Aar, Ellen; Brys, Reginald; Heckmann, Bertrand</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">7371-7392</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Autotaxin (ATX) is a secreted enzyme playing a major role in the prodn. of lysophosphatidic acid (LPA) in blood through hydrolysis of lysophosphatidyl choline (LPC).  The ATX-LPA signaling axis arouses a high interest in the drug discovery industry as it has been implicated in several diseases including cancer, fibrotic diseases and inflammation among others.  An imidazo[1,2-a]pyridine series of ATX inhibitors was identified out of a high throughput screening (HTS).  A co-crystal structure with one of these compds. and ATX revealed a novel binding mode with occupancy of the hydrophobic pocket and channel of ATX but no interaction with zinc ions of the catalytic site.  Exploration of the structure-activity relationship led to compds. displaying high activity in biochem. and plasma assays, exemplified by compd. I.  Compd. I was also able to decrease the plasma LPA levels upon oral administration to rats.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpY6dK8UCSEyLVg90H21EOLACvtfcHk0liGTyrCk9xX1w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXht1WitLvN&md5=2c08b3017e0bc0183c9e8e1911ddab0d</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b00647&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b00647%26sid%3Dliteratum%253Aachs%26aulast%3DJoncour%26aufirst%3DA.%26aulast%3DDesroy%26aufirst%3DN.%26aulast%3DHousseman%26aufirst%3DC.%26aulast%3DBock%26aufirst%3DX.%26aulast%3DBienvenu%26aufirst%3DN.%26aulast%3DCherel%26aufirst%3DL.%26aulast%3DLabeguere%26aufirst%3DV.%26aulast%3DPeixoto%26aufirst%3DC.%26aulast%3DAnnoot%26aufirst%3DD.%26aulast%3DLepissier%26aufirst%3DL.%26aulast%3DHeiermann%26aufirst%3DJ.%26aulast%3DHengeveld%26aufirst%3DW.%2BJ.%26aulast%3DPilzak%26aufirst%3DG.%26aulast%3DMonjardet%26aufirst%3DA.%26aulast%3DWakselman%26aufirst%3DE.%26aulast%3DRoncoroni%26aufirst%3DV.%26aulast%3DLe%2BTallec%26aufirst%3DS.%26aulast%3DGalien%26aufirst%3DR.%26aulast%3DDavid%26aufirst%3DC.%26aulast%3DVandervoort%26aufirst%3DN.%26aulast%3DChristophe%26aufirst%3DT.%26aulast%3DConrath%26aufirst%3DK.%26aulast%3DJans%26aufirst%3DM.%26aulast%3DWohlkonig%26aufirst%3DA.%26aulast%3DSoror%26aufirst%3DS.%26aulast%3DSteyaert%26aufirst%3DJ.%26aulast%3DTouitou%26aufirst%3DR.%26aulast%3DFleury%26aufirst%3DD.%26aulast%3DVercheval%26aufirst%3DL.%26aulast%3DMollat%26aufirst%3DP.%26aulast%3DTriballeau%26aufirst%3DN.%26aulast%3Dvan%2Bder%2BAar%26aufirst%3DE.%26aulast%3DBrys%26aufirst%3DR.%26aulast%3DHeckmann%26aufirst%3DB.%26atitle%3DDiscovery%252C%2520structure-activity%2520relationship%252C%2520and%2520binding%2520mode%2520of%2520an%2520imidazo%255B1%252C2-a%255Dpyridine%2520series%2520of%2520autotaxin%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26spage%3D7371%26epage%3D7392%26doi%3D10.1021%2Facs.jmedchem.7b00647" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Swearingen, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carpenter, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Siegel, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brittain, I. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dotzlaf, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Durham, T. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Toth, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Laska, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marimuthu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brown, D. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carter, Q. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wiley, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duffin, K. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mitchell, P. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thirunavukkarasu, K.</span></span> <span> </span><span class="NLM_article-title">Development of a novel clinical biomarker assay to detect and quantify aggrecanase-generated aggrecan fragments in human synovial fluid, serum and urine</span>. <i>Osteoarthritis and cartilage</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>18</i></span>,  <span class="NLM_fpage">1150</span>– <span class="NLM_lpage">1158</span>, <span class="refDoi"> DOI: 10.1016/j.joca.2010.06.011</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02008&amp;key=10.1016%2Fj.joca.2010.06.011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02008&amp;key=20633682" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02008&amp;key=1%3ACAS%3A280%3ADC%252BC3cjoslCmtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2010&pages=1150-1158&author=C.+A.+Swearingenauthor=J.+W.+Carpenterauthor=R.+Siegelauthor=I.+J.+Brittainauthor=J.+Dotzlafauthor=T.+B.+Durhamauthor=J.+L.+Tothauthor=D.+A.+Laskaauthor=J.+Marimuthuauthor=C.+Liuauthor=D.+P.+Brownauthor=Q.+L.+Carterauthor=M.+R.+Wileyauthor=K.+L.+Duffinauthor=P.+G.+Mitchellauthor=K.+Thirunavukkarasu&title=Development+of+a+novel+clinical+biomarker+assay+to+detect+and+quantify+aggrecanase-generated+aggrecan+fragments+in+human+synovial+fluid%2C+serum+and+urine&doi=10.1016%2Fj.joca.2010.06.011"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Development of a novel clinical biomarker assay to detect and quantify aggrecanase-generated aggrecan fragments in human synovial fluid, serum and urine</span></div><div class="casAuthors">Swearingen C A; Carpenter J W; Siegel R; Brittain I J; Dotzlaf J; Durham T B; Toth J L; Laska D A; Marimuthu J; Liu C; Brown D P; Carter Q L; Wiley M R; Duffin K L; Mitchell P G; Thirunavukkarasu K</div><div class="citationInfo"><span class="NLM_cas:title">Osteoarthritis and cartilage</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1150-8</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">OBJECTIVE:  Proteolytic degradation of aggrecan in articular cartilage is a hallmark feature of osteoarthritis (OA).  The present study was aimed at developing a sensitive enzyme linked immunosorbent assay (ELISA) for the detection of aggrecanase-cleaved fragments of aggrecan in human serum and urine to facilitate the clinical development of aggrecanase inhibitors for OA.  METHODS:  The BC3 monoclonal antibody that detects the ARGS neoepitope sequence in aggrecanase-cleaved aggrecan was engineered and optimized using complementarity determining region (CDR)-saturation mutagenesis to improve its binding affinity to the neoepitope.  A sandwich ELISA (BC3-C2 ELISA) was developed using the optimized alpha-ARGS antibody (BC3-C2) as capture antibody and a commercially available antibody directed against the hyaluronic-acid binding region (HABR) of aggrecan as detection antibody.  Aggrecanase-cleaved fragments of aggrecan present in in vitro digests, human cartilage explant culture supernatants and in human synovial fluid, serum and urine were detected and quantified using this ELISA.  RESULTS:  The optimized antibody had a 4-log improvement in affinity for the ARGS containing peptide compared to the parental BC3 antibody, while maintaining the ability to not cross-react with a spanning peptide.  The BC3-C2 ELISA demonstrated the ability to detect aggrecanase-cleaved aggrecan fragments in the native state, without the need for deglycosylation.  This ELISA was able to measure aggrecanase-generated ARGS containing aggrecan fragments in human articular cartilage (HAC) explant cultures in the basal state (without cytokine stimulation).  Treatment with an aggrecanase inhibitor resulted in a dose-dependent inhibition of ARGS neoepitope released into the culture supernatant.  The ELISA assay also enabled the detection of ARGS containing fragments in human synovial fluid, serum and urine, suggesting its potential utility as a biomarker of aggrecanase activity.  CONCLUSIONS:  We have developed a novel ELISA using an optimized ARGS antibody and have demonstrated for the first time, an ELISA-based measurement of aggrecan degradation products in human serum and urine.  This assay has the potential to serve as a mechanistic drug activity biomarker in the clinic and is expected to significantly impact/accelerate the clinical development of aggrecanase inhibitors and other disease modifying drugs for OA.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRxFBliClGwChpyrDyM_m9cfW6udTcc2ebWRX8m2YuT-rntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3cjoslCmtA%253D%253D&md5=ee9aef4ee3b013250ce95a1825bd89d7</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1016%2Fj.joca.2010.06.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.joca.2010.06.011%26sid%3Dliteratum%253Aachs%26aulast%3DSwearingen%26aufirst%3DC.%2BA.%26aulast%3DCarpenter%26aufirst%3DJ.%2BW.%26aulast%3DSiegel%26aufirst%3DR.%26aulast%3DBrittain%26aufirst%3DI.%2BJ.%26aulast%3DDotzlaf%26aufirst%3DJ.%26aulast%3DDurham%26aufirst%3DT.%2BB.%26aulast%3DToth%26aufirst%3DJ.%2BL.%26aulast%3DLaska%26aufirst%3DD.%2BA.%26aulast%3DMarimuthu%26aufirst%3DJ.%26aulast%3DLiu%26aufirst%3DC.%26aulast%3DBrown%26aufirst%3DD.%2BP.%26aulast%3DCarter%26aufirst%3DQ.%2BL.%26aulast%3DWiley%26aufirst%3DM.%2BR.%26aulast%3DDuffin%26aufirst%3DK.%2BL.%26aulast%3DMitchell%26aufirst%3DP.%2BG.%26aulast%3DThirunavukkarasu%26aufirst%3DK.%26atitle%3DDevelopment%2520of%2520a%2520novel%2520clinical%2520biomarker%2520assay%2520to%2520detect%2520and%2520quantify%2520aggrecanase-generated%2520aggrecan%2520fragments%2520in%2520human%2520synovial%2520fluid%252C%2520serum%2520and%2520urine%26jtitle%3DOsteoarthritis%2520and%2520cartilage%26date%3D2010%26volume%3D18%26spage%3D1150%26epage%3D1158%26doi%3D10.1016%2Fj.joca.2010.06.011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Davis, I. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leaver-Fay, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, V. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Block, J. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kapral, G. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murray, L. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arendall, W. B.,  3rd</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Snoeyink, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Richardson, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Richardson, D. C.</span></span> <span> </span><span class="NLM_article-title">MolProbity: all-atom contacts and structure validation for proteins and nucleic acids</span>. <i>Nucleic Acids Res.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>35</i></span>,  <span class="NLM_fpage">W375</span>– <span class="NLM_lpage">383</span>, <span class="refDoi"> DOI: 10.1093/nar/gkm216</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02008&amp;key=10.1093%2Fnar%2Fgkm216" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02008&amp;key=17452350" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02008&amp;key=1%3ACAS%3A280%3ADC%252BD2svhsVGhtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=2007&pages=W375-383&author=I.+W.+Davisauthor=A.+Leaver-Fayauthor=V.+B.+Chenauthor=J.+N.+Blockauthor=G.+J.+Kapralauthor=X.+Wangauthor=L.+W.+Murrayauthor=W.+B.+Arendallauthor=J.+Snoeyinkauthor=J.+S.+Richardsonauthor=D.+C.+Richardson&title=MolProbity%3A+all-atom+contacts+and+structure+validation+for+proteins+and+nucleic+acids&doi=10.1093%2Fnar%2Fgkm216"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">MolProbity: all-atom contacts and structure validation for proteins and nucleic acids</span></div><div class="casAuthors">Davis Ian W; Leaver-Fay Andrew; Chen Vincent B; Block Jeremy N; Kapral Gary J; Wang Xueyi; Murray Laura W; Arendall W Bryan 3rd; Snoeyink Jack; Richardson Jane S; Richardson David C</div><div class="citationInfo"><span class="NLM_cas:title">Nucleic acids research</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">35</span>
        (<span class="NLM_cas:issue">Web Server issue</span>),
    <span class="NLM_cas:pages">W375-83</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">MolProbity is a general-purpose web server offering quality validation for 3D structures of proteins, nucleic acids and complexes.  It provides detailed all-atom contact analysis of any steric problems within the molecules as well as updated dihedral-angle diagnostics, and it can calculate and display the H-bond and van der Waals contacts in the interfaces between components.  An integral step in the process is the addition and full optimization of all hydrogen atoms, both polar and nonpolar.  New analysis functions have been added for RNA, for interfaces, and for NMR ensembles.  Additionally, both the web site and major component programs have been rewritten to improve speed, convenience, clarity and integration with other resources.  MolProbity results are reported in multiple forms: as overall numeric scores, as lists or charts of local problems, as downloadable PDB and graphics files, and most notably as informative, manipulable 3D kinemage graphics shown online in the KiNG viewer.  This service is available free to all users at http://molprobity.biochem.duke.edu.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRuyhuetoNS59bHMBt0mMIXfW6udTcc2eawZzxjd4VdTrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2svhsVGhtQ%253D%253D&md5=726ca1e7e162ab2a4a05048f493731fb</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1093%2Fnar%2Fgkm216&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fnar%252Fgkm216%26sid%3Dliteratum%253Aachs%26aulast%3DDavis%26aufirst%3DI.%2BW.%26aulast%3DLeaver-Fay%26aufirst%3DA.%26aulast%3DChen%26aufirst%3DV.%2BB.%26aulast%3DBlock%26aufirst%3DJ.%2BN.%26aulast%3DKapral%26aufirst%3DG.%2BJ.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DMurray%26aufirst%3DL.%2BW.%26aulast%3DArendall%26aufirst%3DW.%2BB.%26aulast%3DSnoeyink%26aufirst%3DJ.%26aulast%3DRichardson%26aufirst%3DJ.%2BS.%26aulast%3DRichardson%26aufirst%3DD.%2BC.%26atitle%3DMolProbity%253A%2520all-atom%2520contacts%2520and%2520structure%2520validation%2520for%2520proteins%2520and%2520nucleic%2520acids%26jtitle%3DNucleic%2520Acids%2520Res.%26date%3D2007%26volume%3D35%26spage%3DW375%26epage%3D383%26doi%3D10.1093%2Fnar%2Fgkm216" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lai, L.</span></span> <span> </span><span class="NLM_article-title">Computation of octanol-water partition coefficients by guiding an additive model with knowledge</span>. <i>J. Chem. Inf. Model.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>47</i></span>,  <span class="NLM_fpage">2140</span>– <span class="NLM_lpage">2148</span>, <span class="refDoi"> DOI: 10.1021/ci700257y</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ci700257y" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02008&amp;key=1%3ACAS%3A528%3ADC%252BD2sXht1KisbvF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2007&pages=2140-2148&author=T.+Chengauthor=Y.+Zhaoauthor=X.+Liauthor=F.+Linauthor=Y.+Xuauthor=X.+Zhangauthor=Y.+Liauthor=R.+Wangauthor=L.+Lai&title=Computation+of+octanol-water+partition+coefficients+by+guiding+an+additive+model+with+knowledge&doi=10.1021%2Fci700257y"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Computation of Octanol-Water Partition Coefficients by Guiding an Additive Model with Knowledge</span></div><div class="casAuthors">Cheng, Tiejun; Zhao, Yuan; Li, Xun; Lin, Fu; Xu, Yong; Zhang, Xinglong; Li, Yan; Wang, Renxiao; Lai, Luhua</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Chemical Information and Modeling</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">47</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">2140-2148</span>CODEN:
                <span class="NLM_cas:coden">JCISD8</span>;
        ISSN:<span class="NLM_cas:issn">1549-9596</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">We have developed a new method, i.e., XLOGP3, for logP computation.  XLOGP3 predicts the logP value of a query compd. by using the known logP value of a ref. compd. as a starting point.  The difference in the logP values of the query compd. and the ref. compd. is then estd. by an additive model.  The additive model implemented in XLOGP3 uses a total of 87 atom/group types and two correction factors as descriptors.  It is calibrated on a training set of 8199 org. compds. with reliable logP data through a multivariate linear regression anal.  For a given query compd., the compd. showing the highest structural similarity in the training set will be selected as the ref. compd.  Structural similarity is quantified based on topol. torsion descriptors.  XLOGP3 has been tested along with its predecessor, i.e., XLOGP2, as well as several popular logP methods on two independent test sets: one contains 406 small-mol. drugs approved by the FDA and the other contains 219 oligopeptides.  On both test sets, XLOGP3 produces more accurate predictions than most of the other methods with av. unsigned errors of 0.24-0.51 units.  Compared to conventional additive methods, XLOGP3 does not rely on an extensive classification of fragments and correction factors in order to improve accuracy.  It is also able to utilize the ever-increasing exptl. measured logP data more effectively.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrUq0p6A6frurVg90H21EOLACvtfcHk0ljJSh0WCiQ20w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXht1KisbvF&md5=492b857ffa462283dace225c7dcb9ad5</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1021%2Fci700257y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fci700257y%26sid%3Dliteratum%253Aachs%26aulast%3DCheng%26aufirst%3DT.%26aulast%3DZhao%26aufirst%3DY.%26aulast%3DLi%26aufirst%3DX.%26aulast%3DLin%26aufirst%3DF.%26aulast%3DXu%26aufirst%3DY.%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DWang%26aufirst%3DR.%26aulast%3DLai%26aufirst%3DL.%26atitle%3DComputation%2520of%2520octanol-water%2520partition%2520coefficients%2520by%2520guiding%2520an%2520additive%2520model%2520with%2520knowledge%26jtitle%3DJ.%2520Chem.%2520Inf.%2520Model.%26date%3D2007%26volume%3D47%26spage%3D2140%26epage%3D2148%26doi%3D10.1021%2Fci700257y" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 2 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Keron W. J.  Rose</span>, <span class="hlFld-ContribAuthor ">Nandaraj  Taye</span>, <span class="hlFld-ContribAuthor ">Stylianos Z.  Karoulias</span>, <span class="hlFld-ContribAuthor ">Dirk  Hubmacher</span>. </span><span class="cited-content_cbyCitation_article-title">Regulation of ADAMTS Proteases. </span><span class="cited-content_cbyCitation_journal-name">Frontiers in Molecular Biosciences</span><span> <strong>2021,</strong> <em>8 </em><a href="https://doi.org/10.3389/fmolb.2021.701959" title="DOI URL">https://doi.org/10.3389/fmolb.2021.701959</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3389/fmolb.2021.701959&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3389%2Ffmolb.2021.701959%26sid%3Dliteratum%253Aachs%26jtitle%3DFrontiers%2520in%2520Molecular%2520Biosciences%26atitle%3DRegulation%252Bof%252BADAMTS%252BProteases%26aulast%3DRose%26aufirst%3DKeron%2BW.%2BJ.%26date%3D2021%26date%3D2021%26volume%3D8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Win Min  Oo</span>, <span class="hlFld-ContribAuthor ">Christopher  Little</span>, <span class="hlFld-ContribAuthor ">Vicky  Duong</span>, <span class="hlFld-ContribAuthor ">David J  Hunter</span>. </span><span class="cited-content_cbyCitation_article-title">The Development of Disease-Modifying Therapies for Osteoarthritis (DMOADs): The Evidence to Date. </span><span class="cited-content_cbyCitation_journal-name">Drug Design, Development and Therapy</span><span> <strong>2021,</strong> <em>Volume 15 </em>, 2921-2945. <a href="https://doi.org/10.2147/DDDT.S295224" title="DOI URL">https://doi.org/10.2147/DDDT.S295224</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.2147/DDDT.S295224&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.2147%2FDDDT.S295224%26sid%3Dliteratum%253Aachs%26jtitle%3DDrug%2520Design%252C%2520Development%2520and%2520Therapy%26atitle%3DThe%252BDevelopment%252Bof%252BDisease-Modifying%252BTherapies%252Bfor%252BOsteoarthritis%252B%252528DMOADs%252529%25253A%252BThe%252BEvidence%252Bto%252BDate%26aulast%3DOo%26aufirst%3DWin%2BMin%26date%3D2021%26date%3D2021%26volume%3DVolume%252015%26spage%3D2921%26epage%3D2945" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="_i1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-6/acs.jmedchem.0c02008/20210429/images/medium/jm0c02008_0021.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-6/acs.jmedchem.0c02008/20210429/images/large/jm0c02008_0021.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c02008&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-6/acs.jmedchem.0c02008/20210429/images/medium/jm0c02008_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-6/acs.jmedchem.0c02008/20210429/images/large/jm0c02008_0001.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Docking of compound <b>1</b> in PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3B8Z">3B8Z</a> (ADAMTS-5). The carbon atoms of the binding site and the local backbone structure of ADAMTS-5 are depicted in dark green. Compound <b>1</b> is shown in sticks with light green carbons. The zinc of the catalytic site is magenta. Protein–ligand interactions are presented with dashed lines (hydrogen bond in green, metal interaction in gray, and hydrophobic contacts in pink). The surface is colored by hydrophobicity of the residue (from brown for hydrophobic to blue for hydrophilic).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-6/acs.jmedchem.0c02008/20210429/images/large/jm0c02008_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c02008&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-6/acs.jmedchem.0c02008/20210429/images/medium/jm0c02008_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-6/acs.jmedchem.0c02008/20210429/images/large/jm0c02008_0003.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Importance of the carbonyl group.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-6/acs.jmedchem.0c02008/20210429/images/large/jm0c02008_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c02008&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-6/acs.jmedchem.0c02008/20210429/images/medium/jm0c02008_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-6/acs.jmedchem.0c02008/20210429/images/large/jm0c02008_0004.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Dose–response curve in the human AGC neoepitope ELISA for compound <b>21</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-6/acs.jmedchem.0c02008/20210429/images/large/jm0c02008_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c02008&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-6/acs.jmedchem.0c02008/20210429/images/medium/jm0c02008_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-6/acs.jmedchem.0c02008/20210429/images/large/jm0c02008_0005.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Correlation between inhibition of hs-ADAMTS-5 (IC<sub>50</sub>) and reduction of GAG production in mouse cartilage explants by compounds tested at (a) 10 μM and (b) 1 μM.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-6/acs.jmedchem.0c02008/20210429/images/large/jm0c02008_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c02008&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-6/acs.jmedchem.0c02008/20210429/images/medium/jm0c02008_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-6/acs.jmedchem.0c02008/20210429/images/large/jm0c02008_0002.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Cocrystal structure of GLPG1972 in ADAMTS-5 (PDB ID <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6YJM">6YJM</a>). The carbon atoms of the binding site and the local backbone structure of ADAMTS-5 are depicted in dark green. GLPG1972 is shown in sticks with light green carbons. The zinc of the catalytic site is magenta. Protein–ligand interactions are presented with dashed lines (hydrogen bond in green, metal interaction in gray, and hydrophobic contacts in pink). The surface is colored by hydrophobicity of the residue (from brown for hydrophobic to blue for hydrophilic).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-6/acs.jmedchem.0c02008/20210429/images/large/jm0c02008_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c02008&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-6/acs.jmedchem.0c02008/20210429/images/medium/jm0c02008_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-6/acs.jmedchem.0c02008/20210429/images/large/jm0c02008_0006.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthetic Route for GLPG1972<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-6/acs.jmedchem.0c02008/20210429/images/large/jm0c02008_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c02008&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) LDA, THF, −78 to 0 °C, 35%; (b) NaCN, (NH<sub>4</sub>)<sub>2</sub>CO<sub>3</sub>, EtOH/H<sub>2</sub>O, 60 °C, 68%; (c) HCl 4 M/dioxane, rt, 76%; (d) chiral SFC, AD-3 μm column; <b>(<i>R</i>)-61</b> 42%, <b>(<i>S</i>)-61</b> 43%; (e) Pd<sub>2</sub>(dba)<sub>3</sub>, BINAP, NaOtBu, toluene, 80 °C for 2.5 h then 110 °C, 93%; (f) HCl 4 M/dioxane, acetonitrile, rt, 88%; (g) EDC·HCl, HOBt, DIPEA, DMF, rt, 82%.</p></p></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i69">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_21013" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_21013" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 36 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hunter, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schofield, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Callander, E.</span></span> <span> </span><span class="NLM_article-title">The individual and socioeconomic impact of osteoarthritis</span>. <i>Nat. Rev. Rheumatol.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">437</span>– <span class="NLM_lpage">441</span>, <span class="refDoi"> DOI: 10.1038/nrrheum.2014.44</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02008&amp;key=10.1038%2Fnrrheum.2014.44" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02008&amp;key=24662640" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02008&amp;key=1%3ACAS%3A280%3ADC%252BC2crmvVantQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2014&pages=437-441&author=D.+J.+Hunterauthor=D.+Schofieldauthor=E.+Callander&title=The+individual+and+socioeconomic+impact+of+osteoarthritis&doi=10.1038%2Fnrrheum.2014.44"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">The individual and socioeconomic impact of osteoarthritis</span></div><div class="casAuthors">Hunter David J; Schofield Deborah; Callander Emily</div><div class="citationInfo"><span class="NLM_cas:title">Nature reviews. Rheumatology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">437-41</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Osteoarthritis (OA) is a highly prevalent, disabling disease, with a commensurate tremendous individual and socioeconomic burden.  This Perspectives article focuses on the burden of OA for the individual, the health-care system and society, to draw attention to the magnitude of the current problem with some reference to projected figures.  We have an urgent opportunity to make fundamental changes to the way we care for individuals with OA that will have an effect upon the direct and indirect costs of this disease.  By focusing on the burden of this prevalent, disabling, and costly disease, we hope to highlight the opportunity for shifts in health-care policy towards prevention and chronic-disease management.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSzrLZQFrf-SsSzjBFCN0BJfW6udTcc2eYTMEpQNFUfsLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2crmvVantQ%253D%253D&md5=2c735203ce3ca044913a7710502f69a7</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1038%2Fnrrheum.2014.44&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrrheum.2014.44%26sid%3Dliteratum%253Aachs%26aulast%3DHunter%26aufirst%3DD.%2BJ.%26aulast%3DSchofield%26aufirst%3DD.%26aulast%3DCallander%26aufirst%3DE.%26atitle%3DThe%2520individual%2520and%2520socioeconomic%2520impact%2520of%2520osteoarthritis%26jtitle%3DNat.%2520Rev.%2520Rheumatol.%26date%3D2014%26volume%3D10%26spage%3D437%26epage%3D441%26doi%3D10.1038%2Fnrrheum.2014.44" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">O’Neil, C. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hanlon, J. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marcum, Z. A.</span></span> <span> </span><span class="NLM_article-title">Adverse effects of analgesics commonly used by older adults with osteoarthritis: focus on non-opioid and opioid analgesics</span>. <i>Am. J. Geriatr Pharmacother</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">331</span>– <span class="NLM_lpage">342</span>, <span class="refDoi"> DOI: 10.1016/j.amjopharm.2012.09.004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02008&amp;key=10.1016%2Fj.amjopharm.2012.09.004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02008&amp;key=23036838" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02008&amp;key=1%3ACAS%3A528%3ADC%252BC3sXmtV2ns7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2012&pages=331-342&author=C.+K.+O%E2%80%99Neilauthor=J.+T.+Hanlonauthor=Z.+A.+Marcum&title=Adverse+effects+of+analgesics+commonly+used+by+older+adults+with+osteoarthritis%3A+focus+on+non-opioid+and+opioid+analgesics&doi=10.1016%2Fj.amjopharm.2012.09.004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Adverse Effects of Analgesics Commonly Used by Older Adults With Osteoarthritis: Focus on Non-Opioid and Opioid Analgesics</span></div><div class="casAuthors">O'Neil, Christine K.; Hanlon, Joseph T.; Marcum, Zachary A.</div><div class="citationInfo"><span class="NLM_cas:title">American Journal of Geriatric Pharmacotherapy</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">331-342</span>CODEN:
                <span class="NLM_cas:coden">AJGPB5</span>;
        ISSN:<span class="NLM_cas:issn">1876-7761</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Osteoarthritis (OA) is the most common cause of disability in older adults, and although analgesic use can be helpful, it can also result in adverse drug events.  To review the recent literature to describe potential adverse drug events assocd. with analgesics commonly used by older adults with OA.  To identify articles for this review, a systematic search of the English-language literature from Jan. 2001 to June 2012 was conducted using PubMed, MEDLINE, EBSCO, and the Cochrane Database of Systematic Reviews for publications related to the medical management of OA.  Search terms used were "analgesics," "acetaminophen," "nonsteroidal anti-inflammatory drugs" (NSAIDs), "opioids," "pharmacokinetics," "pharmacodynamics," and "adverse drug events." The search was restricted to those articles that concerned humans aged ≥65 years.  A manual search of the ref. lists from identified articles and the authors' article files, book chapters, and recent reviews was conducted to identify addnl. articles.  From these, the authors identified those studies that examd. analgesic use in older adults.  There are limited data to suggest that non-frail elders are more likely than their younger counterparts to develop acetaminophen-induced hepatotoxicity.  However, decreased hepatic phase II metab. in frail elders may result in increased risk of hepatotoxicity.  It is now well established that older adults are at higher risk of NSAID-induced gastrointestinal toxicity and renal insufficiency.  Insofar as opioids, the data that suggest an increased risk of falls, fractures, or delirium need to be tempered by the potential risk of inadequately treating severe chronic OA-related pain.  Acetaminophen is the mainstay frontline analgesic for treating OA-related pain in older adults.  NSAIDs should be limited to short-term use only, and for moderate to severe OA-related pain, opioids may be preferable in individuals without substance abuse or dependence issues.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoRlmkGVxFgL7Vg90H21EOLACvtfcHk0ljm1tOyg7M1OA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXmtV2ns7c%253D&md5=6f22f392d17a5f4faa03bbad6e370481</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1016%2Fj.amjopharm.2012.09.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.amjopharm.2012.09.004%26sid%3Dliteratum%253Aachs%26aulast%3DO%25E2%2580%2599Neil%26aufirst%3DC.%2BK.%26aulast%3DHanlon%26aufirst%3DJ.%2BT.%26aulast%3DMarcum%26aufirst%3DZ.%2BA.%26atitle%3DAdverse%2520effects%2520of%2520analgesics%2520commonly%2520used%2520by%2520older%2520adults%2520with%2520osteoarthritis%253A%2520focus%2520on%2520non-opioid%2520and%2520opioid%2520analgesics%26jtitle%3DAm.%2520J.%2520Geriatr%2520Pharmacother%26date%3D2012%26volume%3D10%26spage%3D331%26epage%3D342%26doi%3D10.1016%2Fj.amjopharm.2012.09.004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Teichtahl, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cicuttini, F. M.</span></span> <span> </span><span class="NLM_article-title">Osteoarthritis year in review 2015: imaging</span>. <i>Osteoarthritis and cartilage</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>24</i></span>,  <span class="NLM_fpage">49</span>– <span class="NLM_lpage">57</span>, <span class="refDoi"> DOI: 10.1016/j.joca.2015.07.027</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02008&amp;key=10.1016%2Fj.joca.2015.07.027" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02008&amp;key=26707992" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02008&amp;key=1%3ACAS%3A280%3ADC%252BC28rlt1Gjsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2016&pages=49-57&author=Y.+Wangauthor=A.+J.+Teichtahlauthor=F.+M.+Cicuttini&title=Osteoarthritis+year+in+review+2015%3A+imaging&doi=10.1016%2Fj.joca.2015.07.027"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Osteoarthritis year in review 2015: imaging</span></div><div class="casAuthors">Wang Y; Teichtahl A J; Cicuttini F M</div><div class="citationInfo"><span class="NLM_cas:title">Osteoarthritis and cartilage</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">49-57</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">PURPOSE:  This narrative review covers original publications related to imaging in osteoarthritis (OA) published in English between 1 April 2014 and 30 April 2015.  Novel lessons relating to imaging are described.  METHODS:  An extensive PubMed database search was performed based on, but not limited to the terms "OA" in combination with "Magnetic resonance imaging (MRI)", "Imaging", "Radiography", "Ultrasound", "Computed tomography (CT)" and "Nuclear medicine" to extract relevant studies.  In vitro data and animal studies were excluded.  This review focuses on the new developments and observations based on the aforementioned imaging modalities, as well as a 'whole-organ' approach by presenting findings from different tissues (bone, meniscus, synovium, muscle and fat) and joints (hip, lumbar spine and hand).  RESULTS AND CONCLUSIONS:  Over the past year, studies using imagine have made a major contribution to the understanding of the pathogenesis of OA.  Significant work has continued at the knee, with MRI now being increasingly used to assess structural endpoints in clinical trials.  This offers the exciting opportunity to explore potential disease modifying OA therapies.  There has been a clear interest in the role of bone in the pathogenesis of OA.  There is now a growing body of literature examining the pathogenesis of OA at the hip, lumbar spine and hand.  The future of imaging in OA offers the exciting potential to better understand the disease process across all joints and develop more effective preventive and therapeutic interventions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSnG-xUyVai4BWfpMXQLRstfW6udTcc2eYTMEpQNFUfsLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC28rlt1Gjsg%253D%253D&md5=d101c7a60f2d40903d34be8b73c9a894</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1016%2Fj.joca.2015.07.027&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.joca.2015.07.027%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DY.%26aulast%3DTeichtahl%26aufirst%3DA.%2BJ.%26aulast%3DCicuttini%26aufirst%3DF.%2BM.%26atitle%3DOsteoarthritis%2520year%2520in%2520review%25202015%253A%2520imaging%26jtitle%3DOsteoarthritis%2520and%2520cartilage%26date%3D2016%26volume%3D24%26spage%3D49%26epage%3D57%26doi%3D10.1016%2Fj.joca.2015.07.027" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yang, C. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chanalaris, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Troeberg, L.</span></span> <span> </span><span class="NLM_article-title">ADAMTS and ADAM metalloproteinases in osteoarthritis - looking beyond the ‘usual suspects’</span>. <i>Osteoarthritis and cartilage</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>25</i></span>,  <span class="NLM_fpage">1000</span>– <span class="NLM_lpage">1009</span>, <span class="refDoi"> DOI: 10.1016/j.joca.2017.02.791</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02008&amp;key=10.1016%2Fj.joca.2017.02.791" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02008&amp;key=28216310" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02008&amp;key=1%3ACAS%3A280%3ADC%252BC1c3osV2gtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2017&pages=1000-1009&author=C.+Y.+Yangauthor=A.+Chanalarisauthor=L.+Troeberg&title=ADAMTS+and+ADAM+metalloproteinases+in+osteoarthritis+-+looking+beyond+the+%E2%80%98usual+suspects%E2%80%99&doi=10.1016%2Fj.joca.2017.02.791"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">ADAMTS and ADAM metalloproteinases in osteoarthritis - looking beyond the 'usual suspects'</span></div><div class="casAuthors">Yang C-Y; Chanalaris A; Troeberg L</div><div class="citationInfo"><span class="NLM_cas:title">Osteoarthritis and cartilage</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1000-1009</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">INTRODUCTION:  Matrix metalloproteinases (MMPs) and 'aggrecanase' a disintegrin and metalloproteinase with thrombospondin motifs (ADAMTSs) are well established to play key roles in osteoarthritis (OA) through degradation of extracellular matrix (ECM) type II collagen and aggrecan, and are thus potential targets for development of OA therapies.  OBJECTIVE:  This paper aims to provide a comprehensive review of the expression and potential roles of other, lesser-known ADAMTSs and related adamalysins (or a disintegrin and metalloproteinases (ADAMs)) in cartilage, with a view to identifying potentially protective or homeostatic metalloproteinases in the joint and informing consequent selective inhibitor design.  DESIGN:  A comprehensive literature search was performed using PubMed terms 'osteoarthritis' and 'ADAMTS' or 'ADAM'.  RESULTS:  Several ADAMTSs and ADAMs were identified as having reportedly increased expression in OA.  These include enzymes likely to play roles in cartilage matrix anabolism (e.g., the procollagen N-proteinases ADAMTS-2, ADAMTS-3 and ADAMTS-14), chondrocyte differentiation and proliferation (e.g., ADAM9, ADAM10, ADAM12), as well as enzymes contributing to cartilage catabolism (e.g., Cartilage oligomeric protein (COMP)-degrading ADAMTS-7 and ADAMTS-12).  CONCLUSIONS:  In addition to the well-characterised MMPs, ADAMTS-4 and ADAMTS-5, many other ADAMTSs and ADAMs are expressed in cartilage and several show significantly altered expression in OA.  Studies aimed at elucidating the pathophysiological roles of these enzymes in cartilage will contribute to our understanding of OA pathogenesis and enable design of targeted inhibitors that effectively target metalloproteinase-mediated cartilage degradation while sparing cartilage repair pathways.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTGxTBW1-m5KGhHGZei4OW9fW6udTcc2ebnPRHB1cMhlrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1c3osV2gtg%253D%253D&md5=90d9865793e24f56742bfd2495061996</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1016%2Fj.joca.2017.02.791&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.joca.2017.02.791%26sid%3Dliteratum%253Aachs%26aulast%3DYang%26aufirst%3DC.%2BY.%26aulast%3DChanalaris%26aufirst%3DA.%26aulast%3DTroeberg%26aufirst%3DL.%26atitle%3DADAMTS%2520and%2520ADAM%2520metalloproteinases%2520in%2520osteoarthritis%2520-%2520looking%2520beyond%2520the%2520%25E2%2580%2598usual%2520suspects%25E2%2580%2599%26jtitle%3DOsteoarthritis%2520and%2520cartilage%26date%3D2017%26volume%3D25%26spage%3D1000%26epage%3D1009%26doi%3D10.1016%2Fj.joca.2017.02.791" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wojtowicz-Praga, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dickson, R. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hawkins, M. J.</span></span> <span> </span><span class="NLM_article-title">Matrix metalloproteinase inhibitors</span>. <i>Invest. New Drugs</i> <span class="NLM_year" style="font-weight: bold;">1997</span>,  <span class="NLM_volume"><i>15</i></span>,  <span class="NLM_fpage">61</span>– <span class="NLM_lpage">75</span>, <span class="refDoi"> DOI: 10.1023/A:1005722729132</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02008&amp;key=10.1023%2FA%3A1005722729132" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02008&amp;key=9195290" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02008&amp;key=1%3ACAS%3A528%3ADyaK2sXktlOls7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=1997&pages=61-75&author=S.+M.+Wojtowicz-Pragaauthor=R.+B.+Dicksonauthor=M.+J.+Hawkins&title=Matrix+metalloproteinase+inhibitors&doi=10.1023%2FA%3A1005722729132"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Matrix metalloproteinase inhibitors</span></div><div class="casAuthors">Wojtowicz-Praga, Slawomir M.; Dickson, Robert B.; Hawkins, Michael J.</div><div class="citationInfo"><span class="NLM_cas:title">Investigational New Drugs</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">61-75</span>CODEN:
                <span class="NLM_cas:coden">INNDDK</span>;
        ISSN:<span class="NLM_cas:issn">0167-6997</span>.
    
            (<span class="NLM_cas:orgname">Kluwer</span>)
        </div><div class="casAbstract">A review with 94 refs.  The matrix metalloproteinases (MMPs) are a family of at least fifteen secreted and membrane-bound zinc-endopeptidases.  Collectively, these enzymes can degrade all of the components of the extracellular matrix, including fibrillar and non-fibrillar collagens, fibronectin, laminin and basement membrane glycoproteins.  MMPs are thought to be essential for the diverse invasive processes of angiogenesis and tumor metastasis.  Numerous studies have shown that there is a close assocn. between expression of various members of the MMP family by tumors and their proliferative and invasive behavior and metastatic potential.  In some of human cancers a pos. correlation has also been demonstrated between the intensity of new blood vessel growth (angiogenesis) and the likelihood of developing metastases.  Thus, control of MMP activity in these two different contexts has generated considerable interest as a possible therapeutic target.  The tissue inhibitors of metalloproteinases (TIMPs) are naturally occurring proteins that specifically inhibit matrix metalloproteinases, thus maintaining balance between matrix destruction and formation.  An imbalance between MMPs and the assocd. TIMPs may play a significant role in the invasive phenotype of malignant tumors.  TIMP-1 has been shown to inhibit tumor-induced angiogenesis in exptl. systems.  These findings raised the possibility of using an agent that affects expression or activity of MMPs as an anti-cancer therapy.  TIMPs are probably not suitable for pharmacol. applications due to their short half-life in vivo.  Batimastat (BB-94) and marimastat (BB-2516) are synthetic, low-mol. wt. MMP inhibitors.  They have a collagen-mimicking hydroxamate structure, which facilitates chelation of the zinc ion in the active site of the MMPs.  These compds. inhibit MMPs potently and specifically.  Batimastat was the first synthetic MMP inhibitor studied in humans with advanced malignancies, but its usefulness has been limited by extremely poor water soly., which required i.p. administration of the drug as a detergent emulsion.  Marimastat belongs to a second generation of MMP inhibitors.  In contrast to batimastat, marimastat is orally available.  Both of these agents are currently in Phase I/II trials in US, Europe and Canada.  Some other new agents, currently in clin. trials, have been shown to inhibit MMP prodn.  Bryostatins, naturally occurring macrocyclic lactones, have both in vitro and in vivo activity in numerous murine and human tumors.  In culture, bryostatin-1 has been shown to induce differentiation and halt the growth of several malignant cell lines.  While the exact mechanism responsible for anti-tumor activity is unclear, an initial event in the action of bryostatin-1 is activation of protein kinase C (PKC), followed by its down regulation.  Bryostatin-1 does not directly affect the activity of MMPs, but it can inhibit the prodn. of MMP-1, 3, 9, 10 and 11 by inhibiting PKC.  TIMP-1 levels could also be modulated by bryostatin-1, as it is encoded by a PKC responsive gene.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpFfjYPPsjV67Vg90H21EOLACvtfcHk0lizq0VPIb9Q4Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXktlOls7s%253D&md5=e3dda291df34d418d5e6f4cf97786f6c</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1023%2FA%3A1005722729132&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1023%252FA%253A1005722729132%26sid%3Dliteratum%253Aachs%26aulast%3DWojtowicz-Praga%26aufirst%3DS.%2BM.%26aulast%3DDickson%26aufirst%3DR.%2BB.%26aulast%3DHawkins%26aufirst%3DM.%2BJ.%26atitle%3DMatrix%2520metalloproteinase%2520inhibitors%26jtitle%3DInvest.%2520New%2520Drugs%26date%3D1997%26volume%3D15%26spage%3D61%26epage%3D75%26doi%3D10.1023%2FA%3A1005722729132" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Malemud, C. J.</span></span> <span> </span><span class="NLM_article-title">Inhibition of MMPs and ADAM/ADAMTS</span>. <i>Biochem. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>165</i></span>,  <span class="NLM_fpage">33</span>– <span class="NLM_lpage">40</span>, <span class="refDoi"> DOI: 10.1016/j.bcp.2019.02.033</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02008&amp;key=10.1016%2Fj.bcp.2019.02.033" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02008&amp;key=30826330" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02008&amp;key=1%3ACAS%3A528%3ADC%252BC1MXks1eks78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=165&publication_year=2019&pages=33-40&author=C.+J.+Malemud&title=Inhibition+of+MMPs+and+ADAM%2FADAMTS&doi=10.1016%2Fj.bcp.2019.02.033"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of MMPs and ADAM/ADAMTS</span></div><div class="casAuthors">Malemud, Charles J.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Pharmacology (Amsterdam, Netherlands)</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">165</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">33-40</span>CODEN:
                <span class="NLM_cas:coden">BCPCA6</span>;
        ISSN:<span class="NLM_cas:issn">0006-2952</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Matrix metalloproteinases (MMPs), A Disintegrin and Metalloproteinase (ADAM) and Disintegrin and Metalloproteinase with Thrombospondin Motif (ADAMTS) are zinc-dependent endopeptidases that play a crit. role in the destruction of extracellular matrix proteins and, the shedding of membrane-bound receptor mols. in various forms of arthritis and other diseases.  Under normal conditions, MMP, ADAM and ADAMTS gene expression aids in the maintenance of homeostasis.  However, in inflamed synovial joints characteristic of rheumatoid arthritis and osteoarthritis.  MMP, ADAM and ADAMTS prodn. is greatly increased under the influence of pro-inflammatory cytokines.  Analyses based on medicinal chem. strategies designed to directly inhibit the activity of MMPs have been largely unsuccessful when these MMP inhibitors were employed in animal models of rheumatoid arthritis and osteoarthritis.  This is despite the fact that these MMP inhibitors were largely able to suppress pro-inflammatory cytokine-induced MMP prodn. in vitro.  A focus on ADAM and ADAMTS inhibitors has also been pursued.  Thus, recent progress has identified the "sheddase" activity of ADAMs as a viable target and the development of GW280264X is an exptl. ADAM17 inhibitor.  Of note, a monoclonal antibody, GLPG1972, developed as an ADAMTS-5 inhibitor, entered a Phase I OA clin. trial.  However, the failure of many of these previously developed inhibitors to move beyond the preclin. testing phase has required that novel strategies be developed that are designed to suppress both MMP, ADAM and ADAMTS prodn. and activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpodUTdsK4strVg90H21EOLACvtfcHk0lizq0VPIb9Q4Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXks1eks78%253D&md5=8aa04cc97bafeec7f028531fd9e9a3fc</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1016%2Fj.bcp.2019.02.033&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bcp.2019.02.033%26sid%3Dliteratum%253Aachs%26aulast%3DMalemud%26aufirst%3DC.%2BJ.%26atitle%3DInhibition%2520of%2520MMPs%2520and%2520ADAM%252FADAMTS%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D2019%26volume%3D165%26spage%3D33%26epage%3D40%26doi%3D10.1016%2Fj.bcp.2019.02.033" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Glasson, S. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Askew, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sheppard, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carito, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blanchet, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, H. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Flannery, C. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peluso, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kanki, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Majumdar, M. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morris, E. A.</span></span> <span> </span><span class="NLM_article-title">Deletion of active ADAMTS5 prevents cartilage degradation in a murine model of osteoarthritis</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>434</i></span>,  <span class="NLM_fpage">644</span>– <span class="NLM_lpage">648</span>, <span class="refDoi"> DOI: 10.1038/nature03369</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02008&amp;key=10.1038%2Fnature03369" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02008&amp;key=15800624" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02008&amp;key=1%3ACAS%3A528%3ADC%252BD2MXislCmsr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=434&publication_year=2005&pages=644-648&author=S.+S.+Glassonauthor=R.+Askewauthor=B.+Sheppardauthor=B.+Caritoauthor=T.+Blanchetauthor=H.+L.+Maauthor=C.+R.+Flanneryauthor=D.+Pelusoauthor=K.+Kankiauthor=Z.+Yangauthor=M.+K.+Majumdarauthor=E.+A.+Morris&title=Deletion+of+active+ADAMTS5+prevents+cartilage+degradation+in+a+murine+model+of+osteoarthritis&doi=10.1038%2Fnature03369"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Deletion of active ADAMTS5 prevents cartilage degradation in a murine model of osteoarthritis</span></div><div class="casAuthors">Glasson, Sonya S.; Askew, Roger; Sheppard, Barbara; Carito, Brenda; Blanchet, Tracey; Ma, Hak-Ling; Flannery, Carl R.; Peluso, Diane; Kanki, Kim; Yang, Zhiyong; Majumdar, Manas K.; Morris, Elisabeth A.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">434</span>
        (<span class="NLM_cas:issue">7033</span>),
    <span class="NLM_cas:pages">644-648</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Human osteoarthritis is a progressive disease of the joints characterized by degrdn. of articular cartilage.  Although disease initiation may be multifactorial, the cartilage destruction appears to be a result of uncontrolled proteolytic extracellular matrix destruction.  A major component of the cartilage extracellular matrix is aggrecan, a proteoglycan that imparts compressive resistance to the tissue.  Aggrecan is cleaved at a specific 'aggrecanase' site in human osteoarthritic cartilage; this cleavage can be performed by several members of ADAMTS family of metalloproteases.  The relative contribution of individual ADAMTS proteases to cartilage destruction during osteoarthritis has not been resolved.  Here we describe expts. with a genetically modified mouse in which the catalytic domain of ADAMTS5 (aggrecanase-2) was deleted.  After surgically induced joint instability, there was significant redn. in the severity of cartilage destruction in the ADAMTS5 knockout mice compared with wild-type mice.  This is the first report of a single gene deletion capable of abrogating the course of cartilage destruction in an animal model of osteoarthritis.  These results demonstrate that ADAMTS5 is the primary 'aggrecanase' responsible for aggrecan degrdn. in a murine model of osteoarthritis, and suggest rational strategies for therapeutic intervention in osteoarthritis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoN65ylxfcWq7Vg90H21EOLACvtfcHk0lhBvwJipgCI2g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXislCmsr8%253D&md5=1bb0c5c0faeb0591976c84852bebc026</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1038%2Fnature03369&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature03369%26sid%3Dliteratum%253Aachs%26aulast%3DGlasson%26aufirst%3DS.%2BS.%26aulast%3DAskew%26aufirst%3DR.%26aulast%3DSheppard%26aufirst%3DB.%26aulast%3DCarito%26aufirst%3DB.%26aulast%3DBlanchet%26aufirst%3DT.%26aulast%3DMa%26aufirst%3DH.%2BL.%26aulast%3DFlannery%26aufirst%3DC.%2BR.%26aulast%3DPeluso%26aufirst%3DD.%26aulast%3DKanki%26aufirst%3DK.%26aulast%3DYang%26aufirst%3DZ.%26aulast%3DMajumdar%26aufirst%3DM.%2BK.%26aulast%3DMorris%26aufirst%3DE.%2BA.%26atitle%3DDeletion%2520of%2520active%2520ADAMTS5%2520prevents%2520cartilage%2520degradation%2520in%2520a%2520murine%2520model%2520of%2520osteoarthritis%26jtitle%3DNature%26date%3D2005%26volume%3D434%26spage%3D644%26epage%3D648%26doi%3D10.1038%2Fnature03369" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Stanton, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rogerson, F. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">East, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Golub, S. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lawlor, K. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meeker, C. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Little, C. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Last, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Farmer, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Campbell, I. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fourie, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fosang, A. J.</span></span> <span> </span><span class="NLM_article-title">ADAMTS5 is the major aggrecanase in mouse cartilage in vivo and in vitro</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>434</i></span>,  <span class="NLM_fpage">648</span>– <span class="NLM_lpage">652</span>, <span class="refDoi"> DOI: 10.1038/nature03417</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02008&amp;key=10.1038%2Fnature03417" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02008&amp;key=15800625" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02008&amp;key=1%3ACAS%3A528%3ADC%252BD2MXislCmsrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=434&publication_year=2005&pages=648-652&author=H.+Stantonauthor=F.+M.+Rogersonauthor=C.+J.+Eastauthor=S.+B.+Golubauthor=K.+E.+Lawlorauthor=C.+T.+Meekerauthor=C.+B.+Littleauthor=K.+Lastauthor=P.+J.+Farmerauthor=I.+K.+Campbellauthor=A.+M.+Fourieauthor=A.+J.+Fosang&title=ADAMTS5+is+the+major+aggrecanase+in+mouse+cartilage+in+vivo+and+in+vitro&doi=10.1038%2Fnature03417"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">ADAMTS5 is the major aggrecanase in mouse cartilage in vivo and in vitro</span></div><div class="casAuthors">Stanton, Heather; Rogerson, Fraser M.; East, Charlotte J.; Golub, Suzanne B.; Lawlor, Kate E.; Meeker, Clare T.; Little, Christopher B.; Last, Karena; Farmer, Pamela J.; Campbell, Ian K.; Fourie, Anne M.; Fosang, Amanda J.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">434</span>
        (<span class="NLM_cas:issue">7033</span>),
    <span class="NLM_cas:pages">648-652</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Aggrecan is the major proteoglycan in cartilage, endowing this tissue with the unique capacity to bear load and resist compression.  In arthritic cartilage, aggrecan is degraded by one or more 'aggrecanases' from the ADAMTS (a disintegrin and metalloproteinase with thrombospondin motifs) family of proteinases.  ADAMTS1, 8 and 9 have weak aggrecan-degrading activity.  However, they are not thought to be the primary aggrecanases because ADAMTS1 null mice are not protected from exptl. arthritis, and cleavage by ADAMTS8 and 9 is highly inefficient.  Although ADAMTS4 and 5 are expressed in joint tissues, and are known to be efficient aggrecanases in vitro, the exact contribution of these two enzymes to cartilage pathol. is unknown.  Here we show that ADAMTS5 is the major aggrecanase in mouse cartilage, both in vitro and in a mouse model of inflammatory arthritis.  Our data suggest that ADAMTS5 may be a suitable target for the development of new drugs designed to inhibit cartilage destruction in arthritis, although further work will be required to det. whether ADAMTS5 is also the major aggrecanase in human arthritis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqjJz-6pKyUPLVg90H21EOLACvtfcHk0lhBvwJipgCI2g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXislCmsrg%253D&md5=7fd3127cfffec334d18c07aec84e8b83</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1038%2Fnature03417&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature03417%26sid%3Dliteratum%253Aachs%26aulast%3DStanton%26aufirst%3DH.%26aulast%3DRogerson%26aufirst%3DF.%2BM.%26aulast%3DEast%26aufirst%3DC.%2BJ.%26aulast%3DGolub%26aufirst%3DS.%2BB.%26aulast%3DLawlor%26aufirst%3DK.%2BE.%26aulast%3DMeeker%26aufirst%3DC.%2BT.%26aulast%3DLittle%26aufirst%3DC.%2BB.%26aulast%3DLast%26aufirst%3DK.%26aulast%3DFarmer%26aufirst%3DP.%2BJ.%26aulast%3DCampbell%26aufirst%3DI.%2BK.%26aulast%3DFourie%26aufirst%3DA.%2BM.%26aulast%3DFosang%26aufirst%3DA.%2BJ.%26atitle%3DADAMTS5%2520is%2520the%2520major%2520aggrecanase%2520in%2520mouse%2520cartilage%2520in%2520vivo%2520and%2520in%2520vitro%26jtitle%3DNature%26date%3D2005%26volume%3D434%26spage%3D648%26epage%3D652%26doi%3D10.1038%2Fnature03417" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Botter, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Glasson, S. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hopkins, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clockaerts, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weinans, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van Leeuwen, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van Osch, G. J.</span></span> <span> </span><span class="NLM_article-title">ADAMTS5–/– mice have less subchondral bone changes after induction of osteoarthritis through surgical instability: implications for a link between cartilage and subchondral bone changes</span>. <i>Osteoarthritis and cartilage</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">636</span>– <span class="NLM_lpage">645</span>, <span class="refDoi"> DOI: 10.1016/j.joca.2008.09.018</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02008&amp;key=10.1016%2Fj.joca.2008.09.018" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02008&amp;key=19010693" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02008&amp;key=1%3ACAS%3A280%3ADC%252BD1M3pvFWitA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2009&pages=636-645&author=S.+M.+Botterauthor=S.+S.+Glassonauthor=B.+Hopkinsauthor=S.+Clockaertsauthor=H.+Weinansauthor=J.+P.+van+Leeuwenauthor=G.+J.+van+Osch&title=ADAMTS5%E2%80%93%2F%E2%80%93+mice+have+less+subchondral+bone+changes+after+induction+of+osteoarthritis+through+surgical+instability%3A+implications+for+a+link+between+cartilage+and+subchondral+bone+changes&doi=10.1016%2Fj.joca.2008.09.018"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">ADAMTS5-/- mice have less subchondral bone changes after induction of osteoarthritis through surgical instability: implications for a link between cartilage and subchondral bone changes</span></div><div class="casAuthors">Botter S M; Glasson S S; Hopkins B; Clockaerts S; Weinans H; van Leeuwen J P T M; van Osch G J V M</div><div class="citationInfo"><span class="NLM_cas:title">Osteoarthritis and cartilage</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">636-45</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">OBJECTIVE:  Osteoarthritis (OA) is characterized by damaged articular cartilage and changes in subchondral bone.  Previous work demonstrated aggrecanase-2 deficient (ADAMTS5-/-) mice to be protected from cartilage damage induced by joint instability.  This study analyzed whether this protective effect on cartilage is also reflected in the subchondral bone structure.  METHODS:  Right knee joints from 10-week old male wild type (WT) and ADAMTS5-/- mice received transection of the medial meniscotibial ligament to induce OA, whereas left knees were left unoperated.  After 8 weeks knee joints were scanned by micro-CT.  The proximal tibia was selected for further analysis.  Histology was performed to evaluate cartilage damage and osteoclast presence.  RESULTS:  ADAMTS5-/- joints had a significantly thinner subchondral plate and less epiphyseal trabecular bone compared to WT joints.  Histology confirmed previous findings that ADAMTS5-/- mice have significantly less cartilage damage than WT in the instability-induced OA model.  Although the subchondral bone plate became significantly thicker at the medial tibial plateau in operated joints of both genotypes, the percentage increase was significantly smaller in ADAMTS5-/- mice (WT: 20.7+/-4.7%, ADAMTS5-/-: 8.3+/-1.2% compared to the left unoperated control joint).  In ADAMTS5-/- animals a significant decrease was found in both Oc.N./BS and Oc.S./BS.  Finally, in WT but not in ADAMTS5-/- mice a significant correlation was found between medial subchondral bone plate thickness and cartilage damage at the medial tibial plateau.  CONCLUSION:  ADAMTS5-/- joints that were protected from cartilage damage showed minor changes in the subchondral bone structure, in contrast to WT mice where substantial changes were found.  This finding suggests links between the process of cartilage damage and subchondral bone changes in instability-induced OA.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRNHrHVpZU4PyO2kE7krGOBfW6udTcc2ebAuXvpid-wK7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD1M3pvFWitA%253D%253D&md5=222a243320db13dd6f62e46278d20900</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1016%2Fj.joca.2008.09.018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.joca.2008.09.018%26sid%3Dliteratum%253Aachs%26aulast%3DBotter%26aufirst%3DS.%2BM.%26aulast%3DGlasson%26aufirst%3DS.%2BS.%26aulast%3DHopkins%26aufirst%3DB.%26aulast%3DClockaerts%26aufirst%3DS.%26aulast%3DWeinans%26aufirst%3DH.%26aulast%3Dvan%2BLeeuwen%26aufirst%3DJ.%2BP.%26aulast%3Dvan%2BOsch%26aufirst%3DG.%2BJ.%26atitle%3DADAMTS5%25E2%2580%2593%252F%25E2%2580%2593%2520mice%2520have%2520less%2520subchondral%2520bone%2520changes%2520after%2520induction%2520of%2520osteoarthritis%2520through%2520surgical%2520instability%253A%2520implications%2520for%2520a%2520link%2520between%2520cartilage%2520and%2520subchondral%2520bone%2520changes%26jtitle%3DOsteoarthritis%2520and%2520cartilage%26date%3D2009%26volume%3D17%26spage%3D636%26epage%3D645%26doi%3D10.1016%2Fj.joca.2008.09.018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Malfait, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ritchie, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gil, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Austin, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hartke, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qin, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tortorella, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mogil, J. S.</span></span> <span> </span><span class="NLM_article-title">ADAMTS-5 deficient mice do not develop mechanical allodynia associated with osteoarthritis following medial meniscal destabilization</span>. <i>Osteoarthritis and cartilage</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>18</i></span>,  <span class="NLM_fpage">572</span>– <span class="NLM_lpage">580</span>, <span class="refDoi"> DOI: 10.1016/j.joca.2009.11.013</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02008&amp;key=10.1016%2Fj.joca.2009.11.013" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02008&amp;key=20036347" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02008&amp;key=1%3ACAS%3A280%3ADC%252BC3c3itFOrsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2010&pages=572-580&author=A.+M.+Malfaitauthor=J.+Ritchieauthor=A.+S.+Gilauthor=J.+S.+Austinauthor=J.+Hartkeauthor=W.+Qinauthor=M.+D.+Tortorellaauthor=J.+S.+Mogil&title=ADAMTS-5+deficient+mice+do+not+develop+mechanical+allodynia+associated+with+osteoarthritis+following+medial+meniscal+destabilization&doi=10.1016%2Fj.joca.2009.11.013"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">ADAMTS-5 deficient mice do not develop mechanical allodynia associated with osteoarthritis following medial meniscal destabilization</span></div><div class="casAuthors">Malfait A M; Ritchie J; Gil A S; Austin J-S; Hartke J; Qin W; Tortorella M D; Mogil J S</div><div class="citationInfo"><span class="NLM_cas:title">Osteoarthritis and cartilage</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">572-80</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">OBJECTIVE:  To characterize pain-related behavior during the course of knee osteoarthritis (OA) induced by destabilization of the medial meniscus (DMM) in wild type (WT) and in ADAMTS-5 null mice.  METHODS:  DMM surgery was performed in the right knee of CD-1 mice.  At regular intervals up to 8 weeks after surgery, mice were assessed for the following parameters: mechanical allodynia (via withdrawal thresholds to von Frey filaments applied to the plantar surface of both hind paws or to the tail), thermal hyperalgesia, locomotor activity and gait analysis.  In addition, mechanical allodynia was tested in C57BL/6 WT or ADAMTS-5 null mice following DMM surgery.  RESULTS:  In CD-1 mice, a robust and progressive decrease in withdrawal threshold was observed in both hind paws after DMM but not sham surgery.  Allodynia was apparent as early as 14 days postoperatively.  Both sexes developed OA changes after surgery with concurrent mechanical allodynia.  No other pain-related behavioral changes were detected up to 8 weeks post-surgery.  In C57BL/6 mice, a genetic background in which only males develop OA changes after DMM, males but not females developed allodynia in the ipsilateral hind paw.  In contrast, C57BL/6 ADAMTS-5 null mice did not develop OA changes or mechanical allodynia up to 8 weeks post-surgery.  CONCLUSION:  Joint pathology following DMM surgery in mice is associated with progressive mechanical allodynia.  ADAMTS-5 null mice are resistant to DMM-induced OA-like lesions and to the associated mechanical allodynia.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcThJCmZtCkVsENHe_gFldTbfW6udTcc2eZCwSNG8T7zDrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3c3itFOrsw%253D%253D&md5=5929be92d57f0b58ebe16578ac99a303</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1016%2Fj.joca.2009.11.013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.joca.2009.11.013%26sid%3Dliteratum%253Aachs%26aulast%3DMalfait%26aufirst%3DA.%2BM.%26aulast%3DRitchie%26aufirst%3DJ.%26aulast%3DGil%26aufirst%3DA.%2BS.%26aulast%3DAustin%26aufirst%3DJ.%2BS.%26aulast%3DHartke%26aufirst%3DJ.%26aulast%3DQin%26aufirst%3DW.%26aulast%3DTortorella%26aufirst%3DM.%2BD.%26aulast%3DMogil%26aufirst%3DJ.%2BS.%26atitle%3DADAMTS-5%2520deficient%2520mice%2520do%2520not%2520develop%2520mechanical%2520allodynia%2520associated%2520with%2520osteoarthritis%2520following%2520medial%2520meniscal%2520destabilization%26jtitle%3DOsteoarthritis%2520and%2520cartilage%26date%3D2010%26volume%3D18%26spage%3D572%26epage%3D580%26doi%3D10.1016%2Fj.joca.2009.11.013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rong, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guan, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tao, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guan, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tao, T.</span></span> <span> </span><span class="NLM_article-title">Association of ADAMTS5 gene polymorphisms with osteoarthritis in Chinese Han population: a community-based case-control study</span>. <i>Rheumatol. Int.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>33</i></span>,  <span class="NLM_fpage">2893</span>– <span class="NLM_lpage">2897</span>, <span class="refDoi"> DOI: 10.1007/s00296-012-2506-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02008&amp;key=10.1007%2Fs00296-012-2506-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02008&amp;key=22961118" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02008&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhs1KqsL%252FF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2013&pages=2893-2897&author=J.+Guauthor=J.+Rongauthor=F.+Guanauthor=L.+Jiangauthor=T.+Zhangauthor=S.+Taoauthor=G.+Guanauthor=L.+Xuauthor=T.+Tao&title=Association+of+ADAMTS5+gene+polymorphisms+with+osteoarthritis+in+Chinese+Han+population%3A+a+community-based+case-control+study&doi=10.1007%2Fs00296-012-2506-1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Association of ADAMTS5 gene polymorphisms with osteoarthritis in Chinese Han population: a community-based case-control study</span></div><div class="casAuthors">Gu, Jiaao; Rong, Jiesheng; Guan, Fulin; Jiang, Liying; Zhang, Ting; Tao, Shuqing; Guan, Guofa; Xu, Liang; Tao, Tianzun</div><div class="citationInfo"><span class="NLM_cas:title">Rheumatology International</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">33</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">2893-2897</span>CODEN:
                <span class="NLM_cas:coden">RHINDE</span>;
        ISSN:<span class="NLM_cas:issn">0172-8172</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Aggrecanase-2 (ADAMTS5) is reported to play essential roles in the pathophysiol. of osteoarthritis (OA).  To explore the relationship between ADAMTS5 gene polymorphisms and primary OA, we conducted a community-based case-control study.  A total of 732 community residents aged 40-84 years participated in the community-based study in Northeast China.  After taking phys. examn. and radiog. examn., 420 persons of the residents were diagnosed OA (216 women and 204 men).  The other 312 individuals without any symptoms of osteoarthritis or signs in the radiographs (156 women and 156 men) were considered as healthy controls.  After obtaining the DNA of patients and control group, genotypes of the ADAMTS5 gene polymorphisms were detd. by polymerase chain reaction (PCR) followed by restriction enzyme digestion (HAEIII for P692L in exon 7 and BSRBI for R614H in exon 5).  The nos. of patients with different OA subtypes were also calcd.  The genotype and allele frequency of for the exon 5C/T BSRBI polymorphism was significantly different between OA patients and control individuals (P = 0.001, OR = 0.701, 95% CI = 0.569-0.863).  This difference was more obvious in cervical OA patients (P = 0.001, OR = 0.664, 95% CI = 0.521-0.847).  The mutation type of exon 5C/T BSRBI polymorphism would be a protective factor for OA esp. for cervical OA.  Our results suggest that the ADAMTS5 gene polymorphisms may contribute to the susceptibility of osteoarthritis in the Chinese Han population.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqW6-pfC7YaLLVg90H21EOLACvtfcHk0lhuRA9EOKCr5Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhs1KqsL%252FF&md5=97d36af4b3a97fad680d51bae2a11649</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1007%2Fs00296-012-2506-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00296-012-2506-1%26sid%3Dliteratum%253Aachs%26aulast%3DGu%26aufirst%3DJ.%26aulast%3DRong%26aufirst%3DJ.%26aulast%3DGuan%26aufirst%3DF.%26aulast%3DJiang%26aufirst%3DL.%26aulast%3DZhang%26aufirst%3DT.%26aulast%3DTao%26aufirst%3DS.%26aulast%3DGuan%26aufirst%3DG.%26aulast%3DXu%26aufirst%3DL.%26aulast%3DTao%26aufirst%3DT.%26atitle%3DAssociation%2520of%2520ADAMTS5%2520gene%2520polymorphisms%2520with%2520osteoarthritis%2520in%2520Chinese%2520Han%2520population%253A%2520a%2520community-based%2520case-control%2520study%26jtitle%3DRheumatol.%2520Int.%26date%3D2013%26volume%3D33%26spage%3D2893%26epage%3D2897%26doi%3D10.1007%2Fs00296-012-2506-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Song, R. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tortorella, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Malfait, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alston, J. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arner, E. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Griggs, D. W.</span></span> <span> </span><span class="NLM_article-title">Aggrecan degradation in human articular cartilage explants is mediated by both ADAMTS-4 and ADAMTS-5</span>. <i>Arthritis Rheum.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>56</i></span>,  <span class="NLM_fpage">575</span>– <span class="NLM_lpage">585</span>, <span class="refDoi"> DOI: 10.1002/art.22334</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02008&amp;key=10.1002%2Fart.22334" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02008&amp;key=17265492" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02008&amp;key=1%3ACAS%3A528%3ADC%252BD2sXislShurw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2007&pages=575-585&author=R.+H.+Songauthor=M.+D.+Tortorellaauthor=A.+M.+Malfaitauthor=J.+T.+Alstonauthor=Z.+Yangauthor=E.+C.+Arnerauthor=D.+W.+Griggs&title=Aggrecan+degradation+in+human+articular+cartilage+explants+is+mediated+by+both+ADAMTS-4+and+ADAMTS-5&doi=10.1002%2Fart.22334"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Aggrecan degradation in human articular cartilage explants is mediated by both ADAMTS-4 and ADAMTS-5</span></div><div class="casAuthors">Song, Ruo-Hua; Tortorella, Micky D.; Malfait, Anne-Marie; Alston, James T.; Yang, Zhiyong; Arner, Elizabeth C.; Griggs, David W.</div><div class="citationInfo"><span class="NLM_cas:title">Arthritis & Rheumatism</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">575-585</span>CODEN:
                <span class="NLM_cas:coden">ARHEAW</span>;
        ISSN:<span class="NLM_cas:issn">0004-3591</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">Objective. Recent published studies have shown that cartilage from ADAMTS-5-knockout mice, but not ADAMTS-4- or ADAMTS-1-knockout mice, is significantly protected from degrdn.  The present study was undertaken to evaluate the resp. roles of these enzymes in human cartilage breakdown, using a small interfering RNA (siRNA) approach to assess the effects of inhibition of each enzyme in normal and osteoarthritic (OA) explants.  Methods. The activities of siRNA specifically targeting ADAMTS-1, -4, and -5 were assessed by transfection into primary human chondrocytes and cultured human cartilage explants.  At 24 h, a cytokine stimulus was applied to normal, but not OA, samples to initiate a catabolic response.  At designated times, total RNA was isolated and gene expression was measured by quant. real-time reverse transcription-polymerase chain reaction.  Aggrecan release and aggrecanase-generated neoepitope formation were detd. by dye binding anal. and Western blotting, resp.  Results. Human chondrocytes and explants were efficiently transfected with siRNA that specifically decreased the expression of each targeted gene.  Suppression of ADAMTS-4 and ADAMTS-5, individually or in combination, attenuated the degrdn. of aggrecan in cytokine-stimulated normal cartilage.  A redn. in aggrecan degrdn. was also obsd. following siRNA-mediated knockdown of either gene in unstimulated OA cartilage.  In contrast, knockdown of ADAMTS-1 failed to inhibit aggrecan loss.  Conclusion. Despite the apparent dominant role of ADAMTS-5 in genetically modified mice, our data suggest that both ADAMTS-4 and ADAMTS-5 contribute to the structural damage that characterizes human OA.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrWjonvxEQIv7Vg90H21EOLACvtfcHk0lhuRA9EOKCr5Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXislShurw%253D&md5=46b9d8f073555353d2b4a70428a2db8a</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1002%2Fart.22334&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fart.22334%26sid%3Dliteratum%253Aachs%26aulast%3DSong%26aufirst%3DR.%2BH.%26aulast%3DTortorella%26aufirst%3DM.%2BD.%26aulast%3DMalfait%26aufirst%3DA.%2BM.%26aulast%3DAlston%26aufirst%3DJ.%2BT.%26aulast%3DYang%26aufirst%3DZ.%26aulast%3DArner%26aufirst%3DE.%2BC.%26aulast%3DGriggs%26aufirst%3DD.%2BW.%26atitle%3DAggrecan%2520degradation%2520in%2520human%2520articular%2520cartilage%2520explants%2520is%2520mediated%2520by%2520both%2520ADAMTS-4%2520and%2520ADAMTS-5%26jtitle%3DArthritis%2520Rheum.%26date%3D2007%26volume%3D56%26spage%3D575%26epage%3D585%26doi%3D10.1002%2Fart.22334" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chockalingam, P. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rivera-Bermudez, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zeng, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dufield, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Larsson, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lohmander, L. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Flannery, C. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Glasson, S. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Georgiadis, K. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morris, E. A.</span></span> <span> </span><span class="NLM_article-title">Elevated aggrecanase activity in a rat model of joint injury is attenuated by an aggrecanase specific inhibitor</span>. <i>Osteoarthritis and cartilage</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>19</i></span>,  <span class="NLM_fpage">315</span>– <span class="NLM_lpage">323</span>, <span class="refDoi"> DOI: 10.1016/j.joca.2010.12.004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02008&amp;key=10.1016%2Fj.joca.2010.12.004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02008&amp;key=21163358" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02008&amp;key=1%3ACAS%3A280%3ADC%252BC3M3hvFyjtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2011&pages=315-323&author=P.+S.+Chockalingamauthor=W.+Sunauthor=M.+A.+Rivera-Bermudezauthor=W.+Zengauthor=D.+R.+Dufieldauthor=S.+Larssonauthor=L.+S.+Lohmanderauthor=C.+R.+Flanneryauthor=S.+S.+Glassonauthor=K.+E.+Georgiadisauthor=E.+A.+Morris&title=Elevated+aggrecanase+activity+in+a+rat+model+of+joint+injury+is+attenuated+by+an+aggrecanase+specific+inhibitor&doi=10.1016%2Fj.joca.2010.12.004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Elevated aggrecanase activity in a rat model of joint injury is attenuated by an aggrecanase specific inhibitor</span></div><div class="casAuthors">Chockalingam P S; Sun W; Rivera-Bermudez M A; Zeng W; Dufield D R; Larsson S; Lohmander L S; Flannery C R; Glasson S S; Georgiadis K E; Morris E A</div><div class="citationInfo"><span class="NLM_cas:title">Osteoarthritis and cartilage</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">315-23</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">OBJECTIVE:  To evaluate aggrecanase activity after traumatic knee injury in a rat model by measuring the level of aggrecanase-generated Ala-Arg-Gly-aggrecan (ARG-aggrecan) fragments in synovial fluid, and compare with ARG-aggrecan release into joint fluid following human knee injury.  To evaluate the effect of small molecule inhibitors on induced aggrecanase activity in the rat model.  METHOD:  An enzyme-linked immunosorbent assay (ELISA) was developed to measure ARG-aggrecan levels in animal and human joint fluids.  A rat model of meniscal tear (MT)-induced joint instability was used to assess ARG-aggrecan release into joint fluid and the effects of aggrecanase inhibition.  Synovial fluids were also obtained from patients with acute joint injury or osteoarthritis and assayed for ARG-aggrecan.  RESULTS:  Joint fluids from human patients after knee injury showed significantly enhanced levels of ARG-aggrecan compared to uninjured reference subjects.  Similarly, synovial fluid ARG-aggrecan levels increased following surgically-induced joint instability in the rat MT model, which was significantly attenuated by orally dosing the animals with AGG-523, an aggrecanase specific inhibitor.  CONCLUSIONS:  Aggrecanase-generated aggrecan fragments were rapidly released into human and rat joint fluids after injury to the knee and remained elevated over a prolonged period.  Our findings in human and preclinical models strengthen the connection between aggrecanase activity in joints and knee injury and disease.  The ability of a small molecule aggrecanase inhibitor to reduce the release of aggrecanase-generated aggrecan fragments into rat joints suggests that pharmacologic inhibition of aggrecanase activity in humans may be an effective treatment for slowing cartilage degradation following joint injury.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTSEJ86GtNp_UkUaC_kzhvyfW6udTcc2eY__574kfk5Trntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3M3hvFyjtA%253D%253D&md5=202a8e1850e72fcddd1a4772c37672cc</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1016%2Fj.joca.2010.12.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.joca.2010.12.004%26sid%3Dliteratum%253Aachs%26aulast%3DChockalingam%26aufirst%3DP.%2BS.%26aulast%3DSun%26aufirst%3DW.%26aulast%3DRivera-Bermudez%26aufirst%3DM.%2BA.%26aulast%3DZeng%26aufirst%3DW.%26aulast%3DDufield%26aufirst%3DD.%2BR.%26aulast%3DLarsson%26aufirst%3DS.%26aulast%3DLohmander%26aufirst%3DL.%2BS.%26aulast%3DFlannery%26aufirst%3DC.%2BR.%26aulast%3DGlasson%26aufirst%3DS.%2BS.%26aulast%3DGeorgiadis%26aufirst%3DK.%2BE.%26aulast%3DMorris%26aufirst%3DE.%2BA.%26atitle%3DElevated%2520aggrecanase%2520activity%2520in%2520a%2520rat%2520model%2520of%2520joint%2520injury%2520is%2520attenuated%2520by%2520an%2520aggrecanase%2520specific%2520inhibitor%26jtitle%3DOsteoarthritis%2520and%2520cartilage%26date%3D2011%26volume%3D19%26spage%3D315%26epage%3D323%26doi%3D10.1016%2Fj.joca.2010.12.004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shiozaki, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maeda, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miura, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kotoku, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamasaki, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matsuda, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aoki, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yasue, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Imai, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ubukata, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suma, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yokota, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hotta, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tanaka, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hase, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haas, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fryer, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Laird, E. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Littmann, N. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Andrews, S. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Josey, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mimura, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shinozaki, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yoshiuchi, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Inaba, T.</span></span> <span> </span><span class="NLM_article-title">Discovery of (1S,2R,3R)-2,3-dimethyl-2-phenyl-1-sulfamidocyclopropanecarboxylates: novel and highly selective aggrecanase inhibitors</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>54</i></span>,  <span class="NLM_fpage">2839</span>– <span class="NLM_lpage">2863</span>, <span class="refDoi"> DOI: 10.1021/jm101609j</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm101609j" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02008&amp;key=1%3ACAS%3A528%3ADC%252BC3MXjsFKnsb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=2839-2863&author=M.+Shiozakiauthor=K.+Maedaauthor=T.+Miuraauthor=M.+Kotokuauthor=T.+Yamasakiauthor=I.+Matsudaauthor=K.+Aokiauthor=K.+Yasueauthor=H.+Imaiauthor=M.+Ubukataauthor=A.+Sumaauthor=M.+Yokotaauthor=T.+Hottaauthor=M.+Tanakaauthor=Y.+Haseauthor=J.+Haasauthor=A.+M.+Fryerauthor=E.+R.+Lairdauthor=N.+M.+Littmannauthor=S.+W.+Andrewsauthor=J.+A.+Joseyauthor=T.+Mimuraauthor=Y.+Shinozakiauthor=H.+Yoshiuchiauthor=T.+Inaba&title=Discovery+of+%281S%2C2R%2C3R%29-2%2C3-dimethyl-2-phenyl-1-sulfamidocyclopropanecarboxylates%3A+novel+and+highly+selective+aggrecanase+inhibitors&doi=10.1021%2Fjm101609j"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of (1S,2R,3R)-2,3-Dimethyl-2-phenyl-1-sulfamidocyclopropanecarboxylates: Novel and Highly Selective Aggrecanase Inhibitors</span></div><div class="casAuthors">Shiozaki, Makoto; Maeda, Katsuya; Miura, Tomoya; Kotoku, Masayuki; Yamazaki, Takayuki; Matsuda, Isamu; Aoki, Kenta; Yasue, Katsutaka; Imai, Hiroto; Ubukata, Minoru; Suma, Akira; Yokota, Masahiro; Hotta, Takahiro; Tanaka, Masahiro; Hase, Yasunori; Haas, Julia; Fryer, Andrew M.; Laird, Ellen R.; Littmann, Nicole M.; Andrews, Steven W.; Josey, John A.; Mimura, Takayuki; Shinozaki, Yuichi; Yoshiuchi, Hiromi; Inaba, Takashi</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">2839-2863</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Aggrecanases, particularly aggrecanase-1 (ADAMTS-4) and aggrecanase-2 (ADAMTS-5), are believed to be key enzymes involved in the articular cartilage breakdown that leads to osteoarthritis.  Thus, aggrecanases are considered to be viable drug targets for the treatment of this debilitating disease.  A series of (1S,2R,3R)-2,3-dimethyl-2-phenyl-1-sulfamidocyclopropanecarboxylates was discovered to be potent, highly selective, and orally bioavailable aggrecanase inhibitors.  These compds. have unique P1' groups comprising novel piperidine- or piperazine-based heterocycles that are connected to a cyclopropane amino acid scaffold via a sulfamido linkage.  These P1' groups are quite effective in imparting selectivity over other MMPs, and this selectivity was further increased by incorporation of a Me substituent in the 2-position of the cyclopropane ring.  In contrast to classical hydroxamate-based inhibitors that tend to lack metabolic stability, our aggrecanase inhibitors bear a carboxylate zinc-binding group and have good oral bioavailability.  Lead compd. 13b (I), characterized by the novel P1' portion of 1,2,3,4-tetrahydropyrido[3',4':4,5]imidazo[1,2-a]pyridine ring, is a potent and selective aggrecanse inhibitor with excellent pharmacokinetic profiles.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpa2g_2zxHrX7Vg90H21EOLACvtfcHk0li9NyvhZ-SZMw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXjsFKnsb8%253D&md5=d4d5fee4292c93129a83ea22ab0a8964</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1021%2Fjm101609j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm101609j%26sid%3Dliteratum%253Aachs%26aulast%3DShiozaki%26aufirst%3DM.%26aulast%3DMaeda%26aufirst%3DK.%26aulast%3DMiura%26aufirst%3DT.%26aulast%3DKotoku%26aufirst%3DM.%26aulast%3DYamasaki%26aufirst%3DT.%26aulast%3DMatsuda%26aufirst%3DI.%26aulast%3DAoki%26aufirst%3DK.%26aulast%3DYasue%26aufirst%3DK.%26aulast%3DImai%26aufirst%3DH.%26aulast%3DUbukata%26aufirst%3DM.%26aulast%3DSuma%26aufirst%3DA.%26aulast%3DYokota%26aufirst%3DM.%26aulast%3DHotta%26aufirst%3DT.%26aulast%3DTanaka%26aufirst%3DM.%26aulast%3DHase%26aufirst%3DY.%26aulast%3DHaas%26aufirst%3DJ.%26aulast%3DFryer%26aufirst%3DA.%2BM.%26aulast%3DLaird%26aufirst%3DE.%2BR.%26aulast%3DLittmann%26aufirst%3DN.%2BM.%26aulast%3DAndrews%26aufirst%3DS.%2BW.%26aulast%3DJosey%26aufirst%3DJ.%2BA.%26aulast%3DMimura%26aufirst%3DT.%26aulast%3DShinozaki%26aufirst%3DY.%26aulast%3DYoshiuchi%26aufirst%3DH.%26aulast%3DInaba%26aufirst%3DT.%26atitle%3DDiscovery%2520of%2520%25281S%252C2R%252C3R%2529-2%252C3-dimethyl-2-phenyl-1-sulfamidocyclopropanecarboxylates%253A%2520novel%2520and%2520highly%2520selective%2520aggrecanase%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D2839%26epage%3D2863%26doi%3D10.1021%2Fjm101609j" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Deng, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Keefe, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davie, C. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lind, K. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Acharya, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Franklin, G. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Larkin, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matico, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neeb, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thompson, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lohr, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gross, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Centrella, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Donovan, G. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bedard, K. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van Vloten, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mataruse, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Skinner, S. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Belyanskaya, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carpenter, T. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shearer, T. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clark, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cuozzo, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arico-Muendel, C. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morgan, B. A.</span></span> <span> </span><span class="NLM_article-title">Discovery of highly potent and selective small molecule ADAMTS-5 inhibitors that inhibit human cartilage degradation via encoded library technology (ELT)</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">7061</span>– <span class="NLM_lpage">7079</span>, <span class="refDoi"> DOI: 10.1021/jm300449x</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm300449x" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02008&amp;key=1%3ACAS%3A528%3ADC%252BC38Xht1Smu7bM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=7061-7079&author=H.+Dengauthor=H.+O%E2%80%99Keefeauthor=C.+P.+Davieauthor=K.+E.+Lindauthor=R.+A.+Acharyaauthor=G.+J.+Franklinauthor=J.+Larkinauthor=R.+Maticoauthor=M.+Neebauthor=M.+M.+Thompsonauthor=T.+Lohrauthor=J.+W.+Grossauthor=P.+A.+Centrellaauthor=G.+K.+O%E2%80%99Donovanauthor=K.+L.+Bedardauthor=K.+van+Vlotenauthor=S.+Mataruseauthor=S.+R.+Skinnerauthor=S.+L.+Belyanskayaauthor=T.+Y.+Carpenterauthor=T.+W.+Shearerauthor=M.+A.+Clarkauthor=J.+W.+Cuozzoauthor=C.+C.+Arico-Muendelauthor=B.+A.+Morgan&title=Discovery+of+highly+potent+and+selective+small+molecule+ADAMTS-5+inhibitors+that+inhibit+human+cartilage+degradation+via+encoded+library+technology+%28ELT%29&doi=10.1021%2Fjm300449x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of Highly Potent and Selective Small Molecule ADAMTS-5 Inhibitors That Inhibit Human Cartilage Degradation via Encoded Library Technology (ELT)</span></div><div class="casAuthors">Deng, Hongfeng; O'Keefe, Heather; Davie, Christopher P.; Lind, Kenneth E.; Acharya, Raksha A.; Franklin, G. Joseph; Larkin, Jonathan; Matico, Rosalie; Neeb, Michael; Thompson, Monique M.; Lohr, Thomas; Gross, Jeffrey W.; Centrella, Paolo A.; O'Donovan, Gary K.; Bedard, Katie L.; van Vloten, Kurt; Mataruse, Sibongile; Skinner, Steven R.; Belyanskaya, Svetlana L.; Carpenter, Tiffany Y.; Shearer, Todd W.; Clark, Matthew A.; Cuozzo, John W.; Arico-Muendel, Christopher C.; Morgan, Barry A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">7061-7079</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The metalloprotease ADAMTS-5 is considered a potential target for the treatment of osteoarthritis.  To identify selective inhibitors of ADAMTS-5, the authors employed encoded library technol. (ELT), which enables affinity selection of small mol. binders from complex mixts. by DNA tagging.  Selection of ADAMTS-5 against a four-billion member ELT library led to a novel inhibitor scaffold not contg. a classical zinc-binding functionality.  One exemplar, (R)-N-((1-(4-(but-3-en-1-ylamino)-6-(((2-(thiophen-2-yl)thiazol-4-yl)methyl)amino)-1,3,5-triazin-2-yl)pyrrolidin-2-yl)methyl)-4-propylbenzenesulfonamide (I), inhibited ADAMTS-5 with IC50 = 30 nM, showing >50-fold selectivity against ADAMTS-4 and >1000-fold selectivity against ADAMTS-1, ADAMTS-13, MMP-13, and TACE.  Extensive SAR studies showed that potency and physicochem. properties of the scaffold could be further improved.  Furthermore, in a human osteoarthritis cartilage explant study, compds. I and II inhibited aggrecanase-mediated 374ARGS neoepitope release from aggrecan and glycosaminoglycan in response to IL-1β/OSM stimulation.  This study provides the first small mol. evidence for the crit. role of ADAMTS-5 in human cartilage degrdn.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoMOEaetEOSWLVg90H21EOLACvtfcHk0li9NyvhZ-SZMw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xht1Smu7bM&md5=9f7d1a265c7f8089f9fa505f9974483e</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1021%2Fjm300449x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm300449x%26sid%3Dliteratum%253Aachs%26aulast%3DDeng%26aufirst%3DH.%26aulast%3DO%25E2%2580%2599Keefe%26aufirst%3DH.%26aulast%3DDavie%26aufirst%3DC.%2BP.%26aulast%3DLind%26aufirst%3DK.%2BE.%26aulast%3DAcharya%26aufirst%3DR.%2BA.%26aulast%3DFranklin%26aufirst%3DG.%2BJ.%26aulast%3DLarkin%26aufirst%3DJ.%26aulast%3DMatico%26aufirst%3DR.%26aulast%3DNeeb%26aufirst%3DM.%26aulast%3DThompson%26aufirst%3DM.%2BM.%26aulast%3DLohr%26aufirst%3DT.%26aulast%3DGross%26aufirst%3DJ.%2BW.%26aulast%3DCentrella%26aufirst%3DP.%2BA.%26aulast%3DO%25E2%2580%2599Donovan%26aufirst%3DG.%2BK.%26aulast%3DBedard%26aufirst%3DK.%2BL.%26aulast%3Dvan%2BVloten%26aufirst%3DK.%26aulast%3DMataruse%26aufirst%3DS.%26aulast%3DSkinner%26aufirst%3DS.%2BR.%26aulast%3DBelyanskaya%26aufirst%3DS.%2BL.%26aulast%3DCarpenter%26aufirst%3DT.%2BY.%26aulast%3DShearer%26aufirst%3DT.%2BW.%26aulast%3DClark%26aufirst%3DM.%2BA.%26aulast%3DCuozzo%26aufirst%3DJ.%2BW.%26aulast%3DArico-Muendel%26aufirst%3DC.%2BC.%26aulast%3DMorgan%26aufirst%3DB.%2BA.%26atitle%3DDiscovery%2520of%2520highly%2520potent%2520and%2520selective%2520small%2520molecule%2520ADAMTS-5%2520inhibitors%2520that%2520inhibit%2520human%2520cartilage%2520degradation%2520via%2520encoded%2520library%2520technology%2520%2528ELT%2529%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D7061%26epage%3D7079%26doi%3D10.1021%2Fjm300449x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Durham, T. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marimuthu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Toth, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adams, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mudra, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Swearingen, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chambers, M. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thirunavukkarasu, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wiley, M. R.</span></span> <span> </span><span class="NLM_article-title">A highly selective hydantoin inhibitor of aggrecanase-1 and aggrecanase-2 with a low projected human dose</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">5933</span>– <span class="NLM_lpage">5939</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.7b00650</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b00650" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02008&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhtVSjtrrP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=5933-5939&author=T.+B.+Durhamauthor=J.+Marimuthuauthor=J.+L.+Tothauthor=C.+Liuauthor=L.+Adamsauthor=D.+R.+Mudraauthor=C.+Swearingenauthor=C.+Linauthor=M.+G.+Chambersauthor=K.+Thirunavukkarasuauthor=M.+R.+Wiley&title=A+highly+selective+hydantoin+inhibitor+of+aggrecanase-1+and+aggrecanase-2+with+a+low+projected+human+dose&doi=10.1021%2Facs.jmedchem.7b00650"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">A Highly Selective Hydantoin Inhibitor of Aggrecanase-1 and Aggrecanase-2 with a Low Projected Human Dose</span></div><div class="casAuthors">Durham, Timothy B.; Marimuthu, Jothirajah; Toth, James L.; Liu, Chin; Adams, Lisa; Mudra, Daniel R.; Swearingen, Craig; Lin, Chaohua; Chambers, Mark G.; Thirunavukkarasu, Kannan; Wiley, Michael R.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">5933-5939</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Aggrecanase-1 and -2 (ADAMTS-4 and ADAMTS-5) are zinc metalloproteases involved in the degrdn. of aggrecan in cartilage.  Inhibitors could provide a means of altering the progression of osteoarthritis.  We report the identification of 7 which had good oral pharmacokinetics in rats and showed efficacy in a rat chem. model of osteoarthritis.  The projected human dose required to achieve sustained plasma levels ≥10 times the hADAMTS-5 IC50 is 5 mg q.d.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpUR6nsVIkmMLVg90H21EOLACvtfcHk0lhl2_X2TuRvsQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhtVSjtrrP&md5=2797b44e0f9ce99664405758353167d2</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b00650&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b00650%26sid%3Dliteratum%253Aachs%26aulast%3DDurham%26aufirst%3DT.%2BB.%26aulast%3DMarimuthu%26aufirst%3DJ.%26aulast%3DToth%26aufirst%3DJ.%2BL.%26aulast%3DLiu%26aufirst%3DC.%26aulast%3DAdams%26aufirst%3DL.%26aulast%3DMudra%26aufirst%3DD.%2BR.%26aulast%3DSwearingen%26aufirst%3DC.%26aulast%3DLin%26aufirst%3DC.%26aulast%3DChambers%26aufirst%3DM.%2BG.%26aulast%3DThirunavukkarasu%26aufirst%3DK.%26aulast%3DWiley%26aufirst%3DM.%2BR.%26atitle%3DA%2520highly%2520selective%2520hydantoin%2520inhibitor%2520of%2520aggrecanase-1%2520and%2520aggrecanase-2%2520with%2520a%2520low%2520projected%2520human%2520dose%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26spage%3D5933%26epage%3D5939%26doi%3D10.1021%2Facs.jmedchem.7b00650" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liang, J.</span>; <span class="NLM_string-name">Wang, Q. T.</span>; <span class="NLM_string-name">Ku, M. S.</span>; <span class="NLM_string-name">Michalak, R. S.</span>; <span class="NLM_string-name">Huang, J. W.</span></span> <i>Polymorphs of N2-(l, l’-Biphenyl-4-ylcarbonyl)-N 1-[2-(4-Fluorophenyl)-l,l-Dimethylethyl]-L-α-Glutamine</i>. U.S. Patent <span class="NLM_patent">20100216886</span>, November 9, <span class="NLM_year">2007</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2007&author=J.+Liang&author=Q.+T.+Wang&author=M.+S.+Ku&author=R.+S.+Michalak&author=J.+W.+Huang&title=Polymorphs+of+N2-%28l%2C+l%E2%80%99-Biphenyl-4-ylcarbonyl%29-N+1-%5B2-%284-Fluorophenyl%29-l%2Cl-Dimethylethyl%5D-L-%CE%B1-Glutamine"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DLiang%26aufirst%3DJ.%26jtitle%3DPolymorphs%2520of%2520N2-%2528l%252C%2520l%25E2%2580%2599-Biphenyl-4-ylcarbonyl%2529-N%25201-%255B2-%25284-Fluorophenyl%2529-l%252Cl-Dimethylethyl%255D-L-%25CE%25B1-Glutamine%26date%3D2007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sum, P.-E.</span>; <span class="NLM_string-name">How, D. B.</span>; <span class="NLM_string-name">Sabatini, J. J.</span>; <span class="NLM_string-name">Xiang, J. S.</span>; <span class="NLM_string-name">Feyfant, E.</span>; <span class="NLM_string-name">Tam, S. Y.</span>; <span class="NLM_string-name">Skotnicki, J. S.</span>; <span class="NLM_string-name">Mansour, T. S.</span></span> <i>Glutamate Aggrecanase Inhibitors</i>. U.S. Patent <span class="NLM_patent">20070043066A1</span>, July 11, <span class="NLM_year">2006</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2006&author=P.-E.+Sum&author=D.+B.+How&author=J.+J.+Sabatini&author=J.+S.+Xiang&author=E.+Feyfant&author=S.+Y.+Tam&author=J.+S.+Skotnicki&author=T.+S.+Mansour&title=Glutamate+Aggrecanase+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DSum%26aufirst%3DP.-E.%26jtitle%3DGlutamate%2520Aggrecanase%2520Inhibitors%26date%3D2006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Inaba, T.</span>; <span class="NLM_string-name">Haas, J.</span>; <span class="NLM_string-name">Shiozaki, M.</span>; <span class="NLM_string-name">Littman, N. M.</span>; <span class="NLM_string-name">Yasue, K.</span>; <span class="NLM_string-name">Andrews, S. W.</span>; <span class="NLM_string-name">Sakai, A.</span>; <span class="NLM_string-name">Fryer, A. M.</span>; <span class="NLM_string-name">Matsuo, T.</span>; <span class="NLM_string-name">Laird, E. R.</span>; <span class="NLM_string-name">Suma, A.</span>; <span class="NLM_string-name">Shinozaki, Y.</span>; <span class="NLM_string-name">Hori, Y.</span>; <span class="NLM_string-name">Imai, H.</span>; <span class="NLM_string-name">Negoro, T.</span></span> <i>Cyclopropane Compounds and Pharmaceutical Use Thereof</i>. U.S. Patent <span class="NLM_patent">20080306258A1</span>, May 6, <span class="NLM_year">2008</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2008&author=T.+Inaba&author=J.+Haas&author=M.+Shiozaki&author=N.+M.+Littman&author=K.+Yasue&author=S.+W.+Andrews&author=A.+Sakai&author=A.+M.+Fryer&author=T.+Matsuo&author=E.+R.+Laird&author=A.+Suma&author=Y.+Shinozaki&author=Y.+Hori&author=H.+Imai&author=T.+Negoro&title=Cyclopropane+Compounds+and+Pharmaceutical+Use+Thereof"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DInaba%26aufirst%3DT.%26jtitle%3DCyclopropane%2520Compounds%2520and%2520Pharmaceutical%2520Use%2520Thereof%26date%3D2008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Durham, T. B.</span>; <span class="NLM_string-name">Marimuthu, J.</span>; <span class="NLM_string-name">Wiley, R. M.</span></span> <i>Aggrecanase inhibitors</i>. U.S. Patent <span class="NLM_patent">9206139B2</span>, October 18, <span class="NLM_year">2013</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2013&author=T.+B.+Durham&author=J.+Marimuthu&author=R.+M.+Wiley&title=Aggrecanase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DDurham%26aufirst%3DT.%2BB.%26jtitle%3DAggrecanase%2520inhibitors%26date%3D2013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Larkin, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lohr, T. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Elefante, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shearin, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matico, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Su, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xue, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Genell, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miller, R. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tran, P. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Malfait, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maier, C. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matheny, C. J.</span></span> <span> </span><span class="NLM_article-title">Translational development of an ADAMTS-5 antibody for osteoarthritis disease modification</span>. <i>Osteoarthritis and cartilage</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>23</i></span>,  <span class="NLM_fpage">1254</span>– <span class="NLM_lpage">1266</span>, <span class="refDoi"> DOI: 10.1016/j.joca.2015.02.778</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02008&amp;key=10.1016%2Fj.joca.2015.02.778" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02008&amp;key=25800415" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02008&amp;key=1%3ACAS%3A280%3ADC%252BC2MnmvF2ntQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2015&pages=1254-1266&author=J.+Larkinauthor=T.+A.+Lohrauthor=L.+Elefanteauthor=J.+Shearinauthor=R.+Maticoauthor=J.+L.+Suauthor=Y.+Xueauthor=F.+Liuauthor=C.+Genellauthor=R.+E.+Millerauthor=P.+B.+Tranauthor=A.+M.+Malfaitauthor=C.+C.+Maierauthor=C.+J.+Matheny&title=Translational+development+of+an+ADAMTS-5+antibody+for+osteoarthritis+disease+modification&doi=10.1016%2Fj.joca.2015.02.778"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Translational development of an ADAMTS-5 antibody for osteoarthritis disease modification</span></div><div class="casAuthors">Larkin J; Lohr T A; Elefante L; Xue Y; Shearin J; Matico R; Su J-L; Liu F; Genell C; Maier C C; Miller R E; Tran P B; Malfait A-M; Matheny C J</div><div class="citationInfo"><span class="NLM_cas:title">Osteoarthritis and cartilage</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1254-66</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">OBJECTIVE/METHOD:  Aggrecanase activity, most notably ADAMTS-5, is implicated in pathogenic cartilage degradation.  Selective monoclonal antibodies (mAbs) to both ADAMTS-5 and ADAMTS-4 were generated and in vitro, ex vivo and in vivo systems were utilized to assess target engagement, aggrecanase inhibition and modulation of disease-related endpoints with the intent of selecting a candidate for clinical development in osteoarthritis (OA).  RESULTS:  Structural mapping predicts the most potent mAbs employ a unique mode of inhibition by cross-linking the catalytic and disintegrin domains.  In a surgical mouse model of OA, both ADAMTS-5 and ADAMTS-4-specific mAbs penetrate cartilage following systemic administration, demonstrating access to the anticipated site of action.  Structural disease modification and associated alleviation of pain-related behavior were observed with ADAMTS-5 mAb treatment.  Treatment of human OA cartilage demonstrated a preferential role for ADAMTS-5 inhibition over ADAMTS-4, as measured by ARGS neoepitope release in explant cultures.  ADAMTS-5 mAb activity was most evident in a subset of patient-derived tissues and suppression of ARGS neoepitope release was sustained for weeks after a single treatment in human explants and in cynomolgus monkeys, consistent with high affinity target engagement and slow ADAMTS-5 turnover.  CONCLUSION:  This data supports a hypothesis set forth from knockout mouse studies that ADAMTS-5 is the major aggrecanase involved in cartilage degradation and provides a link between a biological pathway and pharmacology which translates to human tissues, non-human primate models and points to a target OA patient population.  Therefore, a humanized ADAMTS-5-selective monoclonal antibody (GSK2394002) was progressed as a potential OA disease modifying therapeutic.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcT56eBi4fPFqhfKb6ELK8t0fW6udTcc2eZaJNMMLAS-Orntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2MnmvF2ntQ%253D%253D&md5=1bf194a9b106bfcfc4e454f41b615e88</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1016%2Fj.joca.2015.02.778&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.joca.2015.02.778%26sid%3Dliteratum%253Aachs%26aulast%3DLarkin%26aufirst%3DJ.%26aulast%3DLohr%26aufirst%3DT.%2BA.%26aulast%3DElefante%26aufirst%3DL.%26aulast%3DShearin%26aufirst%3DJ.%26aulast%3DMatico%26aufirst%3DR.%26aulast%3DSu%26aufirst%3DJ.%2BL.%26aulast%3DXue%26aufirst%3DY.%26aulast%3DLiu%26aufirst%3DF.%26aulast%3DGenell%26aufirst%3DC.%26aulast%3DMiller%26aufirst%3DR.%2BE.%26aulast%3DTran%26aufirst%3DP.%2BB.%26aulast%3DMalfait%26aufirst%3DA.%2BM.%26aulast%3DMaier%26aufirst%3DC.%2BC.%26aulast%3DMatheny%26aufirst%3DC.%2BJ.%26atitle%3DTranslational%2520development%2520of%2520an%2520ADAMTS-5%2520antibody%2520for%2520osteoarthritis%2520disease%2520modification%26jtitle%3DOsteoarthritis%2520and%2520cartilage%26date%3D2015%26volume%3D23%26spage%3D1254%26epage%3D1266%26doi%3D10.1016%2Fj.joca.2015.02.778" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fields, G. B.</span></span> <span> </span><span class="NLM_article-title">The rebirth of matrix metalloproteinase inhibitors: moving beyond the dogma</span>. <i>Cells</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">984</span>, <span class="refDoi"> DOI: 10.3390/cells8090984</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02008&amp;key=10.3390%2Fcells8090984" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02008&amp;key=1%3ACAS%3A528%3ADC%252BB3cXmtVSltrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2019&pages=984&author=G.+B.+Fields&title=The+rebirth+of+matrix+metalloproteinase+inhibitors%3A+moving+beyond+the+dogma&doi=10.3390%2Fcells8090984"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">The rebirth of matrix metalloproteinase inhibitors: moving beyond the dogma</span></div><div class="casAuthors">Fields, Gregg B.</div><div class="citationInfo"><span class="NLM_cas:title">Cells</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">984</span>CODEN:
                <span class="NLM_cas:coden">CELLC6</span>;
        ISSN:<span class="NLM_cas:issn">2073-4409</span>.
    
            (<span class="NLM_cas:orgname">MDPI AG</span>)
        </div><div class="casAbstract">The pursuit of matrix metalloproteinase (MMP) inhibitors began in earnest over three decades ago.  Initial clin. trials were disappointing, resulting in a neg. view of MMPs as therapeutic targets.  As a better understanding of MMP biol. and inhibitor pharmacokinetic properties emerged, it became clear that initial MMP inhibitor clin. trials were held prematurely.  Further complicating matters were problematic conclusions drawn from animal model studies.  The most recent generation of MMP inhibitors have desirable selectivities and improved pharmacokinetics, resulting in improved toxicity profiles.  Application of selective MMP inhibitors led to the conclusion that MMP-2, MMP-9, MMP-13, and MT1-MMP are not involved in musculoskeletal syndrome, a common side effect obsd. with broad spectrum MMP inhibitors.  Specific activities within a single MMP can now be inhibited.  Better definition of the roles of MMPs in immunol. responses and inflammation will help inform clinic trials, and multiple studies indicate that modulating MMP activity can improve immunotherapy.  There is a U.S.  Food and Drug Administration (FDA)-approved MMP inhibitor for periodontal disease, and several MMP inhibitors are in clinic trials, targeting a variety of maladies including gastric cancer, diabetic foot ulcers, and multiple sclerosis.  It is clearly time to move on from the dogma of viewing MMP inhibition as intractable.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpY8YcT4Rj5RLVg90H21EOLACvtfcHk0lgRe0d6HiCY9w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXmtVSltrY%253D&md5=4ff4b435717c123cd5043df32587c853</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.3390%2Fcells8090984&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fcells8090984%26sid%3Dliteratum%253Aachs%26aulast%3DFields%26aufirst%3DG.%2BB.%26atitle%3DThe%2520rebirth%2520of%2520matrix%2520metalloproteinase%2520inhibitors%253A%2520moving%2520beyond%2520the%2520dogma%26jtitle%3DCells%26date%3D2019%26volume%3D8%26spage%3D984%26doi%3D10.3390%2Fcells8090984" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Song, W.</span></span> <span> </span><span class="NLM_article-title">Zinc binding groups for histone deacetylase inhibitors</span>. <i>J. Enzyme Inhib. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>33</i></span>,  <span class="NLM_fpage">714</span>– <span class="NLM_lpage">721</span>, <span class="refDoi"> DOI: 10.1080/14756366.2017.1417274</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02008&amp;key=10.1080%2F14756366.2017.1417274" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02008&amp;key=29616828" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02008&amp;key=1%3ACAS%3A528%3ADC%252BC1cXntVGhtrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2018&pages=714-721&author=L.+Zhangauthor=J.+Zhangauthor=Q.+Jiangauthor=L.+Zhangauthor=W.+Song&title=Zinc+binding+groups+for+histone+deacetylase+inhibitors&doi=10.1080%2F14756366.2017.1417274"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Zinc binding groups for histone deacetylase inhibitors</span></div><div class="casAuthors">Zhang, Lei; Zhang, Jian; Jiang, Qixiao; Zhang, Li; Song, Weiguo</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Enzyme Inhibition and Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">33</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">714-721</span>CODEN:
                <span class="NLM_cas:coden">JEIMAZ</span>;
        ISSN:<span class="NLM_cas:issn">1475-6366</span>.
    
            (<span class="NLM_cas:orgname">Taylor & Francis Ltd.</span>)
        </div><div class="casAbstract">Zinc binding groups (ZBGs) play a crucial role in targeting histone deacetylase inhibitors (HDACIs) to the active site of histone deacetylases (HDACs), thus detg. the potency of HDACIs.  Due to the high affinity to the zinc ion, hydroxamic acid is the most commonly used ZBG in the structure of HDACs.  An alternative ZBG is benzamide group, which features excellent inhibitory selectivity for class I HDACs.  Various ZBGs have been designed and tested to improve the activity and selectivity of HDACIs, and to overcome the pharmacokinetic limitations of current HDACIs.  Herein, different kinds of ZBGs are reviewed and their features have been discussed for further design of HDACIs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqXFywPdICZVrVg90H21EOLACvtfcHk0lgRe0d6HiCY9w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXntVGhtrc%253D&md5=771d801a575618430f1cdcd03044dbdc</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1080%2F14756366.2017.1417274&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F14756366.2017.1417274%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DJiang%26aufirst%3DQ.%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DSong%26aufirst%3DW.%26atitle%3DZinc%2520binding%2520groups%2520for%2520histone%2520deacetylase%2520inhibitors%26jtitle%3DJ.%2520Enzyme%2520Inhib.%2520Med.%2520Chem.%26date%3D2018%26volume%3D33%26spage%3D714%26epage%3D721%26doi%3D10.1080%2F14756366.2017.1417274" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rogers, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hahn, M.</span></span> <span> </span><span class="NLM_article-title">Extended-connectivity fingerprints</span>. <i>J. Chem. Inf. Model.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>50</i></span>,  <span class="NLM_fpage">742</span>– <span class="NLM_lpage">754</span>, <span class="refDoi"> DOI: 10.1021/ci100050t</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ci100050t" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02008&amp;key=1%3ACAS%3A528%3ADC%252BC3cXlt1Onsbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2010&pages=742-754&author=D.+Rogersauthor=M.+Hahn&title=Extended-connectivity+fingerprints&doi=10.1021%2Fci100050t"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Extended-Connectivity Fingerprints</span></div><div class="casAuthors">Rogers, David; Hahn, Mathew</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Chemical Information and Modeling</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">50</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">742-754</span>CODEN:
                <span class="NLM_cas:coden">JCISD8</span>;
        ISSN:<span class="NLM_cas:issn">1549-9596</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Extended-connectivity fingerprints (ECFPs) are a novel class of topol. fingerprints for mol. characterization.  Historically, topol. fingerprints were developed for substructure and similarity searching.  ECFPs were developed specifically for structure-activity modeling.  ECFPs are circular fingerprints with a no. of useful qualities: they can be very rapidly calcd.; they are not predefined and can represent an essentially infinite no. of different mol. features (including stereochem. information); their features represent the presence of particular substructures, allowing easier interpretation of anal. results; and the ECFP algorithm can be tailored to generate different types of circular fingerprints, optimized for different uses.  While the use of ECFPs has been widely adopted and validated, a description of their implementation has not previously been presented in the literature.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGra43orI-Y7lbVg90H21EOLACvtfcHk0lgRe0d6HiCY9w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXlt1Onsbg%253D&md5=cd6c736cd7a3d280b67f5316acce8006</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1021%2Fci100050t&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fci100050t%26sid%3Dliteratum%253Aachs%26aulast%3DRogers%26aufirst%3DD.%26aulast%3DHahn%26aufirst%3DM.%26atitle%3DExtended-connectivity%2520fingerprints%26jtitle%3DJ.%2520Chem.%2520Inf.%2520Model.%26date%3D2010%26volume%3D50%26spage%3D742%26epage%3D754%26doi%3D10.1021%2Fci100050t" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Triballeau, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Acher, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brabet, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pin, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bertrand, H. O.</span></span> <span> </span><span class="NLM_article-title">Virtual screening workflow development guided by the “receiver operating characteristic” curve approach. Application to high-throughput docking on metabotropic glutamate receptor subtype 4</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>48</i></span>,  <span class="NLM_fpage">2534</span>– <span class="NLM_lpage">2547</span>, <span class="refDoi"> DOI: 10.1021/jm049092j</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm049092j" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02008&amp;key=1%3ACAS%3A528%3ADC%252BD2MXitVWrtLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2005&pages=2534-2547&author=N.+Triballeauauthor=F.+Acherauthor=I.+Brabetauthor=J.+P.+Pinauthor=H.+O.+Bertrand&title=Virtual+screening+workflow+development+guided+by+the+%E2%80%9Creceiver+operating+characteristic%E2%80%9D+curve+approach.+Application+to+high-throughput+docking+on+metabotropic+glutamate+receptor+subtype+4&doi=10.1021%2Fjm049092j"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Virtual Screening Workflow Development Guided by the "Receiver Operating Characteristic" Curve Approach. Application to High-Throughput Docking on Metabotropic Glutamate Receptor Subtype 4</span></div><div class="casAuthors">Triballeau, Nicolas; Acher, Francine; Brabet, Isabelle; Pin, Jean-Philippe; Bertrand, Hugues-Olivier</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">48</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">2534-2547</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The "receiver operating characteristic" (ROC) curve method is a well-recognized metric used as an objective way to evaluate the ability of a given test to discriminate between two populations.  This facilitates decision-making in a plethora of fields in which a wrong judgment may have serious consequences including clin. diagnosis, public safety, travel security, and economic strategies.  When virtual screening is used to speed-up the drug discovery process in pharmaceutical research, taking the right decision upon selecting or discarding a mol. prior to in vitro evaluation is of paramount importance.  Characterizing both the ability of a virtual screening workflow to select active mols. and the ability to discard inactive ones, the ROC curve approach is well suited for this crit. decision gate.  As a case study, the first virtual screening workflow focused on metabotropic glutamate receptor subtype 4 (mGlu4R) agonists is reported here.  Six compds. out of 38 selected and tested in vitro were shown to have agonist activity on this target of therapeutic interest.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrUSadKBJXUTbVg90H21EOLACvtfcHk0lh2d45EUGPwzQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXitVWrtLw%253D&md5=b9ea8c34ae0133f8416700e0fab9a17d</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1021%2Fjm049092j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm049092j%26sid%3Dliteratum%253Aachs%26aulast%3DTriballeau%26aufirst%3DN.%26aulast%3DAcher%26aufirst%3DF.%26aulast%3DBrabet%26aufirst%3DI.%26aulast%3DPin%26aufirst%3DJ.%2BP.%26aulast%3DBertrand%26aufirst%3DH.%2BO.%26atitle%3DVirtual%2520screening%2520workflow%2520development%2520guided%2520by%2520the%2520%25E2%2580%259Creceiver%2520operating%2520characteristic%25E2%2580%259D%2520curve%2520approach.%2520Application%2520to%2520high-throughput%2520docking%2520on%2520metabotropic%2520glutamate%2520receptor%2520subtype%25204%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2005%26volume%3D48%26spage%3D2534%26epage%3D2547%26doi%3D10.1021%2Fjm049092j" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sheppeck, J. E.,  2nd</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gilmore, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tebben, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xue, C. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, R. Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Decicco, C. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duan, J. J.</span></span> <span> </span><span class="NLM_article-title">Hydantoins, triazolones, and imidazolones as selective non-hydroxamate inhibitors of tumor necrosis factor-alpha converting enzyme (TACE)</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">2769</span>– <span class="NLM_lpage">2774</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2007.02.076</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02008&amp;key=10.1016%2Fj.bmcl.2007.02.076" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02008&amp;key=17368021" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02008&amp;key=1%3ACAS%3A528%3ADC%252BD2sXkslOqurc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2007&pages=2769-2774&author=J.+E.+Sheppeckauthor=J.+L.+Gilmoreauthor=A.+Tebbenauthor=C.+B.+Xueauthor=R.+Q.+Liuauthor=C.+P.+Deciccoauthor=J.+J.+Duan&title=Hydantoins%2C+triazolones%2C+and+imidazolones+as+selective+non-hydroxamate+inhibitors+of+tumor+necrosis+factor-alpha+converting+enzyme+%28TACE%29&doi=10.1016%2Fj.bmcl.2007.02.076"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Hydantoins, triazolones, and imidazolones as selective non-hydroxamate inhibitors of tumor necrosis factor-α converting enzyme (TACE)</span></div><div class="casAuthors">Sheppeck, James E., II; Gilmore, John L.; Tebben, Andrew; Xue, Chu-Biao; Liu, Rui-Qin; Decicco, Carl P.; Duan, James J.-W.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">2769-2774</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">We have discovered selective and potent inhibitors of TACE that replace the common hydroxamate zinc binding group with a hydantoin, triazolone, and imidazolone heterocycle.  These novel heterocyclic inhibitors of a zinc metalloprotease were designed using a pharmacophore model that we previously described while developing hydantoin and pyrimidinetrione (barbiturate) inhibitors of TACE.  The potency and binding orientation of these inhibitors is discussed and they are modeled into the X-ray crystal structure of TACE and compared to hydroxamate and earlier hydantoin TACE inhibitors which share the same 4-[(2-methyl-4-quinolinyl)methoxy]benzoyl P1' group.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpZyj_difdnHrVg90H21EOLACvtfcHk0lh2d45EUGPwzQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXkslOqurc%253D&md5=2f03480cea9a5e1c3acffa62c4361f91</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2007.02.076&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2007.02.076%26sid%3Dliteratum%253Aachs%26aulast%3DSheppeck%26aufirst%3DJ.%2BE.%26aulast%3DGilmore%26aufirst%3DJ.%2BL.%26aulast%3DTebben%26aufirst%3DA.%26aulast%3DXue%26aufirst%3DC.%2BB.%26aulast%3DLiu%26aufirst%3DR.%2BQ.%26aulast%3DDecicco%26aufirst%3DC.%2BP.%26aulast%3DDuan%26aufirst%3DJ.%2BJ.%26atitle%3DHydantoins%252C%2520triazolones%252C%2520and%2520imidazolones%2520as%2520selective%2520non-hydroxamate%2520inhibitors%2520of%2520tumor%2520necrosis%2520factor-alpha%2520converting%2520enzyme%2520%2528TACE%2529%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2007%26volume%3D17%26spage%3D2769%26epage%3D2774%26doi%3D10.1016%2Fj.bmcl.2007.02.076" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guo, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Orth, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Madison, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dai, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feltz, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Girijavallabhan, V. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kozlowski, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lavey, B. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lundell, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Niu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Piwinski, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Popovici-Muller, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rizvi, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rosner, K. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shankar, B. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shih, N. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Siddiqui, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tong, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Umland, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wong, M. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, D. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, G.</span></span> <span> </span><span class="NLM_article-title">Discovery and SAR of hydantoin TACE inhibitors</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>20</i></span>,  <span class="NLM_fpage">1877</span>– <span class="NLM_lpage">1880</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2010.01.148</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02008&amp;key=10.1016%2Fj.bmcl.2010.01.148" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02008&amp;key=20172725" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02008&amp;key=1%3ACAS%3A528%3ADC%252BC3cXivFGltLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2010&pages=1877-1880&author=W.+Yuauthor=Z.+Guoauthor=P.+Orthauthor=V.+Madisonauthor=L.+Chenauthor=C.+Daiauthor=R.+J.+Feltzauthor=V.+M.+Girijavallabhanauthor=S.+H.+Kimauthor=J.+A.+Kozlowskiauthor=B.+J.+Laveyauthor=D.+Liauthor=D.+Lundellauthor=X.+Niuauthor=J.+J.+Piwinskiauthor=J.+Popovici-Mullerauthor=R.+Rizviauthor=K.+E.+Rosnerauthor=B.+B.+Shankarauthor=N.+Y.+Shihauthor=M.+A.+Siddiquiauthor=J.+Sunauthor=L.+Tongauthor=S.+Umlandauthor=M.+K.+Wongauthor=D.+Y.+Yangauthor=G.+Zhou&title=Discovery+and+SAR+of+hydantoin+TACE+inhibitors&doi=10.1016%2Fj.bmcl.2010.01.148"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery and SAR of hydantoin TACE inhibitors</span></div><div class="casAuthors">Yu, Wensheng; Guo, Zhuyan; Orth, Peter; Madison, Vincent; Chen, Lei; Dai, Chaoyang; Feltz, Robert J.; Girijavallabhan, Vinay M.; Kim, Seong Heon; Kozlowski, Joseph A.; Lavey, Brian J.; Li, Dansu; Lundell, Daniel; Niu, Xiaoda; Piwinski, John J.; Popovici-Muller, Janeta; Rizvi, Razia; Rosner, Kristin E.; Shankar, Bandarpalle B.; Shih, Neng-Yang; Arshad Siddiqui, M.; Sun, Jing; Tong, Ling; Umland, Shelby; Wong, Michael K. C.; Yang, De-yi; Zhou, Guowei</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1877-1880</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">We disclose inhibitors of TNF-α converting enzyme (TACE) designed around a hydantoin zinc binding moiety.  Crystal structures of inhibitors bound to TACE revealed monodentate coordination of the hydantoin to the zinc.  SAR, X-ray, and modeling designs are described.  To our knowledge, these are the first reported X-ray structures of TACE with a hydantoin zinc ligand.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGri6B5mp14eEbVg90H21EOLACvtfcHk0lh2d45EUGPwzQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXivFGltLc%253D&md5=242b5a605e75157211d5917968a5ecb8</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2010.01.148&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2010.01.148%26sid%3Dliteratum%253Aachs%26aulast%3DYu%26aufirst%3DW.%26aulast%3DGuo%26aufirst%3DZ.%26aulast%3DOrth%26aufirst%3DP.%26aulast%3DMadison%26aufirst%3DV.%26aulast%3DChen%26aufirst%3DL.%26aulast%3DDai%26aufirst%3DC.%26aulast%3DFeltz%26aufirst%3DR.%2BJ.%26aulast%3DGirijavallabhan%26aufirst%3DV.%2BM.%26aulast%3DKim%26aufirst%3DS.%2BH.%26aulast%3DKozlowski%26aufirst%3DJ.%2BA.%26aulast%3DLavey%26aufirst%3DB.%2BJ.%26aulast%3DLi%26aufirst%3DD.%26aulast%3DLundell%26aufirst%3DD.%26aulast%3DNiu%26aufirst%3DX.%26aulast%3DPiwinski%26aufirst%3DJ.%2BJ.%26aulast%3DPopovici-Muller%26aufirst%3DJ.%26aulast%3DRizvi%26aufirst%3DR.%26aulast%3DRosner%26aufirst%3DK.%2BE.%26aulast%3DShankar%26aufirst%3DB.%2BB.%26aulast%3DShih%26aufirst%3DN.%2BY.%26aulast%3DSiddiqui%26aufirst%3DM.%2BA.%26aulast%3DSun%26aufirst%3DJ.%26aulast%3DTong%26aufirst%3DL.%26aulast%3DUmland%26aufirst%3DS.%26aulast%3DWong%26aufirst%3DM.%2BK.%26aulast%3DYang%26aufirst%3DD.%2BY.%26aulast%3DZhou%26aufirst%3DG.%26atitle%3DDiscovery%2520and%2520SAR%2520of%2520hydantoin%2520TACE%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2010%26volume%3D20%26spage%3D1877%26epage%3D1880%26doi%3D10.1016%2Fj.bmcl.2010.01.148" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shieh, H. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mathis, K. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Williams, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hills, R. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wiese, J. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Benson, T. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kiefer, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marino, M. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carroll, J. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leone, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Malfait, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arner, E. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tortorella, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tomasselli, A.</span></span> <span> </span><span class="NLM_article-title">High resolution crystal structure of the catalytic domain of ADAMTS-5 (aggrecanase-2)</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>283</i></span>,  <span class="NLM_fpage">1501</span>– <span class="NLM_lpage">1507</span>, <span class="refDoi"> DOI: 10.1074/jbc.M705879200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02008&amp;key=10.1074%2Fjbc.M705879200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02008&amp;key=17991750" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02008&amp;key=1%3ACAS%3A528%3ADC%252BD1cXks1eqsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=283&publication_year=2008&pages=1501-1507&author=H.+S.+Shiehauthor=K.+J.+Mathisauthor=J.+M.+Williamsauthor=R.+L.+Hillsauthor=J.+F.+Wieseauthor=T.+E.+Bensonauthor=J.+R.+Kieferauthor=M.+H.+Marinoauthor=J.+N.+Carrollauthor=J.+W.+Leoneauthor=A.+M.+Malfaitauthor=E.+C.+Arnerauthor=M.+D.+Tortorellaauthor=A.+Tomasselli&title=High+resolution+crystal+structure+of+the+catalytic+domain+of+ADAMTS-5+%28aggrecanase-2%29&doi=10.1074%2Fjbc.M705879200"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">High resolution crystal structure of the catalytic domain of ADAMTS-5 (aggrecanase-2)</span></div><div class="casAuthors">Shieh, Huey-Sheng; Mathis, Karl J.; Williams, Jennifer M.; Hills, Robert L.; Wiese, Joe F.; Benson, Timothy E.; Kiefer, James R.; Marino, Margaret H.; Carroll, Jeffery N.; Leone, Joseph W.; Malfait, Anne-Marie; Arner, Elizabeth C.; Tortorella, Micky D.; Tomasselli, Alfredo</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">283</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1501-1507</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Aggrecanase-2 [a disintegrin and metalloproteinase with thrombospondin motifs-5 (ADAMTS-5)], a member of the ADAMTS protein family, is critically involved in arthritic diseases because of its direct role in cleaving the cartilage component, aggrecan.  Here, the catalytic domain of human recombinant aggrecanase-2/ADAMTS-5 was refolded, purified, and crystd., and its 3-dimensional structure detd. to 1.4 Å resoln. in the presence of an inhibitor.  A high-resoln. structure of an aggrecanase/ADAMTS protein provides an opportunity for the development of therapeutics to treat osteoarthritis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr1HlBpxGGpr7Vg90H21EOLACvtfcHk0ljRpBG4UVLHBQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXks1eqsg%253D%253D&md5=7ccfa1927dfb72cb4c7fc4b6a2c62317</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M705879200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M705879200%26sid%3Dliteratum%253Aachs%26aulast%3DShieh%26aufirst%3DH.%2BS.%26aulast%3DMathis%26aufirst%3DK.%2BJ.%26aulast%3DWilliams%26aufirst%3DJ.%2BM.%26aulast%3DHills%26aufirst%3DR.%2BL.%26aulast%3DWiese%26aufirst%3DJ.%2BF.%26aulast%3DBenson%26aufirst%3DT.%2BE.%26aulast%3DKiefer%26aufirst%3DJ.%2BR.%26aulast%3DMarino%26aufirst%3DM.%2BH.%26aulast%3DCarroll%26aufirst%3DJ.%2BN.%26aulast%3DLeone%26aufirst%3DJ.%2BW.%26aulast%3DMalfait%26aufirst%3DA.%2BM.%26aulast%3DArner%26aufirst%3DE.%2BC.%26aulast%3DTortorella%26aufirst%3DM.%2BD.%26aulast%3DTomasselli%26aufirst%3DA.%26atitle%3DHigh%2520resolution%2520crystal%2520structure%2520of%2520the%2520catalytic%2520domain%2520of%2520ADAMTS-5%2520%2528aggrecanase-2%2529%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2008%26volume%3D283%26spage%3D1501%26epage%3D1507%26doi%3D10.1074%2Fjbc.M705879200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tortorella, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tomasselli, A. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mathis, K. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schnute, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Woodard, S. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Munie, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Williams, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Caspers, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wittwer, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Malfait, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shieh, H. S.</span></span> <span> </span><span class="NLM_article-title">Structural and inhibition analysis reveals the mechanism of selectivity of a series of aggrecanase inhibitors</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>284</i></span>,  <span class="NLM_fpage">24185</span>– <span class="NLM_lpage">24191</span>, <span class="refDoi"> DOI: 10.1074/jbc.M109.029116</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02008&amp;key=10.1074%2Fjbc.M109.029116" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02008&amp;key=19586907" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02008&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtVGgsr%252FP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=284&publication_year=2009&pages=24185-24191&author=M.+D.+Tortorellaauthor=A.+G.+Tomasselliauthor=K.+J.+Mathisauthor=M.+E.+Schnuteauthor=S.+S.+Woodardauthor=G.+Munieauthor=J.+M.+Williamsauthor=N.+Caspersauthor=A.+J.+Wittwerauthor=A.+M.+Malfaitauthor=H.+S.+Shieh&title=Structural+and+inhibition+analysis+reveals+the+mechanism+of+selectivity+of+a+series+of+aggrecanase+inhibitors&doi=10.1074%2Fjbc.M109.029116"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Structural and Inhibition Analysis Reveals the Mechanism of Selectivity of a Series of Aggrecanase Inhibitors</span></div><div class="casAuthors">Tortorella, Micky D.; Tomasselli, Alfredo G.; Mathis, Karl J.; Schnute, Mark E.; Woodard, Scott S.; Munie, Grace; Williams, Jennifer M.; Caspers, Nicole; Wittwer, Arthur J.; Malfait, Anne-Marie; Shieh, Huey-Sheng</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">284</span>
        (<span class="NLM_cas:issue">36</span>),
    <span class="NLM_cas:pages">24185-24191</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Several inhibitors of a series of cis-1(S)2(R)-amino-2-indanol-based compds. were reported to be selective for the aggrecanases, ADAMTS-4 and -5 over other metalloproteinases.  To understand the nature of this selectivity for aggrecanases, the inhibitors, along with the broad spectrum metalloproteinase inhibitor marimastat, were independently bound to the catalytic domain of ADAMTS-5, and the corresponding crystal structures were detd.  By comparing the structures, it was detd. that the specificity of the relative inhibitors for ADAMTS-5 was not driven by a specific interaction, such as zinc chelation, hydrogen bonding, or charge interactions, but rather by subtle and indirect factors, such as water bridging, ring rigidity, pocket size, and shape, as well as protein conformation flexibility.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoI39fzCSuJerVg90H21EOLACvtfcHk0ljRpBG4UVLHBQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtVGgsr%252FP&md5=86e9879fb3359bc2ad78e2ce653ea0de</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M109.029116&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M109.029116%26sid%3Dliteratum%253Aachs%26aulast%3DTortorella%26aufirst%3DM.%2BD.%26aulast%3DTomasselli%26aufirst%3DA.%2BG.%26aulast%3DMathis%26aufirst%3DK.%2BJ.%26aulast%3DSchnute%26aufirst%3DM.%2BE.%26aulast%3DWoodard%26aufirst%3DS.%2BS.%26aulast%3DMunie%26aufirst%3DG.%26aulast%3DWilliams%26aufirst%3DJ.%2BM.%26aulast%3DCaspers%26aufirst%3DN.%26aulast%3DWittwer%26aufirst%3DA.%2BJ.%26aulast%3DMalfait%26aufirst%3DA.%2BM.%26aulast%3DShieh%26aufirst%3DH.%2BS.%26atitle%3DStructural%2520and%2520inhibition%2520analysis%2520reveals%2520the%2520mechanism%2520of%2520selectivity%2520of%2520a%2520series%2520of%2520aggrecanase%2520inhibitors%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2009%26volume%3D284%26spage%3D24185%26epage%3D24191%26doi%3D10.1074%2Fjbc.M109.029116" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mosyak, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Georgiadis, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shane, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Svenson, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hebert, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McDonagh, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mackie, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olland, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhong, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kriz, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reifenberg, E. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Collins-Racie, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Corcoran, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Freeman, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zollner, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marvell, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vera, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sum, P. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lavallie, E. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stahl, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Somers, W.</span></span> <span> </span><span class="NLM_article-title">Crystal structures of the two major aggrecan degrading enzymes, ADAMTS4 and ADAMTS5</span>. <i>Protein Sci.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">16</span>– <span class="NLM_lpage">21</span>, <span class="refDoi"> DOI: 10.1110/ps.073287008</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02008&amp;key=10.1110%2Fps.073287008" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02008&amp;key=18042673" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02008&amp;key=1%3ACAS%3A528%3ADC%252BD1cXmt1CrtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2008&pages=16-21&author=L.+Mosyakauthor=K.+Georgiadisauthor=T.+Shaneauthor=K.+Svensonauthor=T.+Hebertauthor=T.+McDonaghauthor=S.+Mackieauthor=S.+Ollandauthor=L.+Linauthor=X.+Zhongauthor=R.+Krizauthor=E.+L.+Reifenbergauthor=L.+A.+Collins-Racieauthor=C.+Corcoranauthor=B.+Freemanauthor=R.+Zollnerauthor=T.+Marvellauthor=M.+Veraauthor=P.+E.+Sumauthor=E.+R.+Lavallieauthor=M.+Stahlauthor=W.+Somers&title=Crystal+structures+of+the+two+major+aggrecan+degrading+enzymes%2C+ADAMTS4+and+ADAMTS5&doi=10.1110%2Fps.073287008"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Crystal structures of the two major aggrecan degrading enzymes, ADAMTS4 and ADAMTS5</span></div><div class="casAuthors">Mosyak, Lidia; Georgiadis, Katy; Shane, Tania; Svenson, Kristine; Hebert, Tracy; Mcdonagh, Thomas; Mackie, Stewart; Olland, Stephane; Lin, Laura; Zhong, Xiaotian; Kriz, Ronald; Reifenberg, Erica L.; Collins-Racie, Lisa A.; Corcoran, Christopher; Freeman, Bethany; Zollner, Richard; Marvell, Tod; Vera, Matthew; Sum, Phaik-Eng; Lavallie, Edward R.; Stahl, Mark; Somers, William</div><div class="citationInfo"><span class="NLM_cas:title">Protein Science</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">16-21</span>CODEN:
                <span class="NLM_cas:coden">PRCIEI</span>;
        ISSN:<span class="NLM_cas:issn">0961-8368</span>.
    
            (<span class="NLM_cas:orgname">Cold Spring Harbor Laboratory Press</span>)
        </div><div class="casAbstract">Aggrecanases are now believed to be the principal proteinases responsible for aggrecan degrdn. in osteoarthritis.  Given their potential as a drug target, we solved crystal structures of the two most active human aggrecanase isoforms, ADAMTS4 and ADAMTS5, each in complex with bound inhibitor and one wherein the enzyme is in apo form.  These structures show that the unliganded and inhibitor-bound enzymes exhibit two essentially different catalytic-site configurations: an autoinhibited, nonbinding, closed form and an open, binding form.  On this basis, we propose that mature aggrecanases exist as an ensemble of at least two isomers, only one of which is proteolytically active.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoS55VRlPEB4bVg90H21EOLACvtfcHk0ljRpBG4UVLHBQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXmt1CrtA%253D%253D&md5=1cb25cc6bd0043a1881b600eb9f191be</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1110%2Fps.073287008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1110%252Fps.073287008%26sid%3Dliteratum%253Aachs%26aulast%3DMosyak%26aufirst%3DL.%26aulast%3DGeorgiadis%26aufirst%3DK.%26aulast%3DShane%26aufirst%3DT.%26aulast%3DSvenson%26aufirst%3DK.%26aulast%3DHebert%26aufirst%3DT.%26aulast%3DMcDonagh%26aufirst%3DT.%26aulast%3DMackie%26aufirst%3DS.%26aulast%3DOlland%26aufirst%3DS.%26aulast%3DLin%26aufirst%3DL.%26aulast%3DZhong%26aufirst%3DX.%26aulast%3DKriz%26aufirst%3DR.%26aulast%3DReifenberg%26aufirst%3DE.%2BL.%26aulast%3DCollins-Racie%26aufirst%3DL.%2BA.%26aulast%3DCorcoran%26aufirst%3DC.%26aulast%3DFreeman%26aufirst%3DB.%26aulast%3DZollner%26aufirst%3DR.%26aulast%3DMarvell%26aufirst%3DT.%26aulast%3DVera%26aufirst%3DM.%26aulast%3DSum%26aufirst%3DP.%2BE.%26aulast%3DLavallie%26aufirst%3DE.%2BR.%26aulast%3DStahl%26aufirst%3DM.%26aulast%3DSomers%26aufirst%3DW.%26atitle%3DCrystal%2520structures%2520of%2520the%2520two%2520major%2520aggrecan%2520degrading%2520enzymes%252C%2520ADAMTS4%2520and%2520ADAMTS5%26jtitle%3DProtein%2520Sci.%26date%3D2008%26volume%3D17%26spage%3D16%26epage%3D21%26doi%3D10.1110%2Fps.073287008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tom, R.</span>; <span class="NLM_string-name">Bisson, L.</span>; <span class="NLM_string-name">Durocher, Y.</span></span> <span> </span><span class="NLM_article-title">Transient Expression in HEK293-EBNA1 Cells</span>. In  <i>Methods Express: Expression Systems</i>, <span class="NLM_edition">1st</span> ed.; <span class="NLM_contrib-group"><span class="NLM_string-name">Dyson, M.</span>, <span class="NLM_string-name">Durocher, Y.</span></span>, Eds.; <span class="NLM_publisher-name">Scion Publishing Ltd</span>, <span class="NLM_year">2007</span>; pp  <span class="NLM_fpage">203</span>– <span class="NLM_lpage">223</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2007&pages=203-223&author=R.+Tom&author=L.+Bisson&author=Y.+Durocherauthor=M.+Dyson&author=Y.+Durocher&title=Methods+Express%3A+Expression+Systems"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DTom%26aufirst%3DR.%26atitle%3DTransient%2520Expression%2520in%2520HEK293-EBNA1%2520Cells%26btitle%3DMethods%2520Express%253A%2520Expression%2520Systems%26aulast%3DDyson%26aufirst%3DM.%26pub%3DScion%2520Publishing%2520Ltd%26date%3D2007%26spage%3D203%26epage%3D223" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Durocher, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perret, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kamen, A.</span></span> <span> </span><span class="NLM_article-title">High-Level and High-Throughput Recombinant Protein Production by Transient Transfection of Suspension-Growing Human 293-EBNA1 Cells</span>. <i>Nucleic acids research</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>30</i></span>,  <span class="NLM_fpage">9e</span>, <span class="refDoi"> DOI: 10.1093/nar/30.2.e9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02008&amp;key=10.1093%2Fnar%2F30.2.e9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02008&amp;key=1%3ACAS%3A528%3ADC%252BD38XhtFCktb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2002&pages=9e&author=Y.+Durocherauthor=S.+Perretauthor=A.+Kamen&title=High-Level+and+High-Throughput+Recombinant+Protein+Production+by+Transient+Transfection+of+Suspension-Growing+Human+293-EBNA1+Cells&doi=10.1093%2Fnar%2F30.2.e9"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">High-level and high-throughput recombinant protein production by transient transfection of suspension-growing human 293-EBNA1 cells</span></div><div class="casAuthors">Durocher, Yves; Perret, Sylvie; Kamen, Amine</div><div class="citationInfo"><span class="NLM_cas:title">Nucleic Acids Research</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">30</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">e9/1-e9/9</span>CODEN:
                <span class="NLM_cas:coden">NARHAD</span>;
        ISSN:<span class="NLM_cas:issn">0305-1048</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">A scalable transfection procedure using polyethylenimine (PEI) is described for the human embryonic kidney 293 cell line grown in suspension.  Green fluorescent protein (GFP) and human placental secreted alk. phosphatase (SEAP) were used as reporter genes to monitor transfection efficiency and productivity.  Up to 75% of GFP-pos. cells were obtained using linear or branched 25 kDa PEI.  The 293 cell line and two genetic variants, either expressing the SV40 large T-antigen (293T) or the Epstein-Barr virus (EBV) EBNA1 protein (293E), were tested for protein expression.  The highest expression level was obtained with 293E cells using the EBV oriP-contg. plasmid pCEP4.  We designed the pTT vector, an oriP-based vector having an improved cytomegalovirus expression cassette.  Using this vector, 10- and 3-fold increases in SEAP expression was obtained In 293E cells compared with pcDNA3.1 and pCEP4 vectors, resp.  The presence of serum had a pos. effect on gene transfer and expression.  Transfection of suspension-growing cells was more efficient with linear PEI and was not affected by the presence of medium conditioned for 24 h.  Using the pTT vector, >20 mg/l of purified His-tagged SEAP was recovered from a 3.5 I bioreactor.  Intracellular proteins were also produced at levels as high as 50 mg/l, representing up to 20% of total cell proteins.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrU-3OCtMsZRLVg90H21EOLACvtfcHk0ljNP8myJypt-Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XhtFCktb4%253D&md5=feb0b6451bdc147622a7017b7ed65efd</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1093%2Fnar%2F30.2.e9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fnar%252F30.2.e9%26sid%3Dliteratum%253Aachs%26aulast%3DDurocher%26aufirst%3DY.%26aulast%3DPerret%26aufirst%3DS.%26aulast%3DKamen%26aufirst%3DA.%26atitle%3DHigh-Level%2520and%2520High-Throughput%2520Recombinant%2520Protein%2520Production%2520by%2520Transient%2520Transfection%2520of%2520Suspension-Growing%2520Human%2520293-EBNA1%2520Cells%26jtitle%3DNucleic%2520acids%2520research%26date%3D2002%26volume%3D30%26spage%3D9e%26doi%3D10.1093%2Fnar%2F30.2.e9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Joncour, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Desroy, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Housseman, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bock, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bienvenu, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cherel, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Labeguere, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peixoto, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Annoot, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lepissier, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heiermann, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hengeveld, W. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pilzak, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Monjardet, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wakselman, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roncoroni, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Le Tallec, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Galien, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">David, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vandervoort, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Christophe, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Conrath, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jans, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wohlkonig, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Soror, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Steyaert, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Touitou, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fleury, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vercheval, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mollat, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Triballeau, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van der Aar, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brys, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heckmann, B.</span></span> <span> </span><span class="NLM_article-title">Discovery, structure-activity relationship, and binding mode of an imidazo[1,2-a]pyridine series of autotaxin inhibitors</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">7371</span>– <span class="NLM_lpage">7392</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.7b00647</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b00647" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02008&amp;key=1%3ACAS%3A528%3ADC%252BC2sXht1WitLvN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=7371-7392&author=A.+Joncourauthor=N.+Desroyauthor=C.+Houssemanauthor=X.+Bockauthor=N.+Bienvenuauthor=L.+Cherelauthor=V.+Labeguereauthor=C.+Peixotoauthor=D.+Annootauthor=L.+Lepissierauthor=J.+Heiermannauthor=W.+J.+Hengeveldauthor=G.+Pilzakauthor=A.+Monjardetauthor=E.+Wakselmanauthor=V.+Roncoroniauthor=S.+Le+Tallecauthor=R.+Galienauthor=C.+Davidauthor=N.+Vandervoortauthor=T.+Christopheauthor=K.+Conrathauthor=M.+Jansauthor=A.+Wohlkonigauthor=S.+Sororauthor=J.+Steyaertauthor=R.+Touitouauthor=D.+Fleuryauthor=L.+Verchevalauthor=P.+Mollatauthor=N.+Triballeauauthor=E.+van+der+Aarauthor=R.+Brysauthor=B.+Heckmann&title=Discovery%2C+structure-activity+relationship%2C+and+binding+mode+of+an+imidazo%5B1%2C2-a%5Dpyridine+series+of+autotaxin+inhibitors&doi=10.1021%2Facs.jmedchem.7b00647"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery, Structure-Activity Relationship, and Binding Mode of an Imidazo[1,2-a]pyridine Series of Autotaxin Inhibitors</span></div><div class="casAuthors">Joncour, Agnes; Desroy, Nicolas; Housseman, Christopher; Bock, Xavier; Bienvenu, Natacha; Cherel, Laetitia; Labeguere, Virginie; Peixoto, Christophe; Annoot, Denis; Lepissier, Luce; Heiermann, Jorg; Hengeveld, Willem Jan; Pilzak, Gregor; Monjardet, Alain; Wakselman, Emanuelle; Roncoroni, Veronique; Le Tallec, Sandrine; Galien, Rene; David, Christelle; Vandervoort, Nele; Christophe, Thierry; Conrath, Katja; Jans, Mia; Wohlkonig, Alexandre; Soror, Sameh; Steyaert, Jan; Touitou, Robert; Fleury, Damien; Vercheval, Lionel; Mollat, Patrick; Triballeau, Nicolas; van der Aar, Ellen; Brys, Reginald; Heckmann, Bertrand</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">7371-7392</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Autotaxin (ATX) is a secreted enzyme playing a major role in the prodn. of lysophosphatidic acid (LPA) in blood through hydrolysis of lysophosphatidyl choline (LPC).  The ATX-LPA signaling axis arouses a high interest in the drug discovery industry as it has been implicated in several diseases including cancer, fibrotic diseases and inflammation among others.  An imidazo[1,2-a]pyridine series of ATX inhibitors was identified out of a high throughput screening (HTS).  A co-crystal structure with one of these compds. and ATX revealed a novel binding mode with occupancy of the hydrophobic pocket and channel of ATX but no interaction with zinc ions of the catalytic site.  Exploration of the structure-activity relationship led to compds. displaying high activity in biochem. and plasma assays, exemplified by compd. I.  Compd. I was also able to decrease the plasma LPA levels upon oral administration to rats.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpY6dK8UCSEyLVg90H21EOLACvtfcHk0liJl04wegJHaQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXht1WitLvN&md5=2c08b3017e0bc0183c9e8e1911ddab0d</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b00647&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b00647%26sid%3Dliteratum%253Aachs%26aulast%3DJoncour%26aufirst%3DA.%26aulast%3DDesroy%26aufirst%3DN.%26aulast%3DHousseman%26aufirst%3DC.%26aulast%3DBock%26aufirst%3DX.%26aulast%3DBienvenu%26aufirst%3DN.%26aulast%3DCherel%26aufirst%3DL.%26aulast%3DLabeguere%26aufirst%3DV.%26aulast%3DPeixoto%26aufirst%3DC.%26aulast%3DAnnoot%26aufirst%3DD.%26aulast%3DLepissier%26aufirst%3DL.%26aulast%3DHeiermann%26aufirst%3DJ.%26aulast%3DHengeveld%26aufirst%3DW.%2BJ.%26aulast%3DPilzak%26aufirst%3DG.%26aulast%3DMonjardet%26aufirst%3DA.%26aulast%3DWakselman%26aufirst%3DE.%26aulast%3DRoncoroni%26aufirst%3DV.%26aulast%3DLe%2BTallec%26aufirst%3DS.%26aulast%3DGalien%26aufirst%3DR.%26aulast%3DDavid%26aufirst%3DC.%26aulast%3DVandervoort%26aufirst%3DN.%26aulast%3DChristophe%26aufirst%3DT.%26aulast%3DConrath%26aufirst%3DK.%26aulast%3DJans%26aufirst%3DM.%26aulast%3DWohlkonig%26aufirst%3DA.%26aulast%3DSoror%26aufirst%3DS.%26aulast%3DSteyaert%26aufirst%3DJ.%26aulast%3DTouitou%26aufirst%3DR.%26aulast%3DFleury%26aufirst%3DD.%26aulast%3DVercheval%26aufirst%3DL.%26aulast%3DMollat%26aufirst%3DP.%26aulast%3DTriballeau%26aufirst%3DN.%26aulast%3Dvan%2Bder%2BAar%26aufirst%3DE.%26aulast%3DBrys%26aufirst%3DR.%26aulast%3DHeckmann%26aufirst%3DB.%26atitle%3DDiscovery%252C%2520structure-activity%2520relationship%252C%2520and%2520binding%2520mode%2520of%2520an%2520imidazo%255B1%252C2-a%255Dpyridine%2520series%2520of%2520autotaxin%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26spage%3D7371%26epage%3D7392%26doi%3D10.1021%2Facs.jmedchem.7b00647" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Swearingen, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carpenter, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Siegel, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brittain, I. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dotzlaf, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Durham, T. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Toth, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Laska, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marimuthu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brown, D. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carter, Q. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wiley, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duffin, K. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mitchell, P. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thirunavukkarasu, K.</span></span> <span> </span><span class="NLM_article-title">Development of a novel clinical biomarker assay to detect and quantify aggrecanase-generated aggrecan fragments in human synovial fluid, serum and urine</span>. <i>Osteoarthritis and cartilage</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>18</i></span>,  <span class="NLM_fpage">1150</span>– <span class="NLM_lpage">1158</span>, <span class="refDoi"> DOI: 10.1016/j.joca.2010.06.011</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02008&amp;key=10.1016%2Fj.joca.2010.06.011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02008&amp;key=20633682" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02008&amp;key=1%3ACAS%3A280%3ADC%252BC3cjoslCmtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2010&pages=1150-1158&author=C.+A.+Swearingenauthor=J.+W.+Carpenterauthor=R.+Siegelauthor=I.+J.+Brittainauthor=J.+Dotzlafauthor=T.+B.+Durhamauthor=J.+L.+Tothauthor=D.+A.+Laskaauthor=J.+Marimuthuauthor=C.+Liuauthor=D.+P.+Brownauthor=Q.+L.+Carterauthor=M.+R.+Wileyauthor=K.+L.+Duffinauthor=P.+G.+Mitchellauthor=K.+Thirunavukkarasu&title=Development+of+a+novel+clinical+biomarker+assay+to+detect+and+quantify+aggrecanase-generated+aggrecan+fragments+in+human+synovial+fluid%2C+serum+and+urine&doi=10.1016%2Fj.joca.2010.06.011"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Development of a novel clinical biomarker assay to detect and quantify aggrecanase-generated aggrecan fragments in human synovial fluid, serum and urine</span></div><div class="casAuthors">Swearingen C A; Carpenter J W; Siegel R; Brittain I J; Dotzlaf J; Durham T B; Toth J L; Laska D A; Marimuthu J; Liu C; Brown D P; Carter Q L; Wiley M R; Duffin K L; Mitchell P G; Thirunavukkarasu K</div><div class="citationInfo"><span class="NLM_cas:title">Osteoarthritis and cartilage</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1150-8</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">OBJECTIVE:  Proteolytic degradation of aggrecan in articular cartilage is a hallmark feature of osteoarthritis (OA).  The present study was aimed at developing a sensitive enzyme linked immunosorbent assay (ELISA) for the detection of aggrecanase-cleaved fragments of aggrecan in human serum and urine to facilitate the clinical development of aggrecanase inhibitors for OA.  METHODS:  The BC3 monoclonal antibody that detects the ARGS neoepitope sequence in aggrecanase-cleaved aggrecan was engineered and optimized using complementarity determining region (CDR)-saturation mutagenesis to improve its binding affinity to the neoepitope.  A sandwich ELISA (BC3-C2 ELISA) was developed using the optimized alpha-ARGS antibody (BC3-C2) as capture antibody and a commercially available antibody directed against the hyaluronic-acid binding region (HABR) of aggrecan as detection antibody.  Aggrecanase-cleaved fragments of aggrecan present in in vitro digests, human cartilage explant culture supernatants and in human synovial fluid, serum and urine were detected and quantified using this ELISA.  RESULTS:  The optimized antibody had a 4-log improvement in affinity for the ARGS containing peptide compared to the parental BC3 antibody, while maintaining the ability to not cross-react with a spanning peptide.  The BC3-C2 ELISA demonstrated the ability to detect aggrecanase-cleaved aggrecan fragments in the native state, without the need for deglycosylation.  This ELISA was able to measure aggrecanase-generated ARGS containing aggrecan fragments in human articular cartilage (HAC) explant cultures in the basal state (without cytokine stimulation).  Treatment with an aggrecanase inhibitor resulted in a dose-dependent inhibition of ARGS neoepitope released into the culture supernatant.  The ELISA assay also enabled the detection of ARGS containing fragments in human synovial fluid, serum and urine, suggesting its potential utility as a biomarker of aggrecanase activity.  CONCLUSIONS:  We have developed a novel ELISA using an optimized ARGS antibody and have demonstrated for the first time, an ELISA-based measurement of aggrecan degradation products in human serum and urine.  This assay has the potential to serve as a mechanistic drug activity biomarker in the clinic and is expected to significantly impact/accelerate the clinical development of aggrecanase inhibitors and other disease modifying drugs for OA.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRxFBliClGwChpyrDyM_m9cfW6udTcc2eYjxyHGRGU9xrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3cjoslCmtA%253D%253D&md5=ee9aef4ee3b013250ce95a1825bd89d7</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1016%2Fj.joca.2010.06.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.joca.2010.06.011%26sid%3Dliteratum%253Aachs%26aulast%3DSwearingen%26aufirst%3DC.%2BA.%26aulast%3DCarpenter%26aufirst%3DJ.%2BW.%26aulast%3DSiegel%26aufirst%3DR.%26aulast%3DBrittain%26aufirst%3DI.%2BJ.%26aulast%3DDotzlaf%26aufirst%3DJ.%26aulast%3DDurham%26aufirst%3DT.%2BB.%26aulast%3DToth%26aufirst%3DJ.%2BL.%26aulast%3DLaska%26aufirst%3DD.%2BA.%26aulast%3DMarimuthu%26aufirst%3DJ.%26aulast%3DLiu%26aufirst%3DC.%26aulast%3DBrown%26aufirst%3DD.%2BP.%26aulast%3DCarter%26aufirst%3DQ.%2BL.%26aulast%3DWiley%26aufirst%3DM.%2BR.%26aulast%3DDuffin%26aufirst%3DK.%2BL.%26aulast%3DMitchell%26aufirst%3DP.%2BG.%26aulast%3DThirunavukkarasu%26aufirst%3DK.%26atitle%3DDevelopment%2520of%2520a%2520novel%2520clinical%2520biomarker%2520assay%2520to%2520detect%2520and%2520quantify%2520aggrecanase-generated%2520aggrecan%2520fragments%2520in%2520human%2520synovial%2520fluid%252C%2520serum%2520and%2520urine%26jtitle%3DOsteoarthritis%2520and%2520cartilage%26date%3D2010%26volume%3D18%26spage%3D1150%26epage%3D1158%26doi%3D10.1016%2Fj.joca.2010.06.011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Davis, I. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leaver-Fay, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, V. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Block, J. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kapral, G. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murray, L. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arendall, W. B.,  3rd</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Snoeyink, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Richardson, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Richardson, D. C.</span></span> <span> </span><span class="NLM_article-title">MolProbity: all-atom contacts and structure validation for proteins and nucleic acids</span>. <i>Nucleic Acids Res.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>35</i></span>,  <span class="NLM_fpage">W375</span>– <span class="NLM_lpage">383</span>, <span class="refDoi"> DOI: 10.1093/nar/gkm216</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02008&amp;key=10.1093%2Fnar%2Fgkm216" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02008&amp;key=17452350" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02008&amp;key=1%3ACAS%3A280%3ADC%252BD2svhsVGhtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=2007&pages=W375-383&author=I.+W.+Davisauthor=A.+Leaver-Fayauthor=V.+B.+Chenauthor=J.+N.+Blockauthor=G.+J.+Kapralauthor=X.+Wangauthor=L.+W.+Murrayauthor=W.+B.+Arendallauthor=J.+Snoeyinkauthor=J.+S.+Richardsonauthor=D.+C.+Richardson&title=MolProbity%3A+all-atom+contacts+and+structure+validation+for+proteins+and+nucleic+acids&doi=10.1093%2Fnar%2Fgkm216"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">MolProbity: all-atom contacts and structure validation for proteins and nucleic acids</span></div><div class="casAuthors">Davis Ian W; Leaver-Fay Andrew; Chen Vincent B; Block Jeremy N; Kapral Gary J; Wang Xueyi; Murray Laura W; Arendall W Bryan 3rd; Snoeyink Jack; Richardson Jane S; Richardson David C</div><div class="citationInfo"><span class="NLM_cas:title">Nucleic acids research</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">35</span>
        (<span class="NLM_cas:issue">Web Server issue</span>),
    <span class="NLM_cas:pages">W375-83</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">MolProbity is a general-purpose web server offering quality validation for 3D structures of proteins, nucleic acids and complexes.  It provides detailed all-atom contact analysis of any steric problems within the molecules as well as updated dihedral-angle diagnostics, and it can calculate and display the H-bond and van der Waals contacts in the interfaces between components.  An integral step in the process is the addition and full optimization of all hydrogen atoms, both polar and nonpolar.  New analysis functions have been added for RNA, for interfaces, and for NMR ensembles.  Additionally, both the web site and major component programs have been rewritten to improve speed, convenience, clarity and integration with other resources.  MolProbity results are reported in multiple forms: as overall numeric scores, as lists or charts of local problems, as downloadable PDB and graphics files, and most notably as informative, manipulable 3D kinemage graphics shown online in the KiNG viewer.  This service is available free to all users at http://molprobity.biochem.duke.edu.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRuyhuetoNS59bHMBt0mMIXfW6udTcc2eYjxyHGRGU9xrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2svhsVGhtQ%253D%253D&md5=726ca1e7e162ab2a4a05048f493731fb</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1093%2Fnar%2Fgkm216&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fnar%252Fgkm216%26sid%3Dliteratum%253Aachs%26aulast%3DDavis%26aufirst%3DI.%2BW.%26aulast%3DLeaver-Fay%26aufirst%3DA.%26aulast%3DChen%26aufirst%3DV.%2BB.%26aulast%3DBlock%26aufirst%3DJ.%2BN.%26aulast%3DKapral%26aufirst%3DG.%2BJ.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DMurray%26aufirst%3DL.%2BW.%26aulast%3DArendall%26aufirst%3DW.%2BB.%26aulast%3DSnoeyink%26aufirst%3DJ.%26aulast%3DRichardson%26aufirst%3DJ.%2BS.%26aulast%3DRichardson%26aufirst%3DD.%2BC.%26atitle%3DMolProbity%253A%2520all-atom%2520contacts%2520and%2520structure%2520validation%2520for%2520proteins%2520and%2520nucleic%2520acids%26jtitle%3DNucleic%2520Acids%2520Res.%26date%3D2007%26volume%3D35%26spage%3DW375%26epage%3D383%26doi%3D10.1093%2Fnar%2Fgkm216" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lai, L.</span></span> <span> </span><span class="NLM_article-title">Computation of octanol-water partition coefficients by guiding an additive model with knowledge</span>. <i>J. Chem. Inf. Model.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>47</i></span>,  <span class="NLM_fpage">2140</span>– <span class="NLM_lpage">2148</span>, <span class="refDoi"> DOI: 10.1021/ci700257y</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ci700257y" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02008&amp;key=1%3ACAS%3A528%3ADC%252BD2sXht1KisbvF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2007&pages=2140-2148&author=T.+Chengauthor=Y.+Zhaoauthor=X.+Liauthor=F.+Linauthor=Y.+Xuauthor=X.+Zhangauthor=Y.+Liauthor=R.+Wangauthor=L.+Lai&title=Computation+of+octanol-water+partition+coefficients+by+guiding+an+additive+model+with+knowledge&doi=10.1021%2Fci700257y"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Computation of Octanol-Water Partition Coefficients by Guiding an Additive Model with Knowledge</span></div><div class="casAuthors">Cheng, Tiejun; Zhao, Yuan; Li, Xun; Lin, Fu; Xu, Yong; Zhang, Xinglong; Li, Yan; Wang, Renxiao; Lai, Luhua</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Chemical Information and Modeling</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">47</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">2140-2148</span>CODEN:
                <span class="NLM_cas:coden">JCISD8</span>;
        ISSN:<span class="NLM_cas:issn">1549-9596</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">We have developed a new method, i.e., XLOGP3, for logP computation.  XLOGP3 predicts the logP value of a query compd. by using the known logP value of a ref. compd. as a starting point.  The difference in the logP values of the query compd. and the ref. compd. is then estd. by an additive model.  The additive model implemented in XLOGP3 uses a total of 87 atom/group types and two correction factors as descriptors.  It is calibrated on a training set of 8199 org. compds. with reliable logP data through a multivariate linear regression anal.  For a given query compd., the compd. showing the highest structural similarity in the training set will be selected as the ref. compd.  Structural similarity is quantified based on topol. torsion descriptors.  XLOGP3 has been tested along with its predecessor, i.e., XLOGP2, as well as several popular logP methods on two independent test sets: one contains 406 small-mol. drugs approved by the FDA and the other contains 219 oligopeptides.  On both test sets, XLOGP3 produces more accurate predictions than most of the other methods with av. unsigned errors of 0.24-0.51 units.  Compared to conventional additive methods, XLOGP3 does not rely on an extensive classification of fragments and correction factors in order to improve accuracy.  It is also able to utilize the ever-increasing exptl. measured logP data more effectively.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrUq0p6A6frurVg90H21EOLACvtfcHk0lia49Tj2_CTVw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXht1KisbvF&md5=492b857ffa462283dace225c7dcb9ad5</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1021%2Fci700257y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fci700257y%26sid%3Dliteratum%253Aachs%26aulast%3DCheng%26aufirst%3DT.%26aulast%3DZhao%26aufirst%3DY.%26aulast%3DLi%26aufirst%3DX.%26aulast%3DLin%26aufirst%3DF.%26aulast%3DXu%26aufirst%3DY.%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DWang%26aufirst%3DR.%26aulast%3DLai%26aufirst%3DL.%26atitle%3DComputation%2520of%2520octanol-water%2520partition%2520coefficients%2520by%2520guiding%2520an%2520additive%2520model%2520with%2520knowledge%26jtitle%3DJ.%2520Chem.%2520Inf.%2520Model.%26date%3D2007%26volume%3D47%26spage%3D2140%26epage%3D2148%26doi%3D10.1021%2Fci700257y" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><div class="accessionCode mb-5"><div class="toolbar-section accession-codes"><ul><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3B8Z" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3B8Z','PDB','3B8Z'); return false;">PDB: 3B8Z</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3L0%2520V" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3L0%2520V','PDB','3L0%20V'); return false;">PDB: 3L0 V</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6YJM" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6YJM','PDB','6YJM'); return false;">PDB: 6YJM</a></li></ul></div></div><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i64"><a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.0c02008">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_86724"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge at <a class="ext-link" href="/doi/10.1021/acs.jmedchem.0c02008?goto=supporting-info">https://pubs.acs.org/doi/10.1021/acs.jmedchem.0c02008</a>.<ul id="rightTab-silist" class="NLM_list-list_type-label"><li><p class="inline">Details of data collection, processing, and structure-refinement statistics for the protein crystal structure of ADAMTS-5 in complex with inhibitor GLPG1972/S201086; correlation between inhibitory activity (IC<sub>50</sub>, nM) in rn- and hs-ADAMTS-5 preparations; synthetic procedures; and characterization of compounds (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.0c02008/suppl_file/jm0c02008_si_001.pdf">PDF</a>)</p></li><li><p class="inline">Molecular formula string (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.0c02008/suppl_file/jm0c02008_si_002.csv">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.0c02008/suppl_file/jm0c02008_si_001.pdf">jm0c02008_si_001.pdf (1.01 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.0c02008/suppl_file/jm0c02008_si_002.csv">jm0c02008_si_002.csv (8.12 kb)</a></li></ul></div></div><span class="author-information-subsection-header">Accession Codes</span><p class="last">PDB ID <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6YJM">6YJM</a>, GLPG1972 in ADAMTS-5; PDB ID <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3B8Z">3B8Z</a>: compound <b>1</b> in ADAMTS-5. Authors will release the atomic coordinates and experimental data upon article publication.</p><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.0c02008&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2021.64.issue-6%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.0c02008" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.0c02008" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                5MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"677b38526dc32440","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
